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ABSTRACT 
KELBY O. KIZER: Role of the yeast histone methyltransferase Set2 and its regulatory 
domains in RNA polymerase II transcription 
(Under the direction of Dr. Brian Strahl) 
 
 Eukaryotic transcription requires the careful regulation of chromatin structure in order 
to allow access of RNA polymerase II (RNAPII) to DNA.  Histone modifications are well 
established as regulators of chromatin structure and gene transcription.  Although the 
influences of histone acetylation and phosphorylation have been investigated extensiviely, 
the role of histone methylation has recently become a topic of intense study in the field of 
chromatin biology.  The newly discovered histone H3 methylase Set2 is the sole enzyme in 
yeast responsible for H3 lysine 36 (K36) methylation.  Although earlier work suggested a 
role for Set2 and K36 methylation in transcriptional repression, the role of K36 methylation in 
yeast remained largely unexplored.  Through the studies presented here, we have identified 
and characterized a link between Set2 and actively transcribing RNA polymerase II 
(RNAPII).  Importantly, in Chapter 2 we present data identifying a novel domain in Set2 that 
is responsible for interaction with RNAPII.  Further analysis of this domain revealed its 
presence in a number of Set2 homologues in other species, thereby stimulating further 
studies of the role of Set2 and K36 methylation in gene transcription across multiple 
organisms.  
 In addition to studies of the downstream roles of Set2 and K36 methylation in 
transcription, in Chapter 3 we describe our investigation into a network of proteins that are 
involved in the upstream regulation of Set2.  These studies suggest an important link 
 iii
between the regulation of nucleosome conformation and subsequent K36 methylation, 
further supported by concurrent studies from other laboratories.  Through our studies of 
Set2 and histone methylation, we also developed and improved several experimental 
methods that are presented in Chapter 4.  Finally, in Chapter 5 we describe the 
contributions of our work in the larger context of recent studies from other laboratories.  We 
also discuss relevant questions for future work regarding Set2 as well as histone 
modifications in general.  
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CHAPTER 1 
 
 
INTRODUCTION 
 2
1.1 Overview of chromatin 
 
The existence of chromatin was predicted over a century ago, however its 
importance was largely overlooked until the mid 20th century.  Over the past century, 
dramatic evidence was uncovered which implicates chromatin in the control of genome 
integrity and activity.  Here we describe relevant history of predictions, observations, and 
conclusions regarding chromatin and its role in the regulation of gene transcription. 
Discovery of chromatin 
In the late 19th century, following the first isolations of nuclear components and the 
observation of chromosome segregation during mitosis, Walther Flemming hypothesized 
that a type of scaffold exists which supports the key nuclear materials (Flemming, 1882).  
The term “chromatin” was coined based on the dye-affinity of this nuclear matrix and in 
reference to this theoretical scaffold.  Following the identification of chromatin and 
chromosomes, much scientific effort focused on uncovering details of the fundamental 
carrier of genetic information.  A potential influence of chromatin in the ‘central dogma’ of the 
genetic code was largely overlooked when Watson and Crick first published the structure of 
DNA. (Watson and Crick, 1953a; Watson and Crick, 1953b).  
Histones, the building block of chromatin 
Chromatin composes a balancing act between efficiency of packing and accessibility 
that is carefully maintained in the nucleus of every eukaryotic cell.  In humans, 
approximately 2 m of DNA is condensed within a 6 µm nucleus (Orphanides and Reinberg, 
2000).  Using an analogy, this condensation is roughly equivalent to 2 km of 16 gauge wire 
coiled into a 6 mm diameter sphere.  This compaction is accomplished through an 
association between DNA and specialized proteins known as histones, that ultimately result 
in the formation of chromosomes.  Although histones were discovered just two years after 
Flemming published his chromatin hypothesis, it was nearly one hundred years before 
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histones again became the subject of intense study (Kossel, 1884; Ciba Foundation Study 
Group No.24, 1966; Kornberg and Lorch, 1999).  
In the early 1960s, Bonner and Butler found that histones affected the transcription of 
DNA by RNA polymerase II (Huang and Bonner, 1962; Butler, 1965).  This discovery led to 
many exciting studies to determine the means by which histones and DNA interact to form a 
chromosome.  Through the following two decades five unique types of histones were 
identified, known as Histone 2A (H2A), Histone 2B (H2B), Histone 3 (H3), Histone 4 (H4), 
and the linker Histone 1 (H1) (Phillips and Johns, 1965; Kornberg, 1977; Kornberg and 
Lorch, 1999).  Early X-ray structural data indicated that a regular, repeating structure existed 
along the length of chromatin fibers, while in vitro reconstitution experiments indicated that 
four forms of the histones (H2A, H2B, H3 and H4) associate to form a tetramer (Kornberg 
and Thomas, 1974).  Furthermore, histone tetramers were found to associate into an 
octamer of histones, known as the nucleosome.  Approximately 147 base pairs of DNA wrap 
around a nucleosome, compacting DNA and ultimately forming the higher-order structure of 
chromatin as diagrammed in Figure 1.1 (Kornberg and Thomas, 1974; Oudet et al., 1975; 
Kornberg, 1977; Felsenfeld, 1978; Hansen, 2002).  When the nucleosome composition was 
first identified, it remained unclear how this structure would impact DNA replication and 
transcription.  
 
1.2 Transcription through chromatin 
A crucial function of chromatin is the packaging of DNA into an environment that is 
not easily accessible to other protein complexes that require access to the genome.  
Researchers in the late 1960’s discovered that the histone proteins could affect RNA 
polymerase activity on DNA templates, a clue that implicated histones in the regulation of 
gene expression (Huang and Bonner, 1962; Butler, 1965).  Evidence continued to mount 
which ultimately demonstrated that the histone proteins are crucial dynamic components in 
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the regulation of gene transcription (Felsenfeld, 1978; Williamson and Felsenfeld, 1978; 
Grunstein, 1990; Workman and Kingston, 1998; Orphanides and Reinberg, 2000).  Prior to 
gene transcription, therefore, chromatin must first be unraveled in order for RNA polymerase 
and other transcription factors to gain access to the DNA template (van Holde et al., 1992; 
Workman and Kingston, 1998; Kornberg and Lorch, 1999; Sims, III et al., 2004).  Continuing 
with the earlier analogy of DNA as a wire: it is not sufficient to simply compact the wire, but 
rather mechanisms must exist for the controlled loosening at particular regions such that 
writing on the wire (that represent the DNA sequence) could actually be visible.  This 
‘balancing act’ of chromatin involves the protection of DNA through compaction, while also 
allowing regulated structural changes necessary for transcription.  
RNA polymerase II transcription 
Transcription of DNA to mRNA requires recruitment of RNA polymerase II (RNAPII) 
and a variety of transcription factors.  Transcription is accomplished through three general 
phases: 1) initiation, where transcription factors and chromatin structure allow RNAPII to 
assemble and the nascent mRNA is capped; 2) elongation, where RNAPII processivity is 
maintained through the body of a gene by the actions of various transcription factors that 
assist RNAPII in maintenance of the chromatin environment; and 3) termination, where the 
DNA sequence and RNAPII-associated proteins signal for the addition of the 
polyadenylation signal and the dissociation of RNAPII (Lee and Young, 2000; Orphanides 
and Reinberg, 2000; Orphanides and Reinberg, 2002).  Eukaryotic RNAPII is composed of 
twelve subunits, named Rpb1 to Rpb12 in order of decreasing size (Corden, 1990; Young, 
1991).  The largest RNAPII subunit, Rpb1, contains a unique sequence at its C-terminus, 
known as the Carboxy Terminal Domain (CTD).  This CTD is composed of a heptad 
sequence that is repeated in tandem 26 times in the yeast Saccharomyces cerevisiae and 
52 in mammals (Lee and Greenleaf, 1989).  Despite the differences in the number of 
repeats, and the unstructured nature of this “domain”, it is highly conserved across 
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eukaryotes.  Transcription factors, including many involved in mRNA processing, are known 
to bind to the RNAPII-CTD (Komarnitsky et al., 2000; Morris et al., 1999; Morris and 
Greenleaf, 2000; Schroeder et al., 2000).  Therefore, this domain is thought to be a “binding 
platform” through which other as-yet-unidentified proteins may bind and influence 
transcription.   
The phosphorylation state of the CTD is significant to our understanding of RNAPII 
function.  The CTD is highly phosphorylated during active transcription, while non-
transcribing Rpb1 is unphosphorylated (Cadena and Dahmus, 1987; Weeks et al., 1993).  
Phosphorylated RNAPII does not exist as a homogenous population, however, but rather is 
marked with a particular phosphorylation pattern along the CTD corresponding to the phase 
of transcription.  Based on the numbering system assigned to the heptapeptad repeat 
sequence (Y1S2P3T4S5P6S7), the serines at positions two (Ser2) and five (Ser5) within the 
CTD are differentially phosphorylated during transcription, with Ser5 phosphorylation found 
most densely during initiation and early elongation while phosphorylated Ser2 is found 
preferentially during the elongation and termination phases of transcription (for current 
review, see (Phatnani and Greenleaf, 2006).  The kinases that are responsible for the Ser2 
or Ser5 phosphorylation states in yeast have been identified as Ctk1 and Kin28, respectively 
(Hengartner et al., 1998; Lee and Greenleaf, 1989).  A crucial component of RNAPII 
transcription is the regulation of nucleosome positions along genes.  As nucleosomes are  
known to be inhibitory for RNAPII association and activity along genes, the regulation of 
chromatin structure is a primary mechanism by which gene activity can be regulated (Butler, 
1965; Grunstein, 1990; Huang and Bonner, 1962; Williamson and Felsenfeld, 1978; 
Workman and Kingston, 1998).  This is demonstrated by the two general forms of chromatin, 
euchromatin and heterochromatin.  
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Heterochromatin and euchromatin 
 In general, eukaryotic chromatin can be classified according to two forms, known as 
heterochromatin and euchromatin.  Heterochromatin consists of the most tightly packed 
form of chromatin, where access to the DNA is limited and transcription is generally 
repressed, in part due to the increased nucleosome density at those regions (Morse, 1993; 
Williamson and Felsenfeld, 1978; Workman and Kingston, 1998; Workman, 2006).  Studies 
in Drosophila melanogaster ascribed the property of transcription repression to 
heterochromatin (Eissenberg et al., 1990; Hediger and Gasser, 2006; James and Elgin, 
1986; Wallrath and Elgin, 1995).  In contrast to heterochromatin, euchromatin consists of 
lightly packed nucleosomes and allows easier access of RNAPII to DNA, resulting in a 
region of active transcription.  In most organisms, heterochromatin exists near telomeres 
and the chromosome centromeres.  Mammalian heterochromatin occurs in a wide variety of 
regions, including large portions of the Y chromosome of males and the inactivated X 
chromosome in females (Heard and Disteche, 2006).  In contrast, the active X chromosome 
in female mammals is characterized as largely euchromatin.  A wide array of chromatin-
associated proteins exist, some of which bind preferentially to a particular chromatin state 
(Mellor, 2006a).  One example of this specificity is heterochromatin protein 1 (HP1) in 
humans, which is generally associated with heterochromatin or repressed genes in 
euchromatic regions (Hediger and Gasser, 2006; Hiragami and Festenstein, 2005).  
Budding yeast, like higher eukaryotes, contains euchromatic and heterochromatic-like 
regions.  Unlike higher eukaryotes however, almost the entirety of budding yeast’s genome 
exists as euchromatin.  The regions in yeast most resembling heterochromatin are the silent 
mating type loci and sub-telomeric regions (Aparicio et al., 1991; Chien et al., 1993; Loo and 
Rine, 1994; Rusche et al., 2003; Thompson et al., 1993).  Alteration of chromatin structure is 
known to occur, in part, through the binding of transcription factors to euchromatin regions 
which disrupts nucleosomes, thereby enhancing transcription initiation at these regions 
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(Morse, 1993; Workman, 2006).  In addition, chromatin structure can be altered by the 
nucleosome remodeling family of proteins, such as Swi/Snf, which can reposition 
nucleosomes and overcome the repressive effects of chromatin (Cairns et al., 1994; Kwon 
et al., 1994; Lorch et al., 1999; Peterson et al., 1994).  Given the variety of factors involved 
in the regulation of heterochromatin and euchromatin, what is the mechanism by which 
successive generations of a cell ‘remember’ which regions of the genome should be 
transcriptionally active or repressed?  What proteins or molecular markers are involved in 
this process?  These questions continue to be topics of intense study and, in part, will be 
discussed in this report.    
 
1.3 Histone Post-translational Modifications 
A thorough understanding of the histone proteins is key to elucidating the 
mechanisms of transcription regulation.  While our knowledge in the field of chromatin 
structure and function has increased greatly since this work began, here we focus on our 
understanding of the histone post-translational modifications at the time our studies began.  
In subsequent chapters, our findings are discussed in the context of relevant works from 
other laboratories that were published concurrently.  Finally, in Chapter 5, our most recent 
understanding of chromatin biology will be addressed.   
The first high resolution crystal structures of the nucleosome firmly established that 
the histone proteins pack with DNA at a region termed the ‘globular domain’, while the 
smaller N- and C-terminal ‘tail’ regions of histones extend away from the core of the 
chromatin polymer (Arents et al., 1991; Luger et al., 1997).  Specific residues along these 
‘tail’ regions and certain sites within the globular domain are targets for various post-
translational modifications such as acetylation, phosphorylation, ubiquitination, and 
methylation (van Holde, 1989; Wu and Grunstein, 2000; Berger, 2002).  While most 
organisms have multiple enzymes capable of catalyzing a particular modification at a 
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specific site, lower eukaryotes typically possess only one enzyme specific for each 
modification site.  Therefore, analysis of chromatin modifications in yeast provides for a 
more rapid analysis of the functions of an individual modification (Peterson and Laniel, 
2004).  Despite the existence of additional histone modifications in mammals as compared 
to budding yeast, the ease of genetic manipulation in yeast as well as our extensive 
knowledge of their genome provides for their role as an important model system.  Our 
studies presented here were all performed using the budding yeast model system.  Indeed, 
both human and yeast histone post-translational modifications are known to be contributors 
in the regulation of a variety of transcription processes, including alterations of chromatin 
structure, the induction or repression of transcription, and mRNA processing.  Our work 
focuses on particular post-translational modifications of Histone H3 and their downstream 
functions.  Diagrammed in Figure 1.2 are the histone H3 modifications in yeast and related 
enzymes known to exist when we began the studies described in this report.  
The histone code hypothesis 
 It was postulated by the Allis laboratory and others that histone post-translational 
modifications regulate chromatin function through a ‘histone code’ (Strahl and Allis, 2000; 
Turner, 2000).  This hypothesis postulates that specific factors are recruited to a particular 
combination of histone modifications which then subsequently signal for various biological 
outcomes.  This ‘histone code’ hypothesis continues to be tested intensively, but regardless 
of the extent of the code’s complexity it is generally agreed to be a valid theory for a cellular 
transcriptional control mechanism (Jenuwein and Allis, 2001; Marmorstein, 2001; Zhang and 
Reinberg, 2001; Berger, 2002; Millar et al., 2004).  Additional support for the histone code is 
manifested through the discovery of unique regulatory pathways for certain modifications 
such as the trans-histone regulatory pathway where ubiquitination of Histone H2B is 
required for H3 K4 and K79 (but not K36) methylation in yeast (Briggs et al., 2002; Ng et al., 
2003a).  A key facet of the code is the recognition of uniquely modified (or unmodified) 
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histones by certain regulatory proteins, that then signal for specific downstream processes.  
These proteins, when bound, can signal for repression or activation of transcription, 
replication origin firing, or proper repair of DNA damage, as described below.  One example 
of this process includes the recruitment of HP1 to methylated Histone H3 lysine 9 in higher 
eukaryotes, subsequently catalyzing the formation of heterochromatin (Bannister et al., 
2001; Lachner et al., 2001; Nakayama et al., 2001).  The yeast heterochromatin protein Sir3 
has been found to promote gene silencing in yeast when bound to H4 tails, but is inhibited 
by H4 acetylation at lysine 16 (Brachmann et al., 1995; Carmen et al., 2002; Rusche et al., 
2003).  Another example is the involvement of acetylated histone H4 in the timing of 
replication origin firing through the recruitment of replication machinery (Vogelauer et al., 
2002).  In addition, activation of transcription is signaled by histone acetylation through the 
recruitment of various transcription factors (Marmorstein and Roth, 2001; Wang et al., 2002).  
In yeast, phosphorylation of serine 10 was found to be required for lysine 14 acetylation, 
further demonstrating functional cross-talk between separate modifications (Lo et al., 2000).  
Experiments focused on histone phosphorylation also support the histone code, as 
phosphorylation of histone H3 at serine 10 is correlated with transcriptional activation during 
the heat-shock response in Drosophila, and is likely involved with transcriptional activity in 
other species (Bjorklund et al., 1999; Nowak and Corces, 2000).  However, the mechanism 
for phosphorylation in transcriptional activation was not carefully investigated until later 
(Nowak and Corces, 2004).  The most recent data available, as discussed in Chapter 5, 
suggests that the ‘histone code’ consists of a complex cross-communication between 
nucleosomal structure, DNA sequence, and histone modifications that coordinate to regulate 
transcription. 
In addition to observations of various histone modifications and their influence on 
biological processes, clues to the mechanisms of these processes were uncovered through 
the identification of binding domains responsible for recognizing particular histone 
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modifications.  The bromodomain was found to have specificity for binding to acetylated 
lysine residues (Dhalluin et al., 1999), while the chromodomain (present in HP1) was found 
to prefer methylated lysine residues (Bannister et al., 2001; Lachner et al., 2001; Nakayama 
et al., 2001).  Consistent with the theory of the histone code, it was predicted that these and 
other domains would be identified in new proteins, and would be responsible for recognizing 
other sites of histone modification that ultimately signal for unique downstream processes 
(Marmorstein and Berger, 2001; Marmorstein, 2001).  As described further in Chapter 5, 
recent results have supported these predictions.    
Implications in Disease 
Given the role of histone modifications in normal cellular processes, are there 
obvious phenotypes when the enzymes that catalyze these modifications are mis-localized 
or their functions are otherwise disrupted?  It is now known that the improper regulation of 
chromatin modifying factors has consequences for human cancers, possibly due to the 
contribution of chromatin structural changes in gene regulation.  The evidence linking cancer 
to the enzymes responsible for histone modifications is highlighted in several prominent 
reviews (Jacobson and Pillus, 1999; Hanahan and Weinberg, 2000; Johnstone, 2002; 
Schneider et al., 2002; Yang, 2004).  In addition to a role for histone modifications in cancer, 
truncations of the catalytic histone methylase domain in the human Set2 homologue, Nsd1, 
are linked to Sotos syndrome (Kurotaki et al., 2002).  Another putative Set2 homologue in 
humans, Nsd2, is deleted in Wolf-Hirschhorn syndrome (Stec et al., 1998).  The human SET 
domain-containing protein Ezh2, in addition to being upregulated in various tumor cell lines, 
interacts with a protein known to be mutated in various inherited disorders including ATR-X 
syndrome (Cardoso et al., 1998).  Interestingly, deletions of any individual histone modifying 
enzyme do not have an obvious phenotype in yeast.  However, it is predicted that this is due 
to redundant or backup functions of each modification state, preventing a modification’s 
function from being elucidated through cursory observation (Adams and Kamakaka, 1999; 
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Wittschieben et al., 2000; Zhang and Reinberg, 2001; Morillon et al., 2005; Zhang et al., 
1998).  Therefore, a more thorough investigation into the roles of particular yeast 
modifications has been the topic of study for many laboratories.  In Chapter 2 we present 
data from two studies which investigate the function of histone methylation at H3 lysine 36.   
 
1.4 Histone methylation 
Histone methylation is a post-translational modification of particular interest that is 
found on lysine and arginine residues (Wu and Grunstein, 2000; Zhang and Reinberg, 2001; 
Khan and Hampsey, 2002).  At the time our studies began in 2002, lysine methylation had 
been identified in higher eukaryotes at positions 4, 9, 27, 36, 79 of H3 and 20 of H4, 
although methylation in budding yeast is only known to exist at positions 4, 36, and 79 of 
H3.  Arginine residues can be mono- or di-methylated, while lysine residues can be mono-, 
di-, or tri-methylated.  Interestingly, studies reveal that each of these modification states may 
be responsible for unique biological functions, adding another layer of complexity to the 
histone code (Santos-Rosa et al., 2002; Zhang and Reinberg, 2001).  The recent flurry of 
discoveries into the roles of histone methylation is largely due to the identification of the 
specific histone methyltransferase enzymes which target the particular sites along histones, 
as well as the development of tools to study these sites (Kouzarides, 2002; Lachner and 
Jenuwein, 2002; Zhang and Reinberg, 2001).  
Although the existence of histone methylation has been known for some time, only 
recently has its biological significance emerged.  The regulation of chromatin structure is a 
key component of transcriptional regulation and histone modifications are known to play a 
pivotal role in this process.  Histone lysine methylation is no exception, as highlighted in a 
number of studies published over the past six years that implicated this modification in the 
regulation of gene expression (Hampsey and Reinberg, 2003; Kouzarides, 2002; Lachner 
and Jenuwein, 2002; Rea et al., 2000; Rice and Allis, 2001; Stallcup, 2001), and when mis-
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regulated, as a contributor to human diseases such as mixed lineage leukemia (MLL) 
(Chadwick et al., 2000; Cui et al., 1998; Hanahan and Weinberg, 2000; Huang, 2002; 
Jacobson and Pillus, 1999; Kurotaki et al., 2002; Peters et al., 2001; Schneider et al., 2002).   
In addition to a general role in gene regulation, multiple lines of evidence indicated 
that methylation can negatively or positively regulate transcription, depending on the site of 
methylation.  Tri-methylation of H3 K4 was shown to correlate with actively transcribing 
genes (Santos-Rosa et al., 2002), while methylation of H3 K9 in most eukaryotes is 
correlated with repressed regions of the genome (Bannister et al., 2001; Lachner et al., 
2001; Nakayama et al., 2001).  Consistent with the histone code hypothesis, it is predicted 
that each histone modification can result in the preferential binding (or dissociation) of a 
regulatory protein that ultimately effects a particular change in gene expression.  This 
pattern has been demonstrated at sites of acetylation, as discussed earlier, yet the binding 
of HP1 to methylated H3 K9 was the first example of this pattern to be demonstrated at a 
site of lysine methylation.  Do similar mechanisms of methyl-lysine and matching binding 
protein exist for all sites of methylation?  The biochemical mechanisms by which lysine 
methylation contributes to specific biological consequences is the focus of the experiments 
presented in Chapter 2 as well as a number of other more recent studies discussed in 
Chapters 3 and 5.   
Although a relatively frequent turnover of histone acetylation (via de-acetylation) 
occurs (Kurdistani and Grunstein, 2003), initial data suggested that histone methylation is 
quite stable (Byvoet et al., 1972; Duerre and Lee, 1974; Goll and Bestor, 2002).  This 
observation appears inconsistent with a potential role of methylation in signaling for the 
positive or negative regulation of transcription, as introduced above.  How could an non-
removable modification effectively function as a signal along chromatin?  A widely 
considered theory is that of ‘cellular memory’, whereby long-lasting modifications can serve 
as effective markers for transcription (Turner, 2002).  Certain transcription studies also 
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revealed the phenomenon of histone replacement whereby a cell ‘removes’ methylation 
through the exchange of a modified with an unmodified histone (Goll and Bestor, 2002; 
Briggs et al., 2001; Ahmad and Henikoff, 2002).  The most recent studies in the field of 
histone methylation have revealed a set of enzymes responsible for de-methylation, which 
will be discussed in Chapter 5, in the context of recent work published since our studies. 
Histone lysine methyltransferases in yeast 
The focus of our work is histone lysine methylation in budding yeast, and in particular 
methylation at lysine 36.  Three histone methyltransferases (HMTs) have been identified in 
yeast that are responsible for methylating lysines 4, 36 and 79 of H3.  Two of these 
enzymes, Set1 and Set2, contain a domain first identified in the Drosophila proteins 
Su(var)3-9, Enhancer of zeste, and Trithorax.  This region, known as the SET domain, was 
found capable of regulating gene activities (Tschiersch et al., 1994; Zhang and Reinberg, 
2001; Jones and Gelbart, 1993).  Structural examples of the SET domain solidified our 
understanding of the mechanism by which it catalyzes methyl group transfer from S-
adenosylmethionine (SAM) to a histone substrate (Zhang et al., 2002; Zhang et al., 2003).  
The SET domain containing HMTs Set1 and Set2 are the sole enzymes in yeast responsible 
for methylating lysine 4 and 36, respectively (Briggs et al., 2001; Strahl et al., 2002; Zhang 
et al., 2002; Zhang et al., 2003).   A third HMT, Dot1, is specific for methylase activity for 
lysine 79 but does so through a catalytic domain unique from the SET domain (Dlakic, 2001; 
Feng et al., 2002; Ng et al., 2002; San Segundo and Roeder, 2000; Singer et al., 1998).  
Set1 and Set2 share regions of homology adjacent to the SET domain, known as the pre-
SET and post-SET domains (Nagy et al., 2002; Rea et al., 2000; Zhang and Reinberg, 
2001).  These domains contain several invariant cysteines, through which the enzymes 
recognize their particular substrates and catalyze methyl transfer.  While the post-SET 
domains of Set1 and Set2 are nearly identical, the pre-SET domains are more variable.  
Structural data of several human SET domains suggests that the post-SET domain, via its 
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invariant cysteines, forms a zinc cluster that is important in catalysis.  In contrast to the post-
SET domain, the pre-SET domain also forms a zinc cluster, but is implicated in the substrate 
recognition (Xiao et al., 2003a; Zhang et al., 2002; Zhang et al., 2003).  The pre-SET 
domain in Set2 is also termed the AWS domain, for Associated With SET, to indicate its 
distinction from the Set1 post-SET domain and the preference to recognize H3K36 as its 
substrate.  Despite the similarities in the domain architecture between Set1 and Set2, these 
enzymes are regulated using very diverse mechanisms. 
Set1 functions in a complex of seven proteins known as COMPASS (Briggs et al., 
2001; Krogan et al., 2002a; Miller et al., 2001; Nagy et al., 2002; Roguev et al., 2001).  
Although Set1 contains the catalytic SET domain responsible for methyl transfer to H3 lysine 
4, deletion of any other COMPASS members results in a moderate to complete abolition of 
K4 methylation in vivo (Miller et al., 2001; Nagy et al., 2002; Roguev et al., 2001).  Despite 
the recent discovery of Set1, significant inroads toward an understanding of COMPASS 
regulation and downstream function have been completed by several laboratories.  These 
discoveries involve an interesting requirement of ubiquitination on histone H2B for 
subsequent H3 K4 methylation.  This trans-histone regulatory pathway involves the mono-
ubiquitination of H2B at lysine 123 which is required for subsequent H3 K4 and K79 
methylation (Fig. 1.2; Briggs et al., 2002; Dover et al., 2002; Ng et al., 2002; Sun and Allis, 
2002).  This discovery is another example of the cross-talk that exists between separate 
histone modifications which is possible even across separate histones.   
It is interesting to note that the H2B trans-tail pathway does not influence H3 K36 
methylation, suggesting that another mechanism may exist for the regulation of Set2-
mediated K36 methylation.  In contrast to Set1, no evidence exists that Set2 functions within 
a complex.  Aside from the discovery of Set2 as the yeast HMT specific for lysine 36 
methylation, little data was available regarding the function of Set2 and K36 methylation 
(Strahl et al., 2002).  The unanswered questions regarding this newly identified enzyme led 
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us to begin detailed studies of its function and regulation.  In order to better appreciate the 
significance of our studies, we will first explore data regarding Set2’s function in vitro and a 
more detailed background of Set2’s domain architecture.   
 
1.5  Set2 is the H3 lysine 36 methylase in yeast 
With the identification of Set2 as the HMT responsible for K36 methylation in yeast, 
combined with observations that K36 methylation is a modification conserved from yeast to 
humans, it was anticipated that Set2 would influence gene regulation as do many of the 
other histone-modifying enzymes (Kouzarides, 2002; Lachner and Jenuwein, 2002; Sims, III 
et al., 2003; Strahl et al., 2002; Zhang and Reinberg, 2001).  Our investigation into Set2’s 
function began with observations of its domain structure.  As diagrammed in Figure 1.3, 
Set2 contains several confirmed functional domains: the catalytic SET domain and the 
cysteine rich regions described earlier.  The AWS domain is the version of a pre-SET 
domain, likely unique to Set2 and its homologues based on its substrate specificity (Nagy et 
al., 2002; Rea et al., 2000; Zhang et al., 2003; Zhang and Reinberg, 2001).   
Although Set2 has been identified as a histone methyltransferase, little is known 
about this protein’s biological function, the function of the methyl modification it catalyzes, or 
the mechanisms of these activities.  Several lines of evidence provided leads for subsequent 
investigation of these unknown areas, including sequence homology comparisons which 
revealed that Set2 contains a putative WW domain and coiled-coil motif as illustrated in 
Figure 1.3 (Strahl et al., 2002).  Coiled-coil motifs consist of α-helices that are often 
involved in protein-protein interactions.  Interestingly, several reports demonstrated that 
yeast WW domains bind to the phosphorylated CTD of RNAPII (Morris et al., 1999; Morris 
and Greenleaf, 2000).  Could Set2 interact with RNAPII via its WW domain and therefore 
target Set2 to histone H3?  Whether these regions within Set2 were bona fide functional 
domains and contributed to Set2’s function was unclear.  Initial experiments have 
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demonstrated that Set2 functions as a repressor of transcription in vitro, suggesting K36 
methylation could function in a manner analogous (but opposite) to K4 methylation (Strahl et 
al., 2002; Lutfiyya et al., 1995).  Results indicating that Set2 acted as a transcriptional 
repressor remained unconfirmed in vivo.  These early lines of evidence laid the groundwork 
for hypotheses we have tested regarding Set2 and its downstream function.   
 
1.6 Unanswered questions regarding Set2 
The complexity of the histone code can seem endless.  Even in the yeast model 
system, much remains to be investigated regarding each histone modification, its regulation, 
and downstream functions.  The fast-paced field of chromatin research requires continual 
revisions of models for the regulation and function of a histone modification.  In the following 
section I will present some of the unresolved questions regarding Set2 and H3 K36 
methylation in yeast that are addressed in subsequent chapters.  
Set2 domain structure and the function of K36 methylation  
Deletion of SET2 results in a complete loss of global K36me2 levels as observed by 
immunoblot analysis (Strahl et al., 2002).  It was unknown, however, whether Set2 locates 
its H3 substrate by simple diffusion, or if it is targeted specifically to chromatin.  Do the 
putative WW and coiled-coil regions in Set2 have functional relevance?  Since there is no 
evidence that Set2 functions in a complex as does Set1, could the WW or coiled-coil regions 
be responsible for Set2 interaction with an as-yet-unidentified binding partner?  Based on 
the observation that certain WW domain-containing proteins bind to the phosphorylated 
RNAPII-CTD, does Set2 bind to the CTD as well?  What are the downstream functions of 
Set2-catalyzed methylation?  Will Set2, like Set1, be found to contribute to transcriptional 
regulation?  This would seem to be likely, as SET2 was initially identified as a repressor of 
the GAL4 promoter (Lutfiyya et al., 1995), which was later supported by additional evidence 
that Set2 can act as a repressor via its methylase activity in a plasmid-based transcription 
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repression assay (Strahl et al., 2002).  These early data did not provide clear evidence as to 
whether Set2 functions to regulate transcription via regulated targeting to specific genes, nor 
the means by which K36 methylation could accomplish this.  These represent the 
unresolved issues which we began to investigate, the results of which are presented in 
Chapter 2.  Additional studies from our laboratory and others further dissected the 
downstream roles of this modification, and will be discussed in the context of our work, in 
Chapter 5.   
Regulation of Set2 activity on chromatin 
 Set2 has been identified as a histone methyltransferase capable of in vitro 
methylation of nucleosomal substrates, but not free histones (Strahl et al., 2002).  Does the 
fact that Set2 prefers nucleosomal substrates in vitro have biological relevance in vivo?  If 
K36 methylation is responsible for specific biological effects, could the level of K36 
methylation be regulated in vivo?  What are the upstream factors, if any, that are 
responsible for regulating Set2 activity?  Based on new data from our studies and others, 
presented in Chapter 2, we studied specific transcription factors for a potential influence on 
the regulation of Set2 activity and describe these results in Chapter 3.   
 
Figure 1.1: Illustration of chromatin fiber condensation. 
Shown are the steps involved in the folding of extended nucleosomal arrays into maximally 
folded chromatin fibers. Reprinted, with permission, from the Annual Review of Biophysics 
and Biomolecular Structure, Volume 31 (c) 2002 by Annual Reviews 
(www.annualreviews.org).
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Figure 1.2:  Yeast histone H3 post-translational modifications and related enzymes.
(A) The histone H3 post-translational modifications known to occur in yeast at the 
beginning of this study (2002) are indicated, along with the enzymes that catalyze or 
remove these modifications.  (B) Indicated here are protiens known to bind to H3 residues 
in a modification-dependent manner.  A current listing of yeast H3 modifications will be 
presented in Chapter 5.  Reprinted and adapted from TRENDS in Genetics, Volume 22, 
Mellor, J., Dynamic nucleosomes and gene transcription, 320-329, Copyright 2006, with 
permission from Elsevier (Mellor, 2006).
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Figure 1.3: Schematic representation of the domain structure of Set2.  
The N-terminus of Set2 contains the SET domain, which is flanked by cysteine rich region 
noted as the post-SET (PS) and AWS domains (AWS is predicted to be present in putative 
Set2 homologues only).  The C-terminus of Set2 contains a putative proline-binding WW 
domain and a coiled-coil motif, expected to be functionally relevant in protein-protein 
interactions involving Set2.
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CHAPTER 2 
 
A NOVEL DOMAIN IN SET2 IS REQUIRED FOR INTERACTION WITH 
PHOSPHORYLATED RNA POLYMERASE II AND LINKS HISTONE H3 K36 
METHYLATION WITH TRANSCRIPTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
Components of this chapter were published as: 
Xiao T., Hall H., Kizer K.O., Shibata Y., Hall M.C., Borchers C.H., Strahl B.D. (2003) 
Phosphorylation of RNA polymerase II CTD regulates H3 methylation in yeast. Genes Dev., 
17, 654-63. 
 
Kizer K.O., Phatnani H.P., Shibata Y., Hall H., Greenleaf A.L., Strahl B.D. (2005) A novel 
domain in Set2 mediates RNA polymerase II interaction and couples histone H3 K36 
methylation with transcript elongation. Mol. Cell Biol., 25, 3305-3316. 
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Summary 
 Genetic and biochemical evidence has linked histone methylation to the regulation of 
chromatin structure and gene transcription.  The recently discovered histone H3 methylase 
Set2 was found to be the sole enzyme in yeast responsible for H3 lysine 36 (K36) 
methylation.  Although earlier work suggested a role for Set2 and K36 methylation in 
transcriptional repression, the role of K36 methylation in yeast remained largely unexplored.  
Through our collaborative work, we identified an association between the phosphorylated C-
terminal domain (CTD) of RNA polymerase II (RNAPII) and a region of Set2, implying that 
this enzyme has an important role in the transcription elongation process.  Here we show 
that a novel domain in the C-terminus of Set2 is responsible for  interaction between Set2 
and RNAPII.  This domain, termed the Set2 Rpb1 Interacting (SRI) domain, is encompassed 
by amino acid residues 619 to 718 in Set2 and is found to occur in a number of putative 
Set2 homologues from fission yeast to humans.  Unexpectedly, BIACORE analysis reveals 
that the SRI domain binds specifically, and with high affinity, to CTD repeats that are doubly 
modified (serine 2 and serine 5 phosphorylated), indicating that Set2 association across the 
body of genes requires a specific pattern of phosphorylated RNAPII.  Deletion of the SRI 
domain not only abolishes Set2-RNAPII interaction, but also abolishes K36 methylation in 
vivo, indicating that this interaction is required for establishing K36 methylation on 
chromatin.  Using 6-azauracil (6AU) as an indicator of transcription elongation defects, we 
found that deletion of the SRI domain confers a strong resistance to this compound, which 
was identical to that observed with set2 deletion mutants.  Furthermore, yeast strains 
carrying set2 alleles that are catalytically inactive or yeast strains bearing point mutations at 
K36, were also found to be resistant to 6AU.  These data suggest that it is the methylation 
by Set2 that affects transcription elongation.  In agreement with this, we have determined 
that deletion of SET2, its SRI domain, or amino acid substitutions at K36 result in an 
alteration of RNAPII occupancy levels over transcribing genes.  Taken together, these data 
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indicate K36 methylation, established by the SRI domain-mediated association of Set2 with 
RNAPII, plays an important role in the transcription elongation process. 
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2.1 Background 
 Successful synthesis of mRNA by RNA polymerase II (RNAPII) requires tight 
regulation of the initiation, elongation, and termination processes of transcription.  The 
process of transcription elongation is affected in part by the binding of regulatory factors to 
the phosphorylated C-terminal domain (CTD) of the RNAPII subunit Rpb1.  Recent studies 
have highlighted an important role for histone methylation in the process of transcription.  
Earlier studies of methylation in yeast revealed an unexpected trans-histone regulatory 
pathway where H2B ubiquitination is required for subsequent H3 K4 and K79 methylation 
catalyzed by Set1 and Dot1, respectively.  Interestingly, H3 K36 methylation is not regulated 
by this pathway, suggesting an alternate mechanism may exist to signal for the catalysis of 
this modification.  Our early investigations involving the regulation of Set2 revealed that this 
H3 K36 methylase associates with RNAPII in vivo (Xiao et al., 2003b).  Other laboratories 
independently observed similar results, which shed light on a possible mechanism for Set2 
localization on genes and a role in transcription (Krogan et al., 2003b; Landry et al., 2003; Li 
et al., 2003; Li et al., 2002; Schaft et al., 2003).  Furthermore, these studies revealed that 
Set1 and Set2 are associated with RNAPII at different stages of the transcription elongation 
cycle.  While Set1 associates with RNAPII via the Paf1 transcription elongation complex in a 
manner that is dependent on the serine 5 (Ser5) phosphorylated CTD, Set2 is recruited to 
RNAPII in a manner that is dependent on the CTD and the Ctk1 kinase (CTDK-I) that effects 
serine 2 CTD phosphorylation (Gerber and Shilatifard, 2003; Hampsey and Reinberg, 2003; 
Krogan et al., 2003a; Krogan et al., 2003b; Li et al., 2003; Ng et al., 2003b; Xiao et al., 
2003b).  Importantly, while studies show that Set1 preferentially associates with the 5’ end 
of genes, Set2 is found throughout the coding regions of genes (Krogan et al., 2003b; Ng et 
al., 2003b; Schaft et al., 2003; Xiao et al., 2003b).  These observations imply that K4 and 
K36 methylation have differing roles in the transcription elongation process. 
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 Several lines of evidence indicate that Set2 is a phospho-CTD binding protein 
(Gerber and Shilatifard, 2003; Hampsey and Reinberg, 2003; Krogan et al., 2003b; Li et al., 
2003; Li et al., 2002; Ng et al., 2003b; Xiao et al., 2003b).  For example, truncations of the 
RNAPII CTD severely reduce global K36 methylation levels in vivo (Li et al., 2003; Xiao et 
al., 2003b).  In addition, deletion of CTDK-I results in a total abolition of K36 methylation 
(Krogan et al., 2003b; Xiao et al., 2003b).  These data have led to the model that Set2 
preferentially binds to RNAPII that is phosphorylated at the Ser2 position of the CTD, which 
is supported by findings that Set2 binds to Ser2 phosphorylated CTD repeats in vitro (Li et 
al., 2002; Li et al., 2003).  Thus, a function for the CTDK-I generated phospho-CTD in either 
the recruitment of Set2 and/or the control of K36 methylation activity has been proposed 
(Shilatifard, 2004; Sims, III et al., 2004).   
 While the association of Set2 with RNAPII is well established through work from our 
laboratory and others, the region in Set2 required for this interaction, and the functional 
significance of this interaction on K36 methylation and transcription elongation remained 
poorly defined.  In this chapter, we present components of two studies which identified the 
Set2 region responsible for RNAPII interaction.  Importantly, work from our first study as 
presented in this chapter, revealed that the C-terminus of Set2 is responsible for RNAPII 
interaction (Xiao et al., 2003b).  This unexpected result is contradictory to an earlier report 
(Li et al., 2002), but was first reconciled through studies in our laboratory.  This unusual 
result is then more carefully addressed and finally reconciled through results from our 
second study, presented here, where we identified the precise boundaries of a novel domain 
in Set2 that mediates RNAPII interaction (Kizer et al., 2005).  We show that deletion of this 
Set2-Rpb1 interaction (SRI) domain abolishes K36 methylation on chromatin in vivo and 
leads to a transcription elongation defect, as assayed by 6-azauracil (6AU).  In support of a 
direct role for Set2 methylation in the transcription elongation process, we find that set2 
mutants or H3 K36 point mutations that prevent K36 methylation result in 6AU phenotypes 
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similar to those of a complete SET2 deletion, which we in turn correlate with altered 
distribution of RNAPII along genes.  These results define a novel domain in Set2 
responsible for functional interaction with RNAPII and strongly suggest that the K36 
methylation mediated by Set2 influences transcription elongation.  
 
2.2 Materials and Methods 
Yeast strains 
 The p3Flag-KanMX plasmid was used as a PCR template for genomic tagging of 
Set2 (Gelbart et al., 2001).  This provided for the generation of either full-length Set2 (Set2-
3Flag) or a form deleted of the SRI domain (Set2(1-618)-3Flag) by homologous recombination.  
Primers used to generate Set2-3Flag in the BY4742 background were constructed 
previously (Xiao et al., 2003b).  The primers for Set2(1-618)-3Flag were: 5’-
CAAAAGGAAGAGTCCAAAAAACTAGTGGAAGCAAAAGAGGCTAAGCGGTTGAAAAGGG
AACAAAAGCTGGAG-3’ (forward) and 5’-
AAAGAATTTATTCCAGTTGTGCTCTAGTCTTTGGGACTGGGAGACCGTTTTTCTTTACTA
TAGGGCGAATTGGGT-3’ (reverse).  Bases which anneal to the p3Flag-KanMX plasmid are 
underlined, while the remaining sequence corresponds to the SET2 locus insertion position.  
The set2∆ and wild-type strains of the BY4742 background were obtained from Research 
Genetics, while the YCB652 strain, carrying an integrated URA3 gene, was obtained from 
Dr. Jeff Smith, University of Virginia School of Medicine (Smith et al., 2000).  The SET2 
gene was deleted in the W303 and YCB652 backgrounds using a PCR product amplified 
from genomic DNA obtained from the BY4742 set2∆ strain, in which the SET2 gene had 
already been replaced by the KanMX gene (Research Genetics).  
 The H3/H4 shuffle strain WZY42 (in the S288C background) was used in 6AU 
analyses of H3 point mutants, and replacement of wild-type H3 with H3 mutants was 
accomplished as described (Briggs et al., 2001; Zhang et al., 1998).  Plasmids coding for 
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the H3 S10A and K4R mutants have been described previously (Briggs et al., 2001; Hsu et 
al., 2000).  All other H3 point mutations were prepared by standard PCR-based site-directed 
mutagenesis using materials and methods previously described (Briggs et al., 2001; Zhang 
et al., 1998).   
Yeast WCE and nuclei preparation 
Yeast WCEs were prepared as described previously, but differed in the extraction 
buffer (Xiao et al., 2003b).  The extraction buffer used consisted of 50 mM Tris-HCl at pH 
8.0, 300 mM NaCl, 1 mM Mg(C2H3O2)2, 1 mM imidazole, 0.1 % NP40, 0.5 mM EDTA and 10 
% glycerol.  In addition, this buffer contained 0.5 % phosphatase inhibitor cocktail I (Sigma), 
PMSF (2 mM), and Leupeptin/Pepstatin/Aprotinin mix each at 2 µg/ml.  Nuclear extracts 
were prepared as previously described from strains grown in 200 ml of YPD medium to an 
OD600 of 1.5 (Edmondson et al., 1996).   
Electrophoresis and immunoblotting 
Western blotting and SDS-PAGE analyses were performed according to procedures 
and reagents obtained from Amersham Life Sciences.  The ECL Plus Western Blotting 
Detection Kit (Amersham Pharmacia Biotech) was used for specific antibody detection.  The 
rabbit anti-Me2(K36) antibody was obtained from Upstate Biotechnology Inc. and used at a 
dilution of 1:3000.  The rabbit anti-Me3(K36) antibody was obtained from Abcam Inc. 
(AB9050) and used at a dilution of 1:2500.  The antibody targeted against the C-terminus of 
H3 was obtained from Abcam Inc. (AB1791) and used at a dilution of 1:5000.  The anti-
phospho-CTD antibodies H5 and H14 were obtained from Covance Inc. 
Generation of SET2 expression constructs 
The Set2 constructs containing a C-terminal Flag epitope [Set2(1-618), Set2(262-475), 
Set2(445-538), Set2(528-638), Set2(619-733), Set2(634-733), Set2(619-718), and Set2(619-703)] were 
generated by PCR amplification using Vent DNA polymerase (New England Biolabs) and 
the Set2-Flag PN823 expression construct as the template.  Full-length Set2, Set2(1-261), and 
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Set2R195G constructs were prepared previously (Strahl et al., 2002; Xiao et al., 2003b).  The 
PCR products were cloned into the PN823 yeast expression plasmid and sequenced for 
accuracy.  Primer sequences are available upon request.  For in vitro phospho-CTD binding 
experiments, the Set2(1-618) and Set2(619-733) constructs were subcloned into the pMAL-c2G 
vector (New England Biolabs) and proteins were purified according to the manufacturer’s 
protocol.  
Immunoprecipitations 
Co-IP experiments involving the various mutant Set2-Flag constructs or Set2-3Flag 
strains were performed essentially as previously described (Xiao et al., 2003b).  In brief, a 
set2∆ strain (in the BY4742 background) was transformed with the indicated series of Set2 
expression constructs, grown to an OD600 of ~1.0 in synthetic complete media lacking uracil, 
and WCEs were prepared using the described extraction buffer above.  Co-IPs were 
performed in a final volume of 0.9 ml, equalized with extraction buffer, containing 1.5 mg of 
WCE protein (or 2.0 mg for genomically-tagged strains).  The extracts were incubated with 
12.5 µl of pre-equilibrated αFlag affinity beads (M2; Sigma) for 2 h at 4°C, after which 
extracts were washed 3x2min in extraction buffer.  The beads were eluted in SDS-PAGE 
loading buffer with incubation at 100°C for 5 min, and bead-bound proteins analyzed by 
immunoblot analysis using antibodies targeted against the phospho-CTD.   
ChIP assays  
The chromatin immunoprecipitation assay using the H3 K36 di-methyl antibody was 
performed as described previously (Xiao et al., 2003b).  Primers were used to amplify 
regions of SCC2 in the following ranges relative to the ATG start site: -277, -27; 2, 238; 984, 
1222; 3044, 3276; 3981, 4222; 4489, 4679.  Intergenic chromosome V primers were used 
as a reference and loading control, as previously reported (Komarnitsky et al., 2000).  The 
previously characterized general RNAPII-CTD antibody (not specific to any CTD 
modification state) was used in ChIP assays for RNAPII detection (Schroeder et al., 2000). 
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Set2-3Flag and Set2(1-618)-3Flag purification 
Set2-3Flag and Set2(1-618)-3Flag proteins were purified as previously described (Xiao 
et al., 2003b).  A Coomassie-stained gel was used to visualize the associated proteins and 
mass spectrometry analysis confirmed the presence or absence of Rpb1 and Rpb2 from 
excised gel slices.  
In vitro HMT assays 
The E. coli strain BL21 was transformed with pMAL vectors expressing the 
constructs MBP-Set2 and MPB-Set2(1-618), which also contained the C-terminally tagged Flag 
epitope.  Protein expression was induced in 100 µM IPTG for 3 h at 30°C, cells were lysed 
by sonication and 20 µl HMT reactions were prepared as described previously (Strahl et al., 
2002).  In brief, lysate volumes were used that resulted in equal amounts of each MBP-Set2 
fusion per reaction, as analyzed by Western blotting with the Flag antibody.  HMT reactions 
contained 1 µCi of 3H-SAM (Amersham Biosciences), with or without 6 µg of chicken 
nucleosomes.  Reactions were incubated at 30°C for 20 min and spotted on Whatman P-81 
for liquid scintillation counting, or analyzed by SDS-PAGE followed by fluorography.   
Far-Western analysis of Set2 fragments using phospho-CTD probes 
Far-Western analysis using a phospho-CTD probe (generated by CTDK-I) was 
performed essentially as described previously (Morris et al., 1997; Morris et al., 1999).  In 
brief, picomole quantities of recombinant MBP-Set2(1-618) and MBP-Set2(619-733) were resolved 
on a 4-15% Tris-HCl Criterion Gel (Bio-Rad), and transferred to nitrocellulose (Hybond C 
Extra, Amersham Pharmacia Biotech).  The nitrocellulose was stained with Ponceau S to 
visually ensure protein transfer from the gel.  The membrane was blocked at 4°C for 24 h 
and probed with 2.5 µg of GST-32PCTD in blocking buffer for 3.5 h at 4°C.  The membrane 
was washed, air dried, and exposed to film.  Reverse Far-Western analysis was performed 
according to published methods by resolving recombinant unphosphorylated or 
phosphorylated GST-CTD fusions on a 4-15% Tris-HCl gel (Phatnani et al., 2004).  The gel 
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was transferred to a nitrocellulose membrane and probed with MBP-Set2 or MBP-Set2(619-
733), followed by detection using an antibody against MBP. 
Determination of SRI-CTD affinities using BIACORE 
The BIACORE sensor chip carrying 3-repeat CTD peptides (2-phospho, 5-phospho, 
2+5 phospho, 6PC scrambled control) was generated as previously recorded (Jones et al., 
2004; Phatnani et al., 2004).  Purified MBP-Set2(619-733) was interacted with the peptides and 
association and dissociation monitored.  The response curves were normalized to that for 
the 6PC control peptide. 
RT-PCR 
Reverse transcription (RT)-PCR analysis was performed as previously described 
(Xiao et al., 2003b; Xiao et al., 2005).  Primer sequences are available upon request. 
6AU growth assays 
Yeast strains used in this assay, except for YCB652, were transformed with the 
URA3+ CEN plasmid pRS316 and grown in synthetic defined media lacking uracil (SD-Ura).  
Overnight cultures were diluted 1:20, grown to an OD600 of 1.0, and ten-fold serial dilutions 
were plated on SD-Ura media with or without 6-azauracil (Aldrich) or mycophenolic acid 
(Sigma), each at 100 µg/ml.  Plates were photographed after 30°C incubation for 2-3 days.  
Liquid cultures used for RT-PCR analysis were grown with 6AU at 50 µg/ml for 120 min.  
This time point was selected based on a recent study in which the IMD2 steady-state mRNA 
levels of a large-scale 6AU screening of yeast deletion mutants were analyzed (Riles et al., 
2004). 
 
2.3 Results 
A novel C-terminal domain in Set2 mediates RNAPII interaction.  
The initial observations made from our laboratory and others of the RNAPII-Set2 
association did not reveal, however, which region(s) of Set2 are required for this interaction.  
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Using a series of Set2 expression constructs containing a fused C-terminal Flag epitope, we 
examined various forms of Set2 in a co-immunoprecipitation (Co-IP) study with antibodies 
generated against RNAPII to determine the region of Set2 responsible for CTD interaction.  
Either full-length SET2, vector only control, or the indicated SET2 mutant was expressed in 
a set2 deletion mutant (set2∆) and whole cell extracts (WCEs) were prepared.  We found 
that a C-terminal portion of Set2 was capable of interacting with RNAPII (Fig. 2.1), which 
formed a component of the collaborative work from our laboratory (Xiao et al., 2003b).  In 
this study, and those from other laboratories, the association between Set2 and the 
phosphorylated CTD was well established (Krogan et al., 2003b; Li et al., 2003; Li et al., 
2002; Schaft et al., 2003). 
Since our initial analyses demonstrated that specific deletion of the WW domain in 
Set2 does not disrupt Set2-RNAPII co-precipitation, we hypothesized that the coiled-coil 
region of Set2 may be responsible (Xiao et al., 2003b).  Thus, we generated another series 
of Set2 mutant yeast expression constructs with a C-terminal Flag epitope tag (Fig. 2.2A) 
and used them in a Co-IP experiment with antibodies generated against RNAPII as in Fig. 
2.1.  Either full-length SET2, vector only control, or the indicated SET2 mutant was 
expressed in a set2 deletion mutant (set2∆) and whole cell extracts (WCEs) were prepared.  
As expected, immunoprecipitation of full-length Set2-Flag resulted in co-precipitation of 
RNAPII as detected by immunoblotting with anti-phospho-CTD antibodies (Fig. 2.2B).  As 
shown in Fig. 2.2B, we found through further Set2 truncations that a region at the C-
terminus of Set2, encompassing amino acid residues 619-733, is both necessary and 
sufficient to mediate the interaction of Set2 with RNAPII (compare last two lanes).  We 
therefore termed this region the Set2 Rpb1 Interacting (SRI) domain. 
 We next sought to determine the precise boundaries of the SRI domain.  To 
accomplish this, we generated additional Set2 constructs containing N- and C-terminal 
truncations of the SRI region (Fig. 2.2C) and used them in co-IP analyses as before (Fig. 
 35
2.2B).  Results revealed that N-terminal truncation of the SRI domain beyond Set2 amino 
acids 619 abolished RNAPII binding.  However, binding was still possible with a C-terminal 
truncation up to amino acid 718 of Set2 (Fig. 2.2D), thereby identifying the boundaries of the 
SRI domain as amino acids 619-718. 
Set2 also contains a putative coiled-coil motif, a region found in other proteins to be 
a mediator of protein-protein interactions (Xiao 2003).  As with the WW domain, we tested 
the coiled-coil motif of Set2 for a potential role in mediating the Set2-RNAPII interaction.  To 
test this possibility, we generated a series of constructs that expressed forms of Set2 which 
were deleted of precise regions within the coiled-coil motif (Fig. 2.3A).  As we found in the 
case of a WW domain deletion of Set2, we found that deletion of the Set2 coiled-coil motif 
did not disrupt the Set2-RNAPII interaction (Fig. 2.3B) Unexpectedly, when we analyzed 
WCEs of the indicated strains by western blot with an antibody directed against 
trimethylated H3K36 (H3K36me3), we found that expression of a form of Set2 deleted of the 
coiled-coil region could not rescue H3K36me3 (Fig. 2.3C).  This result suggests at least two 
possibilities for the function of the coiled-coil motif within Set2.  First, the coiled-coil motif in 
Set2 may be required for the proper folding and catalytic function of Set2.  We note, 
however, that a large C-terminal truncation of Set2 (truncated of amino acids 262-733) is still 
able to methylate in vitro (data not shown).  A second possibility is that the coiled-coil motif 
may be responsible for an interaction between Set2 and an as-yet-unidentified factor that, 
secondary to RNAPII interaction, is required by Set2 for subsequent H3K36 methylation by 
Set2.  Further testing of the coiled-coil motif in Set2 will be required to distinguish between 
these two possibilities. 
 Due to the possibility that the observed interaction between the SRI domain and 
RNAPII shown in Fig. 2.2 might have been influenced by the high levels of recombinant 
Set2 protein produced (as these constructs are expressed from a plasmid using the highly 
active ADH1 promoter), we genomically tagged Set2 at amino acid 733 or 618 with a triple 
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Flag sequence and re-examined its association with RNAPII.  As shown in Fig. 2.4A, full-
length Set2 (Set2-3Flag) again co-immunoprecipitated RNAPII as analyzed by immunoblot 
analysis using the anti-phospho-CTD antibodies.  In contrast, a form of Set2 deleted of the 
SRI domain (Set2(1-618)-3Flag) resulted in the abolition of RNAPII interaction.  We also 
confirmed these results by examining the protein associations of Set2 by affinity purification, 
which revealed that the readily detectable subunits of RNAPII (Rpb1 and Rpb2) were only 
observed in purifications involving full length Set2 (Fig. 2.4B).  Additionally, while Rpb1 and 
Rpb2 were detected by mass spectrometry in gel-excised bands from the full-length Set2 
purification, these proteins were not detected in a parallel gel region excised from the SRI 
domain-deleted form of Set2 (data not shown).  Collectively, these data confirm the 
importance of the SRI domain in mediating Set2-RNAPII interaction. 
The SRI domain of Set2 is conserved and interacts with the phosphorylated CTD in vitro. 
Previous studies have suggested that Set2 association with RNAPII is dependent, in 
part, on the Paf1 transcription elongation complex (Henry et al., 2003; Krogan et al., 2003b).  
Thus, it was a formal possibility that the SRI domain linked Set2 to the polymerase by 
indirect protein association.  To test whether the SRI domain of Set2 is responsible for direct 
association with the CTD of RNAPII, we generated a variety of maltose-binding-protein 
(MBP) fusions of Set2 and examined their ability to associate with a recombinant GST-CTD 
fusion protein that was either unmodified (GST-yCTD) or exhaustively phosphorylated by 
CTDK-I (GST-yPCTD).  Using a “reverse Far-Western” approach (Phatnani et al., 2004), the 
GST-CTD fusions were resolved by SDS-PAGE, transferred to nitrocellulose, and then 
probed with MBP fusion proteins carrying full length Set2 (Set2) or only the SRI domain of 
Set2 (Set2(619-733)).  Results revealed that both the full length form of Set2 and the SRI 
domain of Set2 preferentially bound to the phosphorylated CTD (Fig. 2.5A).  To 
independently confirm this interaction and further address whether other regions of Set2 
may bind to the phosphorylated CTD in vitro, we transferred increasing amounts of MBP 
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fusions of Set2 lacking the SRI or containing only the SRI domain (Set2(1-618) and Set2(619-
733), respectively) to nitrocellulose and probed with a CTDK-I phosphorylated GST-32PCTD 
fusion.  As shown in Figure 2.5B, this Far-Western approach revealed that while the SRI 
domain of Set2 bound efficiently to the GST-32PCTD fusion, Set2 lacking the SRI domain did 
not.  While Figure 2.5B shows a 3.5 h exposure, it is noteworthy that a 90 h exposure 
revealed a potential weak interaction of Set2(1-618) to phosphorylated CTD (data not shown), 
however it is unclear whether such interaction is physiologically relevant (see Figs. 2.4-2.7 
and (Phatnani et al., 2004).  In summary, our results show that the SRI domain in Set2 binds 
directly to the phospho-CTD of RNAPII.  Thus the ability of the Paf1 complex to modulate 
Set2 activity is likely an indirect consequence of the fact that this complex can regulate CTD 
phosphorylation (Mueller et al., 2004). 
Next, we examined the specificity of the SRI domain for binding phospho-eptitopes 
using BIACORE analysis with three-repeat synthetic CTD peptides that were 
phosphorylated in each repeat at either Ser2 (2-phospho), Ser5 (5-phospho), or both (2+5-
phospho).  As a control, a Ser-phosphorylated peptide that mimics the charge state of the 
2+5-phospho peptide (6PC) was included.  Sensor chips containing these CTD peptides 
were reacted with the SRI domain of Set2 (Set2(619-733)) and binding was monitored.  
Surprisingly, we found that the Set2 SRI domain bound preferentially to CTD repeats that 
were doubly-phosphorylated (Fig. 2.5C, compare 2+5-phospho curve with 2-phospho and 5-
phospho curves).  Moreover, because these response curves were obtained after 
subtracting the contribution of the non-specific control peptide (6PC), this binding depends 
on the presence of both Ser2P and Ser5P in the context of the CTD heptad repeat 
sequence.  Based on additional BIACORE experiments involving titrated amounts of the 
Set2 SRI domain (not shown), we determined that the Set2 SRI domain binds to the 2+5-
phospho peptide (relative to the control) with an apparent dissociation constant of about 6 
µM.  It is important to note that the ability of the SRI domain to bind to the non-specific 
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control peptide was nearly equivalent to that found for binding to the individually 
phosphorylated peptides (not shown).  We take this result to suggest that the SRI domain of 
Set2 has a specific requirement for Ser2 and Ser5 phosphorylated CTD epitopes.  
Collectively, these results reveal a novel and selective requirement for a specific CTD 
phosphorylation pattern in Set2 binding to RNAPII.  
Given these findings, we next asked whether the SRI domain of Set2 is a conserved 
phospho-CTD-binding motif found in other proteins in budding yeast and beyond.  By 
performing a PSI-BLAST search, we determined that the SRI domain of Set2 was unique to 
this enzyme alone in budding yeast (data not shown).  However, the SRI domain showed 
significant homology to the C-terminal regions of proteins in other species that also 
displayed domain organizations similar to that of Set2 (AWS, SET, postSET, and WW), 
suggesting that these proteins may be the functional homologues of budding yeast Set2 and 
function with RNAPII (Table 2.1).  Interestingly, the proteins identified in Table 2.1 represent 
only a subset of proteins that the SMART database revealed to contain AWS, SET, and 
postSET domains (>70), suggesting that not every putative histone methyltransferase that 
contains a AWS, SET, and postSET is by default a functional homolog of Set2.  Indeed, 
recent evidence shows that the Drosophila Ash1 protein, which falls into the Set2-family of 
HMTs (by way of having a AWS domain rather than an archetypal PreSET domain), is a H3 
lysine 4 methyltransferase (Byrd and Shearn, 2003; Beisel et al., 2002).  These results 
suggest that the SRI domain is a probable indicator of RNAPII-interacting enzymes that 
catalyze K36 methylation.  To determine whether any of the putative SRI domains we 
identified by our PSI-BLAST search would actively bind to the phospho-CTD, we expressed 
and purified from bacteria a GST fusion protein carrying the C-terminal 178 residues of the 
human Huntington Interacting Protein B (HYPB) that includes the region of homology to 
Set2’s SRI domain (Table 2.1).  Using the Far-Western approach as described for Fig. 2.5B, 
we found that similar to Set2, the SRI-containing region in HYPB interacts efficiently with a 
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CTDK-I-phosphorylated GST-32PCTD fusion (data not shown).  Furthermore, additional 
BIACORE analyses (as described in Fig. 2.5C) revealed that the human SRI domain 
displays binding properties nearly identical to those of the budding yeast domain (H.P.P., 
A.L.G. and P. Zhou, manuscript in preparation).  Taken together, these results suggest that 
the SRI domain is a highly conserved and novel phospho-CTD interacting domain. 
The Set2-RNAPII interaction is required for H3 K36 methylation.   
Given the conserved nature and potential importance of the SRI domain to Set2’s 
cellular function, we next investigated the consequences of deleting this domain.  Although 
studies suggest that the CTD and its proper phosphorylation are necessary for K36 
methylation, it has not been formally excluded that the phospho-CTD might regulate the 
enzymatic activity of Set2 (Krogan et al., 2003b; Li et al., 2003; Schaft et al., 2003; Xiao et 
al., 2003b).  To determine if the loss of the SRI domain would result in a loss of genome-
wide K36 methylation, we measured the K36 di-methylation levels in strains containing WT 
Set2 or Set2 genomically deleted for the SRI domain.  Nuclei were prepared from these 
strains and then resolved on an SDS-PAGE gel, followed by Western Blotting with an 
antibody specific to di-methylated K36.  Results revealed that deletion of the SRI domain in 
Set2 abolishes global H3-K36 di-methylation (Fig. 2.6A).  As a control, we examined the 
levels of H3 in parallel gels with an antibody specific to the C-terminus of H3, which revealed 
that the levels of histones were similar in both nuclei preparations.  Importantly, the nuclei of 
both strains showed the presence of Set2 by Western blot analysis using an anti-Flag 
antibody (Fig. 2.6A).  This result indicates that the deletion of the SRI domain does not 
influence the nuclear localization of Set2 or significantly affect its stability.  The requirement 
of the SRI domain for K36 methylation was independently confirmed in parallel studies in 
which a different strain background (W303) was genomically tagged either at the C-terminus 
or at the beginning of the SRI domain at residue 618 (data not shown).  In addition, we used 
the chromatin immunoprecipitation (ChIP) assay to analyze chromatin modifications at a 
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gene-specific resolution and also observed a loss of K36 methylation at the SCC2 gene 
when the SRI domain of Set2 is removed (Fig 2.6C).  Analysis of the PMA1, ENO1 and 
ADH1 genes yielded similar results (data not shown). 
 To test the possibility that the SRI domain itself might regulate Set2’s catalytic 
activity, we analyzed recombinant full-length Set2 or SRI-deleted MBP-Set2 fusion proteins 
in HMT assays with chicken oligo-nucleosomes.  Results showed that both forms of the 
enzyme were equally active for K36 methylation, indicating that the SRI domain is not 
required for the catalytic activity of Set2 in vitro (Fig. 2.6B).  In fact, we find that a region of 
Set2 encompassing contains the AWS, SET, and postSET domains (amino acid residues 1-
260 in Set2) is fully active for histone methylation in vitro, indicating that the C-terminus of 
Set2 does not intrinsically regulate its HMT activity (data not shown).  
Set2 methylation influences transcription elongation and RNAPII occupancy on genes.   
Growth phenotypes observed in the presence of the drug 6-azauracil (6AU) are 
frequently used as indicators of defects in transcription elongation (Exinger and Lacroute, 
1992; Mandal et al., 2002; Wu et al., 2003; Morillon et al., 2003b).  We therefore asked 
whether deletion of SET2, or prevention of the Set2-RNAPII association by deletion of the 
SRI domain, would exhibit 6AU-dependent phenotypes.  We began by examining the 6AU 
phenotypes caused by Set2 deletion in several strain backgrounds.  Various wild-type 
(W303, BY4742/SC288C, YCB652) and matched set2D strains were grown on control 
media (no drug) or media containing 6AU.  The parent strain YCB652 contained integrated 
URA3 gene, which is required for the 6AU assay, while others were transformed with the 
URA3 plasmid pRS316 (Smith et al., 2000).  The survival and colony sizes of each strain 
were monitored after several days of growth and compared to control plates.  As shown in 
Figure 2.7A, we found that deletion of SET2 in these strain backgrounds resulted in a 
significant resistance phenotype to 6AU.  Similar results were also observed when we used 
media containing mycophenolic acid, another drug that reveals elongation defects but 
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through a mechanism unique from 6AU (data not shown).  Furthermore, we analyzed a dst1 
null strain of the BY4742 background and observed the characteristic 6AU sensitivity known 
to exist for this mutant (Fig. 2.7A and see (Archambault et al., 1992; Orphanides et al., 
1999; Wu et al., 2003).   
 Given previous studies have demonstrated that a proper response to 6AU is the 
induced expression of the IMD2 gene, which is a result of the elongation machinery’s 
response to depleted nucleotide pools (Shaw et al., 2001), we sought to verify that the 
resistance phenotype observed in the set2∆ deletion mutant was not due to an aberrant 
effect on the metabolism of 6AU.  Using semi-quantitative RT-PCR, we monitored the 
expression levels of IMD2 and SNR6 (a RNA polymerase III transcribed gene used as a 
control) in the presence or absence of 6AU.  As shown in Figure 2.7B, we found that the 
expression of the IMD2 gene was increased to equal degrees in both WT and set2∆ strains 
in the presence of the drug, confirming that the loss of Set2 results in a bona fide 
transcription elongation defect.  Importantly, the IMD2 gene was not induced in the absence 
of 6AU for either the WT or set2∆ strains, indicating that Set2 does not act to repress the 
basal expression of this gene (Fig. 2.7B).  In addition to our results with Set2, 6AU 
resistance has also been observed from the deletion or mutation of a variety of other 
elongation factors including Chd1, Bye1, Isw1, and forkhead factor 1 (Alen et al., 2002; 
Woodage et al., 1997; Wu et al., 2003).  
 Since transcription elongation defects are typically correlated with changes in the 
occupancy and distribution of RNAPII along genes, we therefore asked whether the loss of 
Set2 would result in an alteration in RNAPII levels on actively transcribed genes.  Using an 
antibody that recognizes the general levels of RNAPII irrespective of its phosphorylation 
status (Schroeder et al., 2000), we examined RNAPII levels on the promoters and coding 
regions of active genes in WT and set2∆ strains by ChIP.  As shown in Figure 2.7C, we 
found that RNAPII levels in the set2 deletion mutant were significantly increased in the 
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middle to late coding region of the actively transcribing SCC2 gene, as compared to the WT 
control strain.  Interestingly, the gene locations that showed an RNAPII increase were also 
the same locations determined to be highly methylated by Set2 (see Fig. 2.6C), suggesting 
the possibility that a relationship may exist between regions of chromatin highly methylated 
at K36 and RNAPII occupancy potential.  We next examined a variety of other active genes 
in the set2 deletion mutant to determine how general this RNAPII defect would be.  We 
examined the promoter and coding regions of TOM1, MDN1, PMA1, ENO1, and FIR1 for the 
presence of RNAPII as described above and found a similar pattern of RNAPII increase in 
the set2 deletion mutant as was observed for SCC2 (data not shown).  We addressed the 
possibility that the observed increases in RNAPII might be a result of a general increase in 
transcript formation for these genes in the absence of Set2.  Indeed, Set2 has been shown 
to play a role in the basal repression of GAL4 (Landry et al., 2003).  We therefore examined 
the expression of the genes indicated above by semi-quantitative RT-PCR and observed 
that the increased density of RNAPII did not correlate with any change in the steady-state 
mRNA levels (Fig. 2.7D and data not shown).  These mRNA results were also confirmed 
independently by examining the gene expression microarray profiles found in WT and set2∆ 
cells (personal communication, N. Krogan and J. Greenblatt).   Furthermore, we also 
examined TBP levels by ChIP at the promoters of several genes listed above (SCC2 and 
TOM1) and found no significant increases in TBP occupancy in the set2 deletion mutant 
(data not shown).  Our data indicate that Set2 does not function as a basal repressor of the 
genes analyzed, but rather affects the precise levels of RNAPII on genes, further supporting 
the 6AU results suggesting that Set2 can influence RNAPII elongation.   
 The above results suggest Set2 is important for transcription elongation, but do not 
reveal whether this function of Set2 is dependent on its association with RNAPII and/or K36 
methylation.  To test if loss of the interaction between Set2 and RNAPII is responsible for 
the elongation defect, we assayed the growth of the SRI deleted (Set2(1-618)-3Flag), SET2 
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deleted, and the Set2-3Flag strains using 6AU.   We observed that deletion of the SRI 
domain resulted in a resistance to 6AU that was similar to the set2 deletion mutant, 
indicating that the interaction between Set2 and RNAPII is necessary for the normal 
transcription elongation functions of Set2 (Fig. 2.8A).  
 We next asked whether K36 methylation per se is important for the activity of Set2 in 
this process.  In one case, we transformed set2∆ cells with a plasmid coding for either full-
length Set2 (SET2) or a form of Set2 containing a point mutation (set2R195G) that has been 
shown to abolish K36 methylation activity in vitro and in vivo (Strahl et al., 2002).  We found 
that expression of SET2 in the set2∆ strain nearly restored WT levels of 6AU sensitivity (Fig. 
2.8B).  However, set2∆ cells expressing set2R195G showed resistance to the drug (Fig. 2.8B), 
consistent with a role for K36 methylation in the elongation process.  In the second case, we 
asked whether amino acid substitutions at K36 that prevent methylation (K36A and K36R) 
would result in resistance to 6AU and RNAPII density increases.  As shown in Fig. 2.8C, the 
K36A and K36R strains were significantly resistant to 6AU as compared to the wild-type H3 
strain (WT), whereas strains with mutations at other sites of methylation (K4 and K79) or 
sites of phosphorylation (serine 10) were not.  In addition, the 6AU resistance caused by the 
K36A or K36R mutations were not suppressed by mutation of lysine 4 (Fig. 2.8C, 
K4R/K36R).  Significantly, we also found the same pattern of increased RNAPII density in 
the K36A strain as with the set2∆ strain (Fig. 2.8D), suggesting that the specific lack of K36 
methylation is the primary cause of the 6AU phenotype and RNAPII defect.  These data 
strongly implicate the methylation by Set2 as being functionally important in the elongation 
process.   
 
2.4  Discussion 
 Recent work in S. cerevisiae has revealed an unexpected role for the Set1 and Set2 
histone methyltransferases in transcription elongation.  Although several studies found that 
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Set2 associates with the elongating polymerase, we found that the C-terminus of Set2, 
independent of the WW domain, was responsible for this interaction (Fig 2.1; (Xiao et al., 
2003b).  Despite the discovery of the Set2-RNAPII interaction, very little is known regarding 
the influence of Set2 or K36 methylation on transcription elongation.  Our results presented 
in this chapter reveal that (i) a novel region in the C-terminus of Set2, but not including the 
WW domain as previously reported, is necessary and sufficient for the functional interaction 
between Set2 and RNAPII; (ii) this domain, which we have named the SRI domain, is within 
amino acids 619-718 of Set2 and bind with high affinity to doubly-phosphorylated CTD 
repeats; (iii) the Set2-RNAPII interaction, established through the SRI domain, is required 
for H3 K36 methylation; and (iv) K36 methylation mediated by Set2, in particular, influences 
RNAPII density along the 3’ end of certain genes and therefore suggests are role in RNAPII 
elongation.   
A novel phospho-CTD binding motif in Set2.  
Based on recent observations of other RNAPII CTD-interacting proteins, we 
expected that the WW and/or coiled-coil regions in Set2 would mediate its association with 
RNAPII.  Surprisingly, neither of these domains were found to be involved in RNAPII binding 
as demonstrated in Figs. 2.1-2.5.  Instead, a region from 619-733 in Set2, which we have 
termed the SRI domain, was found to be both necessary and sufficient for Set2-RNAPII 
interaction.   This is in conflict with an earlier report which stated that the WW domain of 
Set2 is required for the association of this enzyme with RNAPII (Li et al., 2002).  However, 
the technical approach used in this earlier study to analyze the involvement of the WW 
domain in RNAPII interaction employed a genomic insertion of the TAP tag in front of the 
WW domain of Set2, which removed its entire C-terminus including the SRI domain.  Even 
though the WW and/or coiled-coil regions in Set2 are not likely to be involved in its 
association with RNAPII, they may play important roles in Set2 function by mediating the 
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association of Set2 with other phosphorylated proteins and/or itself since Set2 is thought to 
exist as a homodimer in the cell (Schaft et al., 2003; Strahl et al., 2002). 
 Through further examination of the binding requirements of the SRI domain, we 
uncovered that this domain binds preferentially to the CTD phosphorylated at both serines 2 
and 5, as compared to the singly-phosphorylated form or a charge-control peptide (Fig. 
2.5C).  This discovery strongly suggests that a synergistic relationship between CTD 
phosphorylation and Set2 binding exists.  Interestingly, Ser2 phosphorylation is 
predominantly found in the body of genes while it has been thought that Ser5 
phosphorylation is generally restricted to the promoters and 5’ region of these same genes.  
Recent studies, however, reveal that Ser5 phosphorylation is indeed found at significant 
levels throughout the transcribed regions of genes (Ahn et al., 2004).  Furthermore, a recent 
paper has noted that CTDK-I preferentially phosphorylates serine 2 of the heptad repeat 
only when the serine 5 position is already phosphorylated  (Jones et al., 2004).  Thus, it 
seems likely that doubly phosphorylated CTD epitopes exist in yeast that may serve to direct 
the interaction of Set2 (and perhaps other phospho-CTD-interacting proteins).  
 Based on our blast search analysis, the SRI domain appears to be conserved in 
other organisms only in proteins that have a domain architecture nearly identical to that of 
Set2 (those containing AWS or SAC, SET, Post-SET, and WW; see Table 1).  We take 
these data to suggest that the SRI domain is a probable indicator of proteins that are bona 
fide functional homologues of Set2.  Consistent with this, we have determined that a 
construct containing the SRI region of HYPB (see Table 1) binds directly to the 
phosphorylated CTD.  Furthermore, later studies in our laboratory also reveal the putative S. 
pombe homolog of Set2 (see Table 1) to be a robust K36 HMT that also interacts with 
RNAPII (Morris et al., 2005).  Based on these observations, it is likely that Set2 and K36 
methylation have a conserved function in transcription elongation.  
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A role for H3 K36 methylation in transcription elongation.   
Previous studies have implicated Set2 in the transcription elongation process.  This 
has been established not only by the numerous biochemical and genetic analyses that have 
been performed on Set2, but also by the use of 6AU, a drug commonly used as an indicator 
for elongation defects.  The compound 6AU depletes the available nucleotide pool by 
inhibition of the enzyme IMP dehydrogenase (IMPDH), which is responsible for catalyzing 
the rate-limiting step in de novo synthesis of GTP (Jackson et al., 1975; Exinger and 
Lacroute, 1992; Hyle et al., 2003).  Inhibition of IMPDH results in a challenge to the 
transcription elongation machinery, which is continually in need of free nucleotides. Thus, 
strains with altered transcription elongation function display a sensitivity to the drug different 
from their wild-type parent strain.  Our 6AU assays revealed that SET2 deletion or deletion 
of the region coding for the SRI domain itself results in resistance to the drug, whether the 
URA3 gene is genomically inserted or carried ectopically on a plasmid (Fig. 2.7A).  This is in 
contrast to some previous studies that showed that set2 mutants are modestly sensitive to 
6AU (Krogan et al., 2003b; Li et al., 2002; Schaft et al., 2003).  While it is unclear why 
varying 6AU results have been reported, it is noteworthy that others have also seen a 6AU 
resistance phenotype with set2 deletion mutants (Li et al., 2003; Xiao et al., 2005) and D. 
Stillman, personal communication), indicating the differences may lie in context-specific 
differences in the genetic background used.   
 In addition to set2 deletion, resistance to 6AU has also been observed in strains 
mutated for a number of other factors including Ess1, Bye1, Chd1, Isw1, and Fkh1 (Alen et 
al., 2002; Wu et al., 2003; Woodage et al., 1997).  Many of these factors have been shown 
to influence transcription elongation via regulation of specific phases in the transcription 
elongation cycle such as the transition between elongation and initiation or termination (Wu 
et al., 2003; Morillon et al., 2003b; Morillon et al., 2003a).  While 6AU phenotypes alone are 
not sufficient to allow conclusions regarding the mechanistic details of how a protein affects 
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the elongation phase of transcription, 6AU resistance can be interpreted as a consequence 
of increased elongation efficiency resulting from the deletion of a factor which negatively 
regulates elongation.  Indeed, it was found that strains deleted for the Ess1 suppressor, 
Bye1, display resistance to 6AU, and this protein may negatively regulate transcription 
elongation by inducing RNAPII pausing at elongation-arrest sites (Wu et al., 2003).  In 
addition, Chd1-null strains were found to exhibit 6AU resistance, which may be due to an 
indirect effect on elongation by its influence on termination (Alen et al., 2002; Woodage et 
al., 1997).  
In an effort to better understand the nature of the 6AU phenotype of the set2 deletion 
mutant, we examined the distribution of RNAPII along genes.  Interestingly, we found that 
RNAPII levels significantly increased at the 3’ ends of genes in the absence of Set2 or when 
methylation is inhibited (Figs. 2.7C, 2.8D).  Furthermore, this increase generally paralleled 
K36 methylation levels, indicating the possibility of a direct mechanistic link between the 
levels of K36 methylation and RNAPII occupancy (Figs. 2.6C, 2.7C).  While our results 
strongly implicate K36 methylation as having a direct role in RNAPII elongation, the precise 
role is currently unclear.  We propose three possibilities based on an influence of K36 
methylation on any of the three general phases of transcription: 1) K36 methylation may 
generate a chromatin structure that is less permissive for RNAPII passage.  In this case, 
K36 methylation acts as a negative regulator of RNAPII elongation, and the loss of this 
‘mark’ permits increased RNAPII density and passage along genes.  However, since the 
termination event at the 3’ end would be under tight checkpoint control and would be rate 
limiting, the loss of K36 methylation would result in a buildup or backlog of RNAPII across 
the gene, while overall transcript production remains consistent.  Such a buildup of RNAPII 
might be viewed as advantageous to cells when presented with 6AU stress.  2) Set2 
mediated K36 methylation could influence transcription initiation, allowing additional RNAPII 
association and initiation, but with a relatively fixed rate of termination the RNAPII could 
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accumulate at the 3’ of a gene.  Finally, 3) termination efficiency could be diminished in the 
absence of K36 methylation.  Thus, similar to chd1 mutants, the reduced efficiency of 
termination would result in a backlog of RNAPII across the gene.  Among these possibilities, 
we suggest scenario one is most likely, given the 6AU resistance of set2∆ strains and the 
fact that negative regulators of RNAPII elongation have been found to result in 6AU 
resistance when these genes were deleted.  In summary, our results provide strong 
evidence that K36 methylation, mediated by the SRI-dependent association of Set2 with 
RNAPII, plays a role in the elongation phase of transcription.  This result is further supported 
by a genome-wide studies completed during the course of our work that revealed 
H3K36me2 is present solely on RNAPII transcribed genes (Rao et al., 2005).  The rise of 
microarray analysis of histone modifications has become crucial to studies in the field of 
chromatin biology, and will be discussed further in Chapter 5.  Whether Set2’s elongation 
role is mediated through the association of factors that bind to K36 methylation, or through 
the ability of this modification to control chromatin structure directly by regulating 
nucleosome-nucleosome or nucleosome-DNA interactions was unknown at the time of this 
work, has been of keen interest in later studies as will be discussed in Chapter 3-5.  
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S. cerevisiae
C. albicans
H. sapiens
M. musculus
D. melanogaster
N. crassa
S. pombe
6322293
46435920
30410779
38090181
24641786
32403484
2408044
619-718
723-820
1956-2056
2393-2493
2262-2356
569-653
703-778
species gene namei gi accession identity/similarity to SRI domainii
n/a
35% / 55%
23% / 37%
23% / 37%
21% / 39%
19% / 37%
17% / 42%
Set2
Ca019.9324
HYPB
XP_135176
CG1716
XP_322355
SPAC29B12
Table 2.1  Putative Set2 homologues identified by PSI-BLAST searching with the 
SRI domain
i All proteins identified contain a domain architecture similar to yeast Set2, including the AWS, 
SET, postSET and in some cases WW domains.  It is notable that the putative SRI domains, as 
with Set2, are found in the C-termini of these proteins.
ii Identity refers to the percentage of identical amino acids present between the yeast Set2 SRI 
domain and the putative SRI domain of the indicated homolog, while similarity indicates amino 
acid replacements that exhibit similar charge or hydrophobicity. 
protein sequence 
position of putative
SRI domain
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Figure 2.1: The C-terminus of Set2 interacts with the phosphorylated CTD of RNAPII.
(A) Schematic representation of the Set2-Flag constructs used to probe for RNAPII 
interaction.  The SET domain along with its flanking Cys-rich domains (AWS and PS), WW 
domain (WW), and coiled-coil motif (CC) are shown.  All constructs contained a C-terminal 
Flag epitope.  (B) set2∆ cells were transformed with either vector only or the indicated
Set2-Flag constructs and WCEs were prepared.  These extracts were immunoprecipitated 
with the α-Flag antibody followed by immunoblot analysis with the (H5; α-Ser2P), (H14; α-
Ser5P), or α-Flag antibodies.  Sizes of the molecular weight markers are shown and 
asterisks indicate the location of expected Set2-Flag products.  All input extracts showed 
equivalent levels of hyperphosphorylated RNAPII (data not shown). 
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Figure 2.2: Identification of a novel region in Set2 required for RNAPII binding.
(A) Schematic representation of the Set2 constructs used to probe for RNAPII interaction 
as in Fig. 2.1.  (B) set2∆ cells were transformed with either vector only or plasmids coding 
for the indicated Set2-Flag construct and whole cell extracts (WCE) were prepared.  WCEs
were immunoprecipitated with a-Flag beads followed by immunoblotting with antibodies 
directed against serine 5 phosphorylated CTD (H14; α-Ser5P), serine 2 phosphorylated 
CTD (H5; α-Ser2P), or the Flag epitope.  Significant to mention is that the H5 antibody may 
also recognize serine 5 CTD phosphorylation in addition to serine 2 phosphorylation (Jones 
et al., 2004).  Asterisks indicate the location of non-specific Flag antibody reactive species.  
(C) Schematic representation of the Set2-SRI domain constructs used to determine the 
boundaries of the functional SRI domain.  N- and C-terminal truncations of the SRI domain 
were made in fifteen amino acid increments as shown.  All constructs contained a C-
terminal Flag epitope.  (D) set2∆ cells were transformed with the indicated plasmids, WCE 
were prepared, and co-IPs performed using the antibodies indicated in (B).  Sizes of the
molecular weight markers are shown.
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Figure 2.3: The coiled-coil region in Set2 is required for H3K36me3, but dispensable 
for RNAPII interaction.
(A) Schematic representation of the Set2 constructs used for examining the coiled-coil (CC) 
region and potential effects on Set2-RNAPII interaction, as in Fig. 2.1.  (B) set2∆ cells were 
transformed with either vector only or plasmids coding for the indicated Set2-Flag construct 
and whole cell extracts (WCE) were prepared.  WCEs were immunoprecipitated with anti-
Flag beads followed by immunoblotting with antibodies directed against serine 5 
phosphorylated CTD (H14; α-Ser5P) or the Flag epitope.  Input levels of serine 5 
phosphorylated CTD are indicated at the top of the panel.  (C) Western blot of set2∆ cells 
transformed with the indicated constructs and blotted with antibodies directed against the 
Flag epitope (α-Flag), tri-methylated H3 lysine 36 (α-H3K36me3), or the C-terminus of H3 
(α-H3). 
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Figure 2.4: The SRI domain is required for interaction of Set2 with RNAPII.
(A) Yeast strains containing full length Set2 (Set2-3Flag) or a form of Set2 without the SRI 
domain (Set2(1-618)-3Flag) were made via genomic tagging with the 3xFlag epitope.  Whole 
cell extracts (WCEs) of these strains were immunoprecipitated with anti-Flag beads 
followed by immunoblotting with antibodies directed against serine 2 phosphorylated CTD 
(H5; α-Ser2P), serine 5 phosphorylated CTD (H14; α-Ser5P) or the Flag epitope.  Sizes of 
the molecular weight markers are shown and asterisks indicate the location of expected 
Set2-Flag products. (B) WCEs from the strains in (A) were incubated with anti-Flag resin 
and the resulting bound proteins eluted with 3xFlag peptide.  Eluted proteins were resolved 
by a 4-12% NuPAGE gel and examined by Coomassie staining.  Arrows indicate the 
protein identity of bands in the Set2-3Flag lane that were examined by Mass Spectrometry 
(MS), while analysis of parallel regions in the Set2(1-618)-3Flag lane were negative for the 
presence of Rpb1 or Rpb2.  Sizes of the molecular weight markers are shown.  This panel 
was prepared by H. Hall as a component of the published results (Kizer et al. 2005).  
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Figure 2.5: The SRI domain of Set2 binds synergistically to the phosphorylated CTD. 
(A) “Reverse” Far-Western.  GST-CTD and CTDK-I-phosphorylated GST-CTD (GST-PCTD) 
fusion proteins were subjected to SDS-PAGE and transferred to nitrocellulose.  Membranes 
were probed individually with purified recombinant full length MBP-Set2 (Set2) or with MBP-
SRI (Set2(619-733)), and the bound MBP fusions detected with an anti-MBP antibody.  As a 
control, a duplicate membrane was probed with an anti-GST antibody (α-GST) to 
demonstrate the presence of both GST-CTD fusion proteins.  (B) Increasing amounts of two 
MBP fusion proteins (Set2(1-618) and Set2(619-733)) were resolved in two SDS polyacrylamide
gels; one gel was subjected to Far-Western analysis with GST-32P-CTD as a probe, and the 
other was stained with Coomassie.  (C) BIACORE analysis of the SRI domain.  The MBP-
SRI fusion protein (MBP-Set2(619-733)) was analyzed by surface plasmon resonance 
(BIACORE) for binding to distinct phosphorylated synthetic three-repeat CTD peptides.  
These peptides were either Ser5 phosphorylated (5-phospho), Ser2 phosphorylated (2-
phospho) or both Ser2 and Ser5 (2+5-phospho) in each repeat (see Materials and Methods).  
Response Units, on the Y axis, represent binding to the peptides.  The binding response to a 
scrambled control peptide carrying six SerPO4 residues (see Chapter 2.2) has been 
subtracted from each of the three response curves.  Only the peptide carrying both Ser2PO4
and Ser5PO4 in each repeat revealed binding above control levels.  We estimate the affinity 
of this interaction, with subtraction of background binding to the control peptide, to be 6 µM.  
These experiments and panels were prepared by H. Phatnani and A. Greenleaf as a 
component of our collaborative work (Kizer et al. 2005). 
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Figure 2.6: Deletion of the SRI domain in Set2 abolishes H3 K36 di-methylation.
(A) Yeast nuclear extracts prepared from set2∆ cells or the indicated genomically tagged 
strains in the BY4742 background were probed with antibodies against di-methylated lysine 
36 at H3 (α-H3K36me2) to monitor the role of the SRI domain in global K36 methylation 
levels.  An antibody directed against the C-terminus of H3 (α-H3) was used as a loading 
control.  Nuclear levels of Set2 in these strains were monitored using the a-Flag antibody.  A 
similar loss of K36 methylation was observed when the SRI domain was genomically 
deleted in the W303 background (data not shown).  (B) Full-length (Set2-Flag) or SRI-
domain truncated (Set2(1-618)-Flag) recombinant forms of Set2, which also contained an N-
terminal MBP epitope, were prepared and analyzed for their HMT activity in vitro.  HMT 
reactions were prepared with bacterial lysates containing the indicated Set2 constructs with 
or without nucleosomes.  Identical samples were analyzed by the filter-binding assay (upper) 
and fluorography (middle).  Immunoblotting with the Flag antibody (lower) was performed to 
ensure equal amounts of protein were present in each reaction.  (C) WT or SRI-deleted 
yeast strains were analyzed by chromatin immunoprecipitation (ChIP) for K36 di-methyl 
levels on genes.  DNA isolated from the K36 methylation IPs was used in PCR reactions 
with primer pairs for the indicated regions of SCC2 gene (top).  PCR products of the input 
DNA (Input) and ChIP DNA (H3K36me2) are shown (middle).  The asterisks indicate the 
location of a PCR product pertaining to an intergenic region at chromosome V (ChV), which 
was used as a loading control in all PCR reactions.  The histogram displays the relative 
enrichment values for K36 di-methylation (bottom).  The values were calculated by dividing 
the ratio of band intensities for IP DNA/ChV with the ratio of intensities for the Input 
DNA/ChV.  Similar results were found for the PMA1, ENO1 and ADH1 genes (data not 
shown).  
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Figure 2.7: Deletion of SET2 results in an elongation phenotype and a disruption of 
RNAPII occupancy on genes.
(A) Various strains containing either wild-type (WT), set2∆ or dst1∆ alleles were plated on 
synthetic dextrose-uracil medium with or without 6-azauracil (6AU, 100 µg/ml) and grown at 
30°C for 2 to 3 days to monitor for transcription elongation phenotypes.  All strains contained 
the plasmid pRS316 containing the URA3 gene, except yeast strain YCB652, which 
contains an integrated URA3 gene.  Results using mycophenolic acid (100 µg/ml) were 
found to yield identical results (data not shown).  (B) The loss of Set2 does not aberrantly 
affect the increased expression of IMD2 in 6AU.  Semi-quantitative RT-PCR was used to 
monitor the expression of IMD2 and SNR6 (a pol III transcribed gene used as a control) in 
WT or set2∆ strains in the absence or presence of 6AU (50 µg/ml).  The results of RT-PCR 
reactions with (PCR amplification cycles indicated above) or without (-RT) reverse 
transcriptase are shown.  The fold change in IMD2 expression in each condition are 
indicated, based on averages of the three cycling parameters for each strain, with WT set to 
1.0 as reference.  This panel was prepared by Y. Shibata as a component of the 
collaborative project (Kizer et al. 2005).  (C) WT or set2∆ strains were analyzed by ChIP for 
RNAPII levels.  Isolated DNA from the RNAPII IPs were used in PCR reactions with primer 
pairs for regions of SCC2 as indicated in the schematic. The data shown represents the 
average of thirteen individual ChIP assays from separate cell pellets.  The standard error of 
the mean (SEM) is indicated.  Asterisks indicate the relative set2∆ RNAPII enrichment 
values that were statistically significant as compared to their WT counterparts (p<0.01 for 
primer set D and p<0.001 for primer sets E and F).  ChIP analyses using other antibodies 
against the RNAPII CTD (8GW16, Covance), Rpb3 (NeoClone), or the N-terminus of Rpb1 
(y-80, Santa Cruz), revealed a similar pattern of RNAPII distribution as displayed in the 
figure (not shown).  (D) SCC2 expression was unchanged in set2∆ despite the increased 
RNAPII density detected.  The expression levels of SCC2 and SNR6 (a pol III transcribed 
gene used as a control) were monitored by semi-quantitative RT-PCR as in (B), with the 
relative change in SCC2 expression for the set2∆ strain displayed relative to WT.  This 
panel was prepared by Y. Shibata as a component of the collaborative project (Kizer et al. 
2005). 
64
WT
SNR6
IMD2
set2∆+6AUWT+6AU set2∆
cycles 27x 31x 35x -R
T
27x 31x 35x -R
T
27x 31x 35x -R
T
27x 31x 35x -R
T
Fold Change 1.0 16.5 1.3 14.8
B
1.21.0
SNR6
SCC2
-R
TWT
cycles
set2∆
27x 31x 35x 27x 31x 35x -R
T
Fold change
D
C
0
8
16
24
32
40 ***
***
**
A B C D E F
WT
set2∆
R
el
at
iv
e 
R
N
A
PI
I 
en
ric
hm
en
t
TATAA1(ATG) 4482(Stop)
A B C D FE
SCC2
A -Uracil-Uracil +6AU
WT
set2∆W303
YCB652 WT
set2∆
WT
set2∆BY4742
dst1∆
65
Figure 2.8: K36 methylation directly influences transcription elongation.
(A) Genomically tagged strains containing either full length Set2 (Set2-3Flag) or Set2 
deleted of the SRI domain (Set2(1-618)-3Flag) were generated and assayed, as in Fig. 2.7A, 
for growth on 6AU as compared to WT and set2∆ strains.  (B) Set2∆ strains were 
transformed with a plasmid expressing wild-type Set2 (SET2) or a mutant form of Set2 
which abolishes its catalytic activity (set2R195G) and assayed for growth on 6AU as before.  
(C) Yeast strains (WZY42 derived) bearing various point mutations on histone H3 were 
assayed for growth on 6AU as in Fig. 2.7A.  (D) WT or set2∆ strains were analyzed by 
ChIP for RNAPII levels as in Fig. 2.7C. The histogram data is representative of two 
independent experiments which revealed similar results.
66
Aset2∆
Set2-3Flag
Set2(1-618)-3Flag
WT
-Uracil +6AU -Uracil
C
WT
-Uracil-Uracil +6AU
K36R
K4R
K4R/K36R
K79R
S10A
K79A
K36A
B
set2∆ + set2R195G
set2∆ + SET2
set2∆
WT
-Uracil +6AU -Uracil
D
A B C D E F
0
7
14
21
28
R
el
at
iv
e 
R
N
A
PI
I 
en
ric
hm
en
t
H3-WT
H3-K36A
67
  
 
 
 
CHAPTER 3 
 
 REGULATION OF SET2-CATALYZED H3 K36 METHYLATION: CTK1 AND THE HhH 
DOMAIN OF SPT6 REGULATE SET2 AND H3K36me3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Components of this chapter will be published as: 
Youdell, M.*, Kizer, K.O.*, Kisseleva-Romanova, E.*, Duro, E., Strahl, B.D., and Mellor, J. 
(2007) The transcription elongation factor Spt6 promotes trimethylation of lysine 36 on 
histone H3. (submitted to EMBO) 
 
* These authors made an equal contribution to this work.
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Summary 
 Transcription in eukaryotes by RNA polymerase II requires the regulated disruption 
and reassembly of nucleosomes. A variety of protein complexes have been identified that 
mediate nucleosome disassembly/reassembly during transcription including FACT 
(facilitates chromatin transcription) and Spt6.  Mutations in these histone chaperones lead to 
reassembly defects that result in the unregulated control of internal initiation in gene bodies.  
Here we show that Spt6 is required for Set2-catalyzed tri-methylation of histone H3 at lysine 
36 (H3K36me3). Specifically, we find that the HhH domain of Spt6, from amino acids 931-
994, is essential for H3K36me3, but not H3K36me1 or me2.   We further show that the loss 
of H3K36me3 is accompanied by a loss of Set2 at the protein level, indicating an important 
role for the HhH domain in Set2 stability.  Surprisingly, overexpression of Set2 in a Spt6 
HhH mutant fails to restore H3K36me3.  This data suggests that the HhH domain of Spt6 
regulates some aspect of chromatin structure that is important for Set2-catalyzed 
methylation, which is supported by in vitro studies using recombinant Set2 on chromatin 
from a spt6 mutant strain.  Further investigations reveal that Ctk1 controls Spt6 association 
to genes, and in agreement with this, the loss of Ctk1 also reduces Set2 proteins levels.  
While the mechanism for Ctk1 regulation of H3K36me3 is thought to be primarily through 
Ctk1 phosphorylation of the RNA polymerase II (RNAPII) carboxy-terminal domain, our work 
demonstrates a new pathway of Ctk1 regulation of H3K36me3.  Intriguingly, we find that the 
Bur1 kinase that stimulates RNAPII elongation also controls H3K36me3 and cryptic 
initiation, suggesting that Bur1, like Spt6, may be an upstream regulator of H3K36me3 via a 
similar mechanism of influence upon nucleosome organization. 
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3.1 Background 
Histone lysine methylation is not regulated in a generic fashion, but rather in unique 
ways, consistent with the theory of the histone code (Briggs et al., 2002; Jenuwein and Allis, 
2001; Lachner et al., 2003; Xiao et al., 2003b; Zhang and Reinberg, 2001).  Methylation at 
H3 K4 in yeast is regulated through association of the Paf1 complex with RNAPII, 
subsequent H2B ubiquitination by PAF complex members, and then methylation by Set1.  
H3 K4 methylation is dependent on phosphorylation at the Ser5 position along the CTD, 
whereas Set2 directly interacts with the RNAPII-CTD in a manner dependent on Ctk1 
phosphorylation of the Ser2 positions (Krogan et al., 2003b; Krogan et al., 2003a; Li et al., 
2003; Li et al., 2002; Ng et al., 2003b; Schaft et al., 2003; Xiao et al., 2003b).  Therefore 
Ctk1, with its role in maintaining RNAPII processivity along genes (Mason and Struhl, 2005), 
is also one factor involved in the regulation of Set2-catalyzed K36 methylation and its 
downstream function.  After the publication of results from our laboratory and others which 
suggested a repressive effect of H3 K36 methylation in transcription elongation (Kizer et al., 
2005; Li et al., 2003; Xiao et al., 2003b), several studies examined these effects in greater 
detail and found that H3 K36 methylation is a target for Rpd3C(S) binding through its Eaf3 
member (Carrozza et al., 2005; Joshi and Struhl, 2005; Keogh et al., 2005).  Through the 
K36me-Eaf3/Rpd3 association, Set2 can direct deacetylation at H3K14 and H4K12 in the 
coding regions of genes.  Removing acetylation associated with the elongating polymerase 
is important to repress spurious transcription initiation from cryptic start sites within certain 
ORFs.  These new data, published since the work presented in Chapter 2 (Kizer et al., 
2005; Xiao et al., 2003b), promoted our interest in determining the pathway by which Set2 
activity is regulated, and will also be discussed further in Chapter 5 where we present an up-
to-date picture of the role and regulation of K36 methylation.  As Set2 is known to be linked 
to transcription and RNAPII density along certain genes (Kizer et al., 2005; Li et al., 2003; 
Schaft et al., 2003; Xiao et al., 2003b), we selected two factors for examination, which at the 
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time, were known to be involved in the regulation of chromatin structure or certain phases of 
RNAPII transcription.  In this chapter we describe our attempt to better understand the 
regulation of Set2 through an examination of these factors. 
 One factor we investigated for involvement in the regulation of Set2 activity is the 
Bur1 kinase, which was examined in an earlier study for its role in transcription elongation.  
Through the study by the Buratowski group, Bur1 kinase was examined for its ability to 
phosphorylate the CTD of Rpb1 (Keogh et al., 2003).  Unlike Ctk1 or Kin28, Bur1 was not 
found to be a significant source of CTD phosphorylation in vivo, however it was found to 
associate with actively transcribing genes and to interact genetically with Ctk1, suggesting 
that Bur1 is required for efficient transcription elongation.  The role of the Bur1/2 kinase in 
transcription was later expanded by others who showed that Bur1 and Bur2 selectively 
regulate H2B ubiquitination and H3 K4 tri-methylation (Laribee et al., 2005; Wood et al., 
2005a).  Through studies of the Rpd3C(S), it was also discovered that deletions of the 
Rpd3C(S) members, or SET2 deletion, could rescue the growth of BUR1 null strains, which 
are otherwise characterized as inviable (Keogh et al., 2003; Keogh et al., 2005).  Based on 
these data we considered whether Bur1 would also regulate Set2 activity on genes.   
 In addition, existing data suggests that Spt16-Pob3 (yeast FACT) is involved in 
transcription elongation through genetic and physical interactions with defined elongation 
factors (Formosa et al., 2002; Krogan et al., 2003b; Squazzo et al., 2002).  Other evidence 
suggested FACT may influence transcription initiation including data that FACT contributes 
to the repression of cryptic initiation (Kaplan et al., 2003; Malone et al., 1991).  Preliminarily, 
we tested whether Spt16 and Set2 may functionally interact, however we found no evidence 
for an interaction in vivo or in vitro despite several attempts (data not shown).  Although we 
initially considered FACT as a candidate protein in the upstream regulation of Set2, a recent 
paper from the Stillman laboratory, in collaboration with members of the Strahl lab, tested 
this hypothesis and found that SET2 deletion can suppress the growth defects of a spt16 or 
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pob3 mutation (Biswas et al., 2006).  In their publication, they concluded that Set2 and 
FACT have opposing roles in transcription, as FACT promotes binding of RNAPII at 
promoters, while Set2 negatively regulates transcription as suggested by our earlier work 
(Kizer et al., 2005) and later by others (Carrozza et al., 2005; Joshi and Struhl, 2005; Keogh 
et al., 2005).   
  Secondly, we considered Spt6 as a possible regulator of Set2 function based in part 
on evidence that it controls the elongation and termination phases of transcription (Hartzog 
et al., 1998; Kaplan et al., 2003; Kaplan et al., 2005).  Spt6 is capable of assembling 
nucleosomes in vitro and binding to H3 (Bortvin and Winston, 1996).  As RNAPII transcribes 
through nucleosomes, histone removal and deposition are, in general, in equilibrium 
(Kristjuhan and Svejstrup, 2004; Schwabish and Struhl, 2004).  Due to the ability of Spt6 to 
bind H3, others have postulated that Spt6 contributes to the maintenance of nucleosome 
integrity during the eviction and deposition occurring during transcription (Formosa et al., 
2002; Saunders et al., 2003).  Interestingly, it was also shown that certain Spt6 mutations 
result in faulty nucleosome reformation across genes and cryptic initiation from within certain 
genes (Kaplan et al., 2003).  Based on these data we postulated that Spt6 is an upstream 
regulator of Set2 function.   
 Here we present an analysis of these candidate upstream regulators of Set2.  
However, several publications released while our studies were in progress either validated 
our preliminary data or resulted in changes to our hypotheses.  These will be addressed in 
the Results and Discussion sections.    
 
3.2 Materials and Methods 
Yeast strains, genetic manipulation, and media 
 Yeast rich media (YPD) was prepared as 1% yeast extract, 1% peptone, and 2% 
dextrose.  Media containing raffinose (YPR) or galactose (YPG) contained 2% raffinose or 
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2% galactose in place of dextrose.  Yeast cultures (100ml) were grown in YPD, YPR, or 
YPD (as indicated) at 30°C with shaking, or at 39°C for 90min for inactivation of the spt6-
1004 allele.  S. cerevisiae strains are based on the BY4741 background (Open Biosystems) 
unless otherwise indicated.  The FY2181 “WT” Mata leu2∆1 his4-912, lys2-128, 
SPT6/FLAG, and FY2180 “spt6-1004” Mata leu2∆1 his4-912; lys2-128; spt6-1004/FLAG 
were a gift of F. Winston.  The bur1 double-deletion strains were a kind gift of S. Buratowski 
(Keogh et al., 2005).  Genetic manipulations in these strains were performed using single 
step gene replacement with DNA fragments generated by PCR amplification (Gelbart et al., 
2001).  Genetic manipulations were confirmed by PCR detection of disruption cassettes and 
then by western blotting.   
Generation of an antiserum specific for Set2 
Bacterially expressed, recombinant Set2 containing N-terminal amino acids 1-261 
was prepared using induction and purification procedures as previously described (Strahl et 
al., 2002).  This N-terminal Set2 fragment was emulsified in Freund’s Complete Adjuvant 
and injected into rabbits following protocol and procedures from Covance, Inc.  The resulting 
bleeds from several injected rabbits were screened for specificity to Set2 via western blot 
analysis of yeast wild-type and set2∆ whole cell extracts.  Antisera were compared to the 
matched pre-immunune serum for each rabbit as a control, and the bleed of highest 
antibody avidity was selected.   
Preparation of WCE and immunoblotting 
 WCEs and western blotting protocols were performed as described in our earlier 
publication and presented in Chapter 2.2.  The source and blotting concentrations of the 
H3K36me3, general H3, and G6PDH antibodies are described in Chapter 4.2 and were 
previously reported (Kizer et al., 2006).  The Set2 antiserum was used at a concentration of 
1:11000 except where otherwise indicated. 
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Co-immunoprecipitation 
Co-IP experiments involving the WT and spt6-1004 strains with the genomic GAL1-
SET2 fusion were performed essentially as described previously (Ch. 2 and (Kizer et al., 
2005).  In brief, WCEs were prepared from GAL-induced cell pellets of the WT and spt6-
1004 strains.  Co-IPs contained 0.75 mg of extract brought to a final volume of 0.8 ml with 
Buffer II.  The components of the WCE Buffer II have been described previously (Kizer et al., 
2005; Kizer et al., 2006) and Chapter 2.2 and 4.2.  Each sample was then incubated with 3 
µl of Set2 (or H3 antibody in the case of the spt6-1004 Histone H3 Co-IP) strain HA antibody 
for 2 h at 4°C, after which 10 ml of protein A sepharose beads were added to each tube and 
incubated for an additional 1 h.  After incubations, the supernatant in each sample was 
separated from protein A beads by centrifugation, beads were rinsed 2 x 10 min with Buffer 
II, eluted using SDS-PAGE loading buffer and boiled 4 min prior to separation by SDS-
PAGE.   
Histone methyltransferase (HMT) assays 
Yeast strains containing SET2 expressed from GAL1 promoter were grown in 
raffinose to prevent Set2 expression. Whole cell extracts were prepared as described (Kizer 
et al., 2005), except that the extraction buffer contained 150mM NaCl, 50mM Tris pH 9.0, 
0.5mM EDTA and 10% glycerol. These extracts were then sonicated using the same 
procedure as described for the ChIP assay. Preparation and expression of full-length 
recombinant Set2 fused to calmodulin binding protein (rSet2) was performed essentially as 
described (Kizer et al., 2005; Strahl et al., 2002), where the resulting cell lysate was used 
directly for the in vitro histone methyltransferase assay. HMT reactions contained 100µg of 
sonicated yeast cell extract with or without 2µl of rSet2 lysate, HMT buffer (50 mM Tris-pH 
9.0), and 50µM S-adenyosylmethionine.  Samples were incubated for 45min at 30°C, 
resolved by SDS-PAGE and analyzed for H3K36 methylation by western blotting. 
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RT-PCR 
Total RNA was prepared using hot acid-phenol, reverse transcribed, and SET2 
mRNA was analyzed by our collaborators using real time PCR with a Corbett Rotorgene and 
Sybr Green mix (Sensymix, Quantace).  Real time PCR was used to amplify regions 
corresponding to those shown at STE11. Data was calculated (IP-NO)/TOT and expressed 
as a percentage of input.  Error bars reflect the standard deviation of the average signal 
obtained between different experiments (n=2 to 4).  The positions of SET2 primers, of 20 bp, 
were +1880 (forward primer) and +2019 (reverse primer), relative to the start site.   
 
3.3 Results 
Spt6 is required for H3 K36 tri-methylation 
 Earlier observations of an spt6 mutant revealed that, like set2∆, the spt6-1004 
mutation allows for initiation from cryptic sites within certain genes (Carrozza et al., 2005; 
Joshi and Struhl, 2005; Kaplan et al., 2003; Keogh et al., 2005).  As illustrated in Figure 
3.1A, the spt6-1004 mutation produces a form of Spt6 containing a deletion of the helix-
hairpin-helix (HhH) domain between residues 931-994 (Doherty et al., 1996; Kaplan et al., 
2000; Kaplan et al., 2003).  This mutation results in temperature sensitive growth and 
altered nucleosomal structure at 39°C, (Kaplan et al., 2003).  Therefore, we hypothesized 
that the spt6-1004 mutant, like set2∆, would have reduced or abolished K36me3.  Recently, 
the Prelich laboratory investigated this possibility and found that H3K36me3 was absent in 
the presence of the spt6-1004 mutation at a non-permissive temperature of 37°C (Carrozza 
et al., 2005; Chu et al., 2006).  Interestingly, we found that spt6-1004 mutation results in an 
abolition of H3K36me3 at both the permissive and non-permissive temperatures (Fig. 3.1B).  
The Spt6-1004 mutant can still interact with H3 at 30°C 
 Spt6 has been shown to function similar to a H3 chaperone (Bortvin and Winston, 
1996).  Through our collaboration with the Mellor laboratory, we asked whether the spt6-
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1004 mutant is incapable of interaction with H3, which could be related to the loss of H3 
K36me3.  Our collaborators found that FLAG-tagged Spt6 or spt6-1004 could equally co-
immunoprecipitate H3 in cell extracts prepared at the permissive temperature of 30°C (Fig. 
3.2A, used with permission).  In addition, our collaborators found that chromatin from the 
WT and Spt61004 strains, when analyzed by micrococcal nuclease digestion, revealed an 
equivalent ladder of nucleosomes at the STE11 locus (Fig 3.2B, used with permission).  
Collectively, these data along with previously published results (Kaplan et al., 2003; Kaplan 
et al., 2005) indicate that the Spt6 HhH domain is not required for H3 interaction or the 
distribution of nucleosomes at 30°C.  
Loss of the Spt6 HhH domain affects Set2 protein levels 
 We further examined the relationship between Set2 and Spt6 by monitoring the 
levels of Set2 protein in the spt6-1004 mutant at 30°C.  The FY2181 (WT) and FY2181 
(spt6-1004) strains were grown at 30°C, WCEs prepared and analyzed by western blotting 
with antibodies directed against H3 K36me3, H3 or the N-terminus of Set2.  In addition, the 
set2∆, ctk1∆, and WT strains of the BY4741 background were analyzed in parallel.  
Unexpectedly, we found a near complete loss of Set2 protein in the ctk1∆ and spt6-1004 
strains.  Although we note differences exist in the levels of Set2 across various WT strain 
backgrounds (Fig. 3.3A-B), the level of H3 K36me3 correlates with the amount of histone 
H3 in the extracts.  We then asked whether this loss of Set2 protein could be due to 
decreased steady state transcript levels.  As shown in Figure 3.3C, our collaborators found 
that SET2 mRNA levels in the spt61004 strain are equivalent to those in the WT strain.  This 
suggests that despite subtle variations in Set2 protein levels based on the parent strain 
background, Ctk1 and Spt6 may regulate H3 K36me3 at least in part, through Set2 protein 
levels.  Given this unexpected result suggests a link between Ctk1 and Spt6 in the 
regulation of Set2 function, we examined the Spt6 protein levels in a ctk1∆ strain.  We found 
that CTK1 deletion results in a significant reduction of Spt6 protein (Fig. 3.3D, used with 
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permission), indicating that in addition to regulating Set2-RNAPII binding via 
phosphorylation of the CTD, Ctk1 may also influence Set2 activity indirectly through the 
reduction of Spt6 protein abundance. 
The Spt6 HhH domain is required for H3 K36 methylation by Set2 
 Given our results in Fig. 3.3A suggest that the absence of H3 K36me3 in the spt6-
1004 mutant is due to reduced Set2 protein levels, we then predicted that a restoration of 
Set2 protein would restore H3 K36me3 in the spt6-1004 strain. We restored Set2 protein 
levels in the WT and spt6-1004 strains by expressing SET2 from its genomic locus using the 
GAL1 promoter and then inducing SET2 through growth in galactose.  Similar levels of Set2 
protein were detected in WCE prepared from the WT and spt6-1004 strains when induced 
with galactose (Fig. 3.4A, lanes 7 and 8), while no Set2 is detectable in these same strains 
grown in raffinose (Fig. 3.4A, lanes 3 and 4).  Unexpectedly, restoration of full Set2 protein 
levels in the spt6-1004 strain was unable to restore H3 K36me3 (Fig. 3.4A).  Although Set2 
protein levels were restored in the spt6-1004 strain, we reasoned that the inability of Set2 to 
methylate H3 K36 could be due to a defect in Set2’s ability to bind to RNAPII.  Using our N-
terminal Set2 antibody, we performed co-IPs in both the WT and spt6-1004 strains when 
SET2 is driven by the GAL1 promoter and expression is induced.  When we blotted for the 
presence of RNAPII, we found that Set2 from both the WT and spt6-1004 strains were able 
to immunoprecipitate phosphorylated RNAPII-CTD equally well (Fig. 3.4B).  This result 
demonstrates that the inability of Set2 to methylate chromatin in the spt6-1004 strain is not 
due to an inability of Set2 to interact with the polymerase.  Collectively, these data support 
an intriguing possibility that the HhH domain of Spt6 is required for Set2 activity on genes, 
perhaps by arranging nucleosomes in a manner suitable for recognition by Set2.   
Spt6 may configure H3 within nucleosomes for recognition by Set2 
To test our hypothesis that Spt6 configures nucleosomes for recognition by Set2, we 
analyzed chromatin from the WT and spt6-1004 strains in which SET2 is not expressed 
 78
(Fig. 3.4A lanes 4 and 5).  Using extracts from these strains as a source of chromatin, we 
incubated with or without recombinant Set2 and S-adenosylmethionine (SAM) for 30 min at 
30°C.  We analyzed these reactions by western blotting using antibodies directed against 
H3 K36me3, H3, or Set2.  In support of our hypothesis, we detected a significant reduction 
in the ability of recombinant Set2 to methylate chromatin from the spt6-1004 extract as 
compared to the WT extract (Fig. 3.5).  For the control reactions, no H3 K36me3 was 
detectable when the extracts were incubated in the absence of recombinant Set2 (Fig. 3.5, 
lanes 3 and 4) or in the absence of SAM (data not shown).  These results suggest that the 
chromatin in the spt6-1004 strain is defective as a substrate for Set2.   
Bur1 kinase is required for H3 K36 tri-methylation 
Based on genetic interaction data (Krogan et al., 2002a) and published results 
showing that mutations in the BUR kinase can lead to cryptic initiation patters similar to Spt6 
mutations, we next examined a potential upstream effect of Bur1 on Set2-catalyzed H3 
K36me3.  As deletion of BUR1 is inviable, we could not measure H3 K36me3 in that 
background, but instead examined a strain deleted of the Bur1 cyclin, Bur2.  Indeed, by 
western blot analysis we found that global H3 K36me3 levels in a bur2∆ strain are nearly 
abolished (Fig. 3.6A).  These data were in agreement with earlier unpublished results by R. 
Laribee and T. Xiao. 
Given deletion of SET2 and downstream factors (Rpd3C(S) members) were found to 
suppress lethality of a BUR1 deletion, and that bur1 and bur2 mutations were shown earlier 
to result in cryptic initiation within the FLO8 gene (Kaplan et al., 2003), we next asked 
whether H3 K36me3 is affected in these strains.  The rescued growth of the BUR1 deletion 
in these double-deletion strains allowed us to test whether the absence of Bur1 would affect 
global levels of H3 K36me3.  Interestingly, deletion of the genes coding for Rpd3C(S) 
members Eaf3, in combination with BUR1 deletion, resulted in a loss of H3 K36me3 (Fig. 
3.6B).  These results are in support of a regulatory role for Bur1 upstream of Set2.  In 
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support of these data, a later publication from the Prelich laboratory independently observed 
these results and further characterized the Bur1 effect on K36me3 at a gene specific level 
(Chu et al., 2006). 
 
3.4 Discussion 
 The proteins Ctk1, Bur1, and Spt6 are already known to be required for proper 
transcription initiation or elongation (Kaplan et al., 2003; Keogh et al., 2003; Xiao et al., 
2003b).  We have demonstrated in this work a defect in H3K36me3 in a bur1, bur2, or spt6-
1004 mutant (Fig. 3.1 and 3.6), which during the course of our studies has been confirmed 
by recent independent observations (Chu et al., 2006).  Our work presented here, along with 
other recent studies (Chu et al., 2006; Laribee et al., 2005), suggests that a likely 
component of Bur1 and Spt6’s influence on transcription initiation and elongation is through 
their influence on H3K36me3.  As discussed below, we propose a model whereby Ctk1, 
Bur1, and Spt6 influence H3K36me3 either directly or indirectly through proper configuring 
of nucleosomes prior to and after each round of transcription.  To arrive at this model, we 
will first consider data regarding Spt6, followed by a discussion of Bur1 and then incorporate 
new and old data regarding Ctk1. 
Spt6 as an upstream regulator of Set2 
 Collectively, the work presented here (and that of others) has demonstrated a link 
between Spt6, H3 K36 methylation and the repression of cryptic initiation (Figs 3.1-3.6) 
(Chu et al., 2006; Kaplan et al., 2003; Kaplan et al., 2005; Keogh et al., 2005).  Prior work 
has already implicated Spt6, Spt4, and Spt5, in transcription initiation and elongation 
(Hartzog et al., 1998).  Of particular interest is our observation that the spt6-1004 mutation 
leads to a reduction of Set2 protein levels.  The spt6-1004 allele is deleted of the HhH 
domain, a domain which is suggested to recognize and bind to DNA (Doherty et al., 1996).  
Although this region is absent in spt6-1004, this strain has been shown to maintain normal 
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nucleosome density and positions at the permissive temperature (Kaplan et al., 2003; 
Kaplan et al., 2005).  A disruption of H3 levels and nucleosome density over active genes is 
detected at the non-permissive growth temperature for spt6-1004 of 39°C (Kaplan et al., 
2003), while the binding of Spt6 to H3 is unaffected in the spt6-1004 strain at the permissive 
temperature (Fig. 3.2B).  As this additional loss of function is only detected during heat-
inactivation of spt6-1004, it would appear that Spt6 has distinct functions including: 1) a 
histone chaperone function required for nucleosome positioning (Kaplan et al., 2003) and 2) 
a DNA binding capability via the HhH domain leading to separate downstream functions 
such as H3K36 methylation (Bortvin and Winston, 1996; Doherty et al., 1996).  The distinct 
functions of Spt6 is supported by data of other Spt6 mutants which have normal levels of 
H3K36me3, still contain the HhH domain, yet are defective for chaperone function (Chu et 
al., 2006).   
 We propose the following possibilities which could explain the regulation of 
H3K36me3 by Spt6. 1) Through the ability of the Spt6 HhH domain to bind DNA, we 
propose that Spt6 regulates the orientation and/or configuration of nucleosomes in a manner 
conducive for Set2 catalysis of H3K36 methylation, which may first require Spt6 to bind 
histones via its histone chaperone activity.  Our results presented in Figure 3.5 support this 
model, as do other published data (Kaplan et al., 2003; Kaplan et al., 2005).  We do not rule 
out a potential effect of Spt6 on any of the recently identified histone demethylases (for 
recent review, see (Shi and Whetstine, 2007), as will be discussed further in Chapter 5.  Yet, 
based on our model, what is the cause of the reduction in Set2 protein levels?  We note that 
an influence of Spt6 in the proper translation of Set2-coding mRNA cannot yet be ruled out, 
however we predict that the absence of a properly configured nucleosomal substrate for 
Set2 releases the protein for targeting by degradation machinery.  This is consistent with 
recent data that revealed an abnormally short half-life for Set2 (Belle et al., 2006).  The 
preference of Set2 for properly configured nucleosomes is suggested by earlier data 
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revealing Set2’s preference for nucleosomes over free histones in vitro (Strahl et al., 2002).  
2) Spt6 may stabilize Set2, perhaps through a direct or indirect interaction with Set2, 
dependent in some unknown fashion on the HhH domain of Spt6.  We note that our 
collaborators were unable to detect any interaction between Set2 and Spt6 in vivo, however 
the possibility remains that Spt6 stabilizes Set2 indirectly through Spt6 interaction with an 
unknown factor.  3) Spt6 may recruit other factors to chromatin via its HhH domain, which in 
turn affects chromatin structure and/or Set2 in a way that promotes Set2 recognition of 
nucleosomal substrates.  Consistent with this possibility, Spt4 and Spt5 have been found to 
interact with Spt6 and also influence nucleosomal structure (Krogan et al., 2003b; Lindstrom 
et al., 2003; Swanson and Winston, 1992).  In addition, a recent report reveals a striking 
similarity between the functions of Spt6 and Spt2, such as Spt2 association with the coding 
regions of genes, repression of transcription from cryptic promoters, and regulation of the 
histone H3 levels over transcribed regions (Nourani et al., 2006).  When SPT2 deletion was 
combined with deletions of either CDC73 (PAF complex) or HIR3, but not SPT2 deletion 
alone, cryptic transcription was observed as with spt6-1004 (Nourani et al., 2006).  
Strikingly, the recruitment of Spt2, also a histone chaperone, was found to be defective in 
the spt6-1004 mutant  (Nourani et al., 2006).  Spt2 has also been shown to directly recruit 
polyadenylation machinery (Hershkovits et al., 2006).  4) Finally, the HhH domain itself may 
adjust the chaperone function of Spt6, allowing it to adjust nucleosomal structure in a way 
not yet understood.  We considered this possibility based on the recently identified 
acetylation within Hsp90 which allows subsequent regulation of this protein’s chaperone 
function (Scroggins et al., 2007).  Based on existing data, the first and third possibilities 
described above  are the most consistent with the established coupling of histone 
modifications with the regulated disruption and reassembly of nucleosomes during 
transcription, as chromatin shifts between a transcriptionally permissive or non-permissive 
state (Mellor, 2006a; Workman, 2006).  We therefore have based our model of Spt6 function 
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on the first explanation described above, which also appears most consistent with data 
regarding the effects of transcription factors Bur1 and Ctk1 on H3K36 methylation as 
discussed below. 
Bur1 kinase as an upstream regulator of Set2 
 The Bur1 kinase has already been shown to selectively influence H3K4 tri-
methylation through reduction of Paf1 complex-mediated H2B ubiquitination (Laribee et al., 
2005; Wood et al., 2005a).  We and others have observed a reduction of H3K36 methylation 
in bur1 or bur2 mutants, while Bur1 is also implicated in the pathway of Set2 regulation via 
genetic links between Bur1, the Rpd3C(S) members (Eaf3 and Rco1), and Rad6 (Fig. 3.6, 
(Chu et al., 2006; Keogh et al., 2005).  How is this regulation of Set2-dependent H3K36 
methylation accomplished by Bur1?  We suggest the following three possibilities to address 
this question.   
One possibility involves an influence of Bur1 on other transcription elongation factors 
with similar function, such as the yeast DSIF complex, which includes Spt4 and Spt5.  
Recently it was shown that when Spt4 is absent, a selective reduction of H3K4me3 results 
(Qiu et al., 2006).  In addition, this reduction follows, and is dependent on, a similar 
reduction of PAF complex recruitment to genes.  Based on similarities between the roles of 
yeast DSIF and Bur1 in the regulation of H3K4me3 and PAF-mediated H2B ubiquitination, 
we suggest that Bur may influence Spt4 and Spt5 which then regulate chromatin integrity in 
a manner similar to that which we proposed for Spt6.  It is also interesting to note that Spt6, 
like Spt4 and Bur1, has been shown to affect the recruitment of the PAF complex member 
Ctr9 to genes, although Spt6’s effect does not appear significant enough to affect H3K4me3 
levels (Chu et al., 2006; Kaplan et al., 2005).  In addition to the similar functions of Spt6 and 
Spt2 described earlier, we note that Spt2 has been shown to interact genetically with PAF.  
Most importantly, PAF is required for Spt2 recruitment to transcribing genes.  As Bur1 has 
been shown to affect PAF complex-mediated H2B ubiquitination, it follows that Bur1 may 
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affect Spt2 recruitment to genes, via the Bur1 effect on PAF (Nourani et al., 2006).  As 
described earlier, deletion of SPT2 in combination with deletion of CDC73 (PAF), but neither 
deletion alone, results in cryptic transcription as seen with mutation of SET2, BUR1 or 
SPT6.  Consistent with these data, we found no defect in H3K36me3 in a SPT2 deletion 
strain (data not shown).  Based on the observation of a cryptic initiation defect in the SPT2 
and CDC73 double deletion strain, it remains a possibility that Spt2, with PAF complex, 
have redundant roles in the regulation of H3K36me3.  Mutation of Bur1 is known to cause 
cryptic transcription (Kaplan et al., 2003), consistent with an effect on H3K36me3, but is 
likely not due to Bur1’s effect on Paf1, since CDC73 deletion alone does not result in the 
presence of cryptic transcripts (Nourani et al., 2006).  This supports a model that one 
downstream function of Bur1, possibly through PAF, is to regulate other transcription factors 
such as Spt2 – a protein similar to function in Spt6 through configuring nucleosomes 
(Nourani et al., 2006).  We recognize that existing data indicates Spt4/5 and Spt6 may have 
opposing roles, however we also note that dual roles (positive and negative) have been 
reported for certain transcription factors, such as Spt4/5 (Lindstrom et al., 2003).  Further 
investigation of potential effects of Bur1 on Spt6, Spt2, or Spt4/5 will be crucial in testing this 
hypotheses.   
A second possibility of the mechanism for Bur1 regulation of Set2 involves Bur1-
mediated phosphorylation of Set2 (or other factors) which in turn influences Set2 recognition 
of nucleosomal substrates and subsequent catalysis of H3K36me3.  A third possibility is that 
Bur1 regulation of Set2 does not involve Spt2, Spt4/6 or Spt6, but rather the defect of 
H3K36me3 in a BUR1 deletion may be a consequence of general transcription defects in a 
BUR1 mutant.  This possibility could be consistent with observations that the level of 
H3K36me3 is correlated with actively transcribing genes, which would likely be affected by 
mutation of the transcription factor Bur1 (Keogh et al., 2003; Pokholok et al., 2005), as will 
be described further in Chapter 5.  These last two possibilities have been suggested by 
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others (Chu et al., 2006), however in our opinion, the first possibility is the most consistent 
with existing data demonstrating similarities of Spt4, Spt5, and Spt6 in the regulation of 
transcription elongation (Winston, 2001).    
An alternate mechanism for Ctk1 regulation of Set2-catalyzed H3 K36 methylation 
The enzyme Ctk1 was previously thought to regulate Set2 function solely through 
phosphorylation of Ser2 repeats along the CTD.  Our data are the first to reveal that Set2 
protein levels are nearly abolished in the absence of Ctk1.  In addition, Set2 protein levels 
are also reduced in a spt6-1004 mutant while Spt6 protein is itself in lower abundance when 
CTK1 is deleted.  Our work suggests a new mechanism for Ctk1 regulation of Set2-
catalyzed H3K36me3 - through Ctk1’s affect on the Spt6 protein.  
A model for nucleosomal integrity and Set2-mediated methylation during transcription 
It has been shown that strains containing either the spt6-1004 allele at 39°C, deletion 
of CTK1 or deletion of BUR2 have reduced histone H3 levels (Chu et al., 2006; Laribee et 
al., 2005; Xiao et al., 2007).  Could it be that spt6-1004, ctk1∆, or bur1∆ each result in a 
defect in nucleosome integrity via a conformation change of histone H3, while overall 
nucleosome density is unaffected, that results in the observed effects on Set2 protein and 
H3K36me3?  We propose a model, illustrated in Figure 3.7, whereby nucleosome integrity 
is influenced either directly as in the case of Spt6, or indirectly through Spt6 by Ctk1, or 
potentially via Spt2 by Bur1.  Defects in nucleosome integrity could restrict recognition by 
the methyltransferase Set2, and contribute to the downstream effect of increased acetylation 
and cryptic initiation.  We predict that when Set2 is unable to locate and bind to the proper 
substrate, it is subsequently targeted for degradation.   
Our model is consistent with suggestions that only certain histone modifications are 
present on a nucleosome at a particular point in the transcription cycle (reviewed in (Mellor, 
2006a).  As most studies, including ours, were performed in unsynchronized cells, changes 
in H3K36me3 could occur at various stages of transcription but would be missed using our 
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analysis methods.  Much work is needed to test this model.  We note that our observed 
results which indicate Set2 has a reduced ability to methylate chromatin in the spt6-1004 
strain (Figs. 3.1 and 3.4) only suggest a role that altered nucleosomes are the cause of this 
effect.  Even carefully purified nucleosomes from the spt6-1004 could potentially have an 
unknown negative regulator of Set2 present.  Ideally, future work will involve the preparation 
of reconstituted nucleosomes in the presence or absence of Spt6 (and compared to the 
Spt6 mutant of the spt6-1004 allele).  A thorough test of the  hypothesized pathways of 
Bur1, Spt6, and Ctk1 influence on Set2 (Fig. 3.7), regardless of the results, will provide for a 
greater understanding of the upstream regulation of Set2. 
 
 
Figure 3.1: Spt6 is required for histone H3 lysine 36 tri-methylation.
(A) Schematic representation of the protein products of the SPT6 or spt6-1004 strains.  The 
following domains and their known or predicted functions are indicated in the schematic.  
The YqgFc domain (YqgFc) is likely a non-functional derivative of a Holliday junction 
resolvase catalytic domain.  The Helix-hairpin-helix domain (HhH) is predicted to have 
generic DNA binding capability based on structural evidence of this domain in other proteins 
(Doherty et al., 1996).  The SH2 domain (SH2) was identified in humans as a phospho-
tyrosine recognition domain found to bind proteins at residues near, but not including, a 
phosphorylated tyrosine.  The putative coiled-coil motifs (CC) are also indicated.  The 
positions of the indicated domains and predicted functions were identified using the SMART 
database and published results (Kaplan et al., 2003).  (B) The indicated strains were grown 
at to the reported permissive (30°C) or non-permissive (39°C) temperatures for the spt6-
1004 allele (Kaplan et al., 2003) and WCEs were prepared.  Extracts were resolved by 
SDS-PAGE, and analyzed by western blot using antibodies directed against H3K36me3 
(αH3K36me3), the metabolic enzyme glucose-6-phosphate dehydrogenase (αG6PDH; 
loading control), or the C-terminus of H3 (αH3; loading control).  
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Figure 3.2: Spt6-dependent nucleosome density and H3-binding are unchanged in the 
spt6-1004 strain at 30°C.
(A) A micrococcal nuclease (MNase) digestion was completed using the indicated strains, 
cultured at 30°C, permeabilized and incubated with increasing concentrations of 
micrococcal nuclease (MNase; 15, 40, 75, 150, 300 and 600 units per ml) for 4 minutes at 
30°C.  DNA was isolated, separated by size and hybridized with a probe from the 3’ region 
of STE11.  The positions of migration of mono-, di- and tri-, tetra- and penta- nucleosomal 
sized fragments are indicated.  This panel and matching protocol were obtained from our 
collaborators, the Mellor laboratory, and used with permission from J. Mellor. (B) Total cell 
extracts from strains FY2181 and FY2180 expressing FLAG-tagged derivatives of Spt6 
cultured at 30°C were immunoprecipitated with (+) or without (-) anti-FLAG antibodies and 
precipitates collected on protein A sepharose.  Precipitated material, together with aliquots 
of the input cell extracts (Input, lane 1) and the supernatant remaining after separation of 
precipitates (Sup) with (+) (lanes 2 and 5) or without (-) (lanes 3 and 7) antibody were 
separated on a 15% gel and western blotted with an antibody to the C-terminal region of 
histone H3 (Abcam).  Lanes 4 and 6 are empty.  This panel and matching protocol were 
completed by our collaborators, the Mellor laboratory, and used with permission from J. 
Mellor.
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Figure 3.3: Ctk1 and Spt6 control Set2 protein stability.
(A) The indicated strains were grown at 30°C and WCEs were prepared.  Extracts were 
analyzed by western blotting using antibodies directed against Set2 (αSet2), H3K36me3 
(αH3K36me3), the metabolic enzyme glucose-6-phosphate dehydrogenase (αG6PDH; 
loading control), or the C-terminus of H3 (αH3; loading control).  (B) The indicated strains of 
the BY4741 background were grown as in part (A) and analyzed by western blotting using 
antibodies directed against Set2 (αSet2), H3K36me3 (αH3K36me3), or the C-terminus of 
H3 (αH3; loading control).  The cps30∆ strain (lacking the COMPASS member Cps30) was 
used as an additional positive control for the presence of Set2. The Set2 band of higher 
intensity, as compared to the same strain in (A), is due to a longer exposure time and higher 
antibody concentration (1:10000 vs. 1:11000) used here.  (C) Steady-state levels of SET2
mRNA were monitored using PCR amplification of SET2 and U4 snRNA primers.  The data 
are displayed as a ratio of signals for the SET2 mRNA over the U4 snRNA loading control.  
This panel and matching protocol were obtained from our collaborators at the Mellor 
laboratory and used with permission.  (D) WCEs were prepared from WT and ctk1∆ strains 
in which the HA-tagged Spt6 was expressed from the genomic locus.  HA-Spt6 levels were 
monitored by western blot using antibodies against HA (α-HA) and tubulin (atubulin) as a 
loading control.  This panel and matching protocol were obtained from our collaborators at 
the Mellor laboratory and used with permission.
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Figure 3.4: Over-expression of SET2 in the spt6-1004 strain cannot restore 
H3K36me3.
(A) WCEs were prepared from the indicated strains in which the GAL1 promoter was fused 
to the SET2 genomic locus.  Strains were grown at 30°C in raffinose (YPR) for repression of 
SET2 (lanes 1-4), or in galactose (YPG) to induce SET2 expression (lanes 5-8).  The 
extracts were analyzed by western blotting using antibodies against Set2, H3K36me3, 
histone H3, or G6PDH.  (B) Set2 from the spt6-1004 strain was assayed for association with 
RNAPII by Co-IP.  The indicated strains were grown in YPG to induce Set2 expression as in 
(A), and whole cell extracts were prepared.  Co-IPs were performed in a final volume of 0.8 
ml, equalized with extraction buffer, containing 1.5 mg of WCE protein.  The extracts were 
incubated with 4µl of Set2 Ab or 4µl of the matched pre-immune serum for 2 h at 4°C, after 
which each sample was incubated for 1h with 15 ml protein A sepharose beads (GE 
Healthcare).  The beads were then washed 2x10min in extraction buffer, eluted in SDS-
PAGE loading buffer, incubated at 100°C for 5 min, and bead-bound proteins analyzed by 
immunoblot analysis using antibodies targeted against the Ser5 phospho-CTD (H14, 
Covance Inc.) or the Set2 antibody.
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Figure 3.5: Chromatin from the spt6-1004 strain is a poor substrate for Set2.
The indicated strains were grown in YPR (raffinose) to ensure repression of SET2 under the 
GAL1 promoter. Equal amounts of sonicated whole cell extract were used in a histone 
methyltransferase (HMT) reaction in which the extracts were incubated with 50 µM SAM 
and with (lanes 1-2) or without (lanes 3-4) an equal amount of purified recombinant Set2 
(rSet2) (Kizer et al. 2005) at 30°C for 45 minutes.  Aliquots of the reaction were analyzed by 
western blot using antibodies against Set2, H3K36me3 and histone H3.  Asterisks indicate 
breakdown products of rSet2 and H3, likely due to incubation at 30°C during the HMT 
reaction. 
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Figure 3.6: Bur1 and Bur2 are required for histone H3 lysine 36 tri-methylation.
(A) WCEs of the BUR2 deletion strain and its matching parent strain (BY4741) were 
analyzed by western blot using antibodies against H3K36me3 (αH3K36me3) or the C-
terminus of H3 (αH3) as a loading control.  Approximately two times the extract amount was 
loaded for the BUR2 deletion strain (according to total protein concentration) due to the 
decreased histone levels reported for that strain (Laribee et al., 2005).  (B) Since BUR1
deletion is inviable, we tested whether BUR1 affects H3K36me3 using the indicated double-
deletion strains that were reported to rescue BUR1 lethality (Keogh et al., 2005).  WCEs of 
the indicated strains were analyzed by western blot using antibodies directed against 
H3K36me3 (αH3K36me3) or the C-terminus of H3 (αH3) as a loading control.  The 
indicated strains were a kind gift from the Buratowski laboratory.
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Figure 3.7: A possible model for the pathway of Ctk1, Bur1, and Spt6 effects on Set2.
Based on results from our laboratory and others, Ctk1, Bur1, and Spt6 are known to control 
H3K36me3.  We have demonstrated that Ctk1 and Spt6 influence Set2 protein levels and 
therefore may specifically regulate H3K36me3 using similar mechanisms.  Alternative 
possibilities for these effects are discussed in the text.  The reference abbreviations 
indicated in the illustration are as follows: a, (Lee and Greenleaf 1989); b, (Xiao et al. 
2003b); c, (Laribee et al. 2005); d, (Wood et al. 2005a); e, (Kaplan et al. 2003); f, (Nourani
et al. 2006); g, (Wood et al. 2003); h, (Krogan et al. 2003b); i, (Qiu et al. 2006); j, (Sun et al. 
2002); k, (Dover et al. 2002).
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CHAPTER 4 
 
ACCELERATED NUCLEI PREPARATION AND METHODS FOR ANALYSIS OF 
HISTONE MODIFICATIONS IN YEAST. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter was published as: 
 
Kizer K.O., Xiao T., Strahl B.D. (2006) Accelerated nuclei preparation and methods for 
analysis of histone modifications in yeast. Methods, 40, 296-302. 
 
* These authors made an equal contribution to this work.
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Summary 
The continuing identification of new histone post-translational modifications and 
ongoing discovery of their roles in nuclear processes has increased the demand for quick, 
efficient, and precise methods for their analysis.  In the budding yeast Saccharomyces 
cerevisiae, a variety of methods exist for the characterization of histone modifications on a 
global scale.  However, a wide gap in preparation time and histone abundance exists 
between the most widely used extraction methods, a simple whole cell extraction (WCE) and 
an intensive histone extraction.  In this work we evaluate various published WCE buffers for 
their relative effectiveness in the detection of histone modifications by western blot analysis.  
We also present a precise, yet  time-efficient method for the detection of subtle changes in 
histone modification levels.  Lastly, we present a protocol for the rapid small-scale 
purification of nuclei that improves the performance of antibodies that do not work efficiently 
in WCE, and aids in the detection of histone modifications that are low in abundance.  These 
new methods are ideal for the analysis of histone modifications and could be applied to the 
analysis and improved detection of other nuclear proteins. 
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4.1 Background 
The investigation of chromatin structure and function in eukaryotes continues to be a 
fast-paced field.  The basic unit of the highly organized chromatin structure is the 
nucleosome, in which ~147 base pairs of DNA is wrapped around an octamer of the core 
histone proteins (Kornberg, 1977; McGhee and Felsenfeld, 1980).  Chromatin is crucial for 
protection of the genome from environmental insult, as well as the regulation of all 
processes in eukaryotes using the DNA template, such as gene transcription, replication, 
and recombination.  The N- and C-terminal “tail” domains of the histone proteins extend 
away from the nucleosome core particle and, along with the globular domains, are targeted 
for various post-translational modifications including methylation, acetylation and 
phosphorylation (Briggs et al., 2002; Feng et al., 2002; Strahl and Allis, 2000).  Studies have 
revealed that these modifications are involved in transcriptional regulation, and likely specify 
a ‘histone code’ by which the proper regulation of chromatin structure and gene expression 
is maintained (Lachner and Jenuwein, 2002; Strahl and Allis, 2000; Turner, 2000).   
Histone methylation, in particular, has recently been intensely studied.  While lysines 
can be mono-, di-, or trimethylated, arginines can be either mono- or dimethylated (Briggs et 
al., 2001; Miranda et al., 2006; Santos-Rosa et al., 2002; Strahl et al., 1999; Strahl et al., 
2001; van Holde, 1989; Zhang and Reinberg, 2001).  Strikingly, recent studies show that the 
distinct methyl states of these residues can be independently regulated and are subject to 
demethylation (Eissenberg and Shilatifard, 2006; Klose et al., 2006; Laribee et al., 2005; 
Schneider et al., 2005; Shahbazian et al., 2005; Tsukada et al., 2006; Wood et al., 2005a).  
Modest or dramatic changes (local or genome-wide) in histone methylation can result in 
significant effects on chromatin organization, the outcome of other histone modification 
patterns, and gene transcription (Lee et al., 2005; Shilatifard, 2006; Wood et al., 2005b). 
Key to our understanding of chromatin function is the detection of even modest 
changes in the level of histone post-translational modifications.  Most often, detection 
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requires high-quality antibodies specific to the modification of choice and, in many cases, 
core histones extracted using a time-intensive procedure.  Analyses of global changes in 
histone modifications in yeast commonly begin with a whole cell extraction (WCE), however 
much variability exists in the components of buffers that are widely used (Briggs et al., 2001; 
Keogh et al., 2002; Kizer et al., 2005; Xiao et al., 2003b).  It is unclear whether the 
differences between these distinct extraction buffers (i.e. salt type and/or salt concentration) 
lead to changes in histone yield or purity.   
Outside of rapid WCE production, labor-intensive histone acid-extraction protocols are 
often needed to detect rare or low abundance histone modifications in yeast, which 
otherwise may be missed by the use of WCE alone (Seligy et al., 1980; Wintersberger et al., 
1973).  In addition, certain antibodies are difficult to use with WCE due to either low 
abundance of the antigen or a large relative amount of cytoplasmic proteins in the extract, 
resulting in detection of a large number of cross-reacting bands.  In these cases, the histone 
acid-extraction method can provide purified histones that are suitable for analysis by 
western blotting.  Although a variety of nuclear isolation/histone acid-extraction protocols 
over several decades have been described, the vast majority require large scale cultures 
and multiple time-consuming centrifugation and wash steps (Almer and Horz, 1986; 
Braunstein et al., 1993; Edmondson et al., 1996; Lowary and Widom, 1989; Santos-Rosa et 
al., 2003; Seligy et al., 1980; Wintersberger et al., 1973).  While a rapid method used to 
detect the histone ubiquitin moiety has been presented by others, an abbreviated method for 
the analysis of low-abundance nuclear proteins, histone methyl states, or for detecting small 
changes in methylation states would be beneficial (Kao and Osley, 2003).   
In this chapter, we compare several widely used WCE buffers with the goal of 
identifying whether a particular salt type or concentration would preferentially enrich for 
histones.  We also describe a titration loading method that maximizes the precision of 
histone modification analysis via WCE, an approach recently used to demonstrate changes 
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in various histone modification states (Laribee et al., 2005; Qiu et al., 2006).  Finally, we 
present a protocol for the small-scale and streamlined preparation of crude nuclei suitable 
for histone modification analyses by western blot procedures.  These crude nuclei are 
enriched in histones, and although the purity is not at the level of most histone purification 
methods that involve acid extraction, they provide an ideal starting material for the rapid 
analysis of histone modifications (and presumably other nuclear proteins) that are in low 
abundance or to which only low avidity antibodies are available.  
 
4.2. Methods 
4.2.1 Detection of histone modifications in budding yeast using whole cell extraction. 
Whole cell extraction (WCE) by glass bead disruption is the most common method of 
lysing yeast cells for histone modification analysis.  This method is rapid and effective for 
analyzing most histone modifications from a large number of yeast strains simultaneously.  
Interestingly, buffers have been used which contain a wide variety of salt types and 
concentrations, as well as other components (Briggs et al., 2001; Keogh et al., 2002; Kizer 
et al., 2005; Xiao et al., 2003b).  A recent publication thoroughly analyzed sample 
preparation methods and buffers for their effectiveness in global metabolite extraction, and 
reported that some buffer components enrich for certain metabolites (Villas-Boas et al., 
2005).  Therefore, will altering WCE buffer components such as salt type or concentration 
increase the relative yield of histone proteins extracted, and therefore result in clearer 
analysis with antibodies directed against histone modifications?  We investigated these 
questions using the following method. 
Yeast strains, antibodies, and buffers.  
The wild-type (WT), set2∆, rtf1∆, and bur2∆ strains in the BY4741 background used in 
this and following sections were obtained from Open Biosystems.  The extraction buffers 
evaluated for effectiveness in detecting histone modifications are described in Table 4.1.  
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The antibodies used to detect histone modifications were from Upstate Biotechnology and 
used at the following concentrations for western blotting: H3 lysine 36 di-methyl 
(H3K36me2, catalog 07-274) used at 1:3000 dilution, general H3 C-terminal (H3, catalog 
05-928) for loading controls used at 1:10000 dilution, H3 lysine 4 di-methyl (H3K4Me2, 
catalog 07-030) used at 1:25000, H3 lysine 79 di-methyl (H3K79me2, catalog 08-835) used 
at 1:5000 dilution, and H3 lysine 4 tri-methyl (H3K4me3, catalog 07-473) used at 1:5000.  
Additional antibodies obtained from Abcam were used as follows: H3 lysine 36 tri-methyl 
(H3K36me3, catalog 9050) used at 1:3000 dilution, and H3 lysine 79 tri-methyl (H3K79me3, 
catalog 2621) used at 1:3000 dilution.  Secondary antibodies used were sheep anti-mouse 
IgG Horseradish peroxidase and anti-rabbit IgG peroxidase linked (GE Healthcare), each 
used at 1:5000 dilution.  
Comparison of various extraction buffers for effectiveness in detection of histone 
modifications. 
Described below is the method utilized for comparison of various WCE buffers and 
their effectiveness in histone modification analysis.  The approach follows a common WCE 
preparation using four unique published buffers, differing primarily in their salt type and salt 
concentration (Briggs et al., 2001; Keogh et al., 2002; Kizer et al., 2005; Xiao et al., 2003b).  
Complete descriptions of the buffer components are presented in Table 1. 
1. Yeast WT, set2∆, and rtf1∆ strains were grown overnight and each was inoculated 
into fresh 100 ml YPD at a starting O.D.600 of 0.1.  Cells were grown to an O.D.600 of 
1.1, then each 100 ml culture was separated into four identical 25 ml portions, 
pelleted, and stored at -80 °C.   
2. The cell pellets were thawed on ice, washed, and then re-suspended in 400 µl 
extraction buffer.  A unique extraction buffer (see Table 1) was used in the lysis of 
one pellet from each of the three strains: WT, set2∆, rtf1∆.  
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3. WCE was performed for each sample according to a published method, differing in 
the extraction buffers and loading amounts (Briggs et al., 2001).  The extraction 
method consisted of cell cultures (5 ml) grown overnight, diluted in fresh 100 ml 
YPD culture to a starting O.D.600 of 0.1, and grown to a final O.D.600 of 1.0.  Pelleted 
cells were resuspended in extraction buffer and then disrupted by acid-washed 
glass beads using a mini-beadbeater (Biospec Products) for 3 x 30 sec pulses with 
1 min on ice between each step.  Tube bottoms were punctured, and cell extracts 
were separated by brief centrifugation.  Lysates were clarified by centrifugation at 
16,000 x g for 15 min, after which the supernatant (WCE) was transferred to a fresh 
tube for protein analysis. 
4. WCE protein concentrations were determined using Coomassie Plus reagent 
(Pierce Biochem) according to the manufacturer’s directions and assayed using the 
Bradford method. 
5. Following addition of 10 µl 2 x Laemmli SDS-PAGE loading buffer to 10 µl of each 
WCE, the samples were boiled for 5 min. 
6. Samples (30 µg) were resolved by SDS-PAGE using a 15% acrylamide gel. 
7. Resolved proteins were transferred to PVDF (Millipore Immobilon-P) using a Hoefer 
TE-77 semi-dry transfer unit at 45 mA per 8 x 7 cm membrane for 90 min total. 
8. Membranes were each blocked in 10 ml of a 5% non-fat dry milk solution and TBS 
(50 mM Tris pH 8.0, 138 mM NaCl, 2.7 mM KCl) at room temperature for 1 h.  
Histone modifications were detected by incubation of primary antibody overnight at 
4 °C.  Membranes were then washed 2 x 5 min in TBS-Tween (TBS + 0.1% Tween 
20), and secondary antibodies were added to a fresh 10 ml solution of 5% milk and 
TBS-Tween with incubation at room temperature for 2 h, then washed as before.  
Membranes were developed using the ECL Plus Western Blotting Detection Kit (GE 
Healthcare) according to the manufacturer’s directions. 
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The relative effectiveness of each buffer tested is presented in Fig. 4.1.  Although we 
initially predicted that changes in salt type or concentration of the WCE buffers would 
result in a significantly greater elution of proteins and/or histones in the lysate, we found 
that analysis of total protein concentration revealed that the concentration of all WCEs 
examined were nearly the same - within 10% (data not shown).  In addition, we found 
that the relative concentration of histones and the background binding of the antibodies 
to cellular proteins were nearly identical regardless of the buffer components tested 
(data not shown).  These data indicate that changes in the salt types or concentrations 
(i.e. ionic strength) within the ranges we tested have little to no effect on the global 
extraction of protein in the WCE method, nor does it affect the purity of histones 
extracted.   
4.2.2. Titration and stripping approach for precise detection of changes in specific histone 
modifications 
To determine whether a gene deletion or mutation affects a particular histone 
modification, histones from the wild type and deletion strain must be equally loaded for 
comparison.  In most cases, especially when a deletion completely abolishes a histone 
modification, the histone loading amount may not be critical.  However, when a deletion only 
partially reduces or increases a given histone modification, loading too much WCE (or using 
too high an antibody concentration) can cause an over or underestimate of the amount of 
modified histone.  In addition, loading too little WCE could appear as though a factor 
abolishes a particular modification when it may only moderately reduce that modification.  
To address this issue, we have combined a titration assay and membrane stripping 
procedure.  The membrane stripping approach we present here ensures proper comparison 
between modification levels and equal histone loading, as variations in sample loading or 
transfer efficiency are common and can make for difficult interpretations.  This method is 
particularly useful when more than one histone modification is being investigated.  In our 
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experience, a single membrane can be stripped and reused up to four times if the 
membrane has not dried after each immunoblotting assay.  The titration and stripping 
approach is described below.   
1. Prepare cells and WCE using a general method such as that described in section 
4.2.1. 
2. For each mutant or strain to be analyzed, load at least three different amount of 
protein in adjacent gel lanes.  Suggested ranges should begin near 10 µg of WCE 
and increase at two or three-fold increments when using the Hoefer Mighty Small 
gel apparatus (1.0 mm spacers, 10 well combs).   
3. Analyze the extracts using a standard western blotting approach for the first 
antibody of choice. 
4. Begin the stripping procedure by placing the membrane in a plastic bag filled with 
~10 ml stripping buffer (65 mM Tris-HCl pH 6.8, 2% SDS, 0.75% β-
mercaptoethanol). 
5. Seal plastic bag and put it in water bath set at 55 °C for 30 min.  Invert bag 3 times 
every 10 min. 
6. Decant stripping buffer, and transfer membrane to a box.  
7. Wash membrane with 1 x TBS at room temperature for 5 min, repeat 3 times. 
8. Verify that the membrane is stripped of the first antibody by re-probing with the 
matching secondary antibody and ECL.   
9. Proceed to standard immunoblotting assay with the next antibody. 
The effectiveness of this approach is demonstrated in Fig. 4.2.  The use of at least three 
WCE concentrations per strain in adjacent lanes makes it likely that at least one lane will 
not produce a saturated signal when blotted with the desired antibody.  This, in 
combination with the stripping approach, allows for effective screening of defects in 
histone modification levels that may otherwise be missed in a cursory screening.  We 
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note that while a stripping approach is recommended, a non-stripping approach that 
involves examining parallel blots can also be effective, although it may require multiple 
independent repeats to quantitatively detect a subtle change in a particular histone 
modification. 
4.2.3. Detection of histone modifications when only low-avidity antibodies are available or 
the modification is in low abundance 
For detecting histone modifications in yeast by western analysis, two types of histone 
preparations are generally used: the WCE method and histone acid-extraction method.  The 
choice depends on the quality of antibody and/or the relative abundance of the particular 
histone modification of interest.  In the first method, all cellular proteins are extracted with 
one simple buffer, which allows rapid preparation of histones along with other cellular 
proteins.  However, since the histone abundance is generally low as compared to a histone 
acid-extraction procedure, the WCE method is most useful when antibody avidity is high.  
The second method is designed to first isolate nuclei from cells followed by detergent 
washes and acid extraction; therefore, its histone yield is much higher than in the first 
method.  However, existing versions of this method in the literature require significant time 
and effort (Almer and Horz, 1986; Braunstein et al., 1993; Edmondson et al., 1996; Lowary 
and Widom, 1989; Santos-Rosa et al., 2003; Wintersberger et al., 1973).  For this reason, a 
histone purification method is only used when antibody avidity is low, or if the modification of 
interest is rare. 
Small-scale accelerated nuclei preparation 
Here we present a modified nuclear extraction method to detect histone modifications.  
Typical large-scale histone purification methods require approximately seven hours of 
preparation time once the cell pellet is obtained.  This small-scale method requires less than 
half the time of a histone purification method (3 h versus 7 h), yet is superior to WCE for the 
detection of low-abundance histone modifications or when an antibody of low avidity is 
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utilized.  In addition, the common nuclei cushion step of most histone purification methods is 
omitted.  The required culture volume is also decreased to 200 ml, from the 1 L volume 
commonly used in histone purifications.  The protocol for this approach is described below. 
1. Yeast strains are grown overnight and inoculated into fresh 200 ml YPD at a starting 
O.D.600 of 0.1.  Inoculated cultures are grown at 30°C with shaking to an O.D.600 of 
1.1.  
2. Centrifuge cells at 4000 x g for 15 min at 4 °C, then wash once with 40 ml ice-cold 
H2O, and spin as before.  For convenience, pellets can be frozen at -80 °C at this 
step. 
3. Suspend each pellet in 3 ml of spheroplasting buffer (1 M Sorbitol, 50 mM K2HPO4 
pH 6.5 buffer, 0.018% β-mercaptoethanol).  Cells pellets should be mixed gently in 
this and subsequent steps. 
4. Centrifuge cells 3500 x g for 10 min at 4 °C. 
5. Suspend each pellet in 3 ml of spheroplasting buffer containing 40 units/ml Zymolase 
100T (MP Biomedicals). 
6. Incubate mixture at 30 °C for 30 min (when ~90 % of the cells should be 
spheroplasted).  Complete spheroplasting can be analyzed by measuring the O.D.600 
in a 1:100 dilution of spheroplasts with 1% SDS.  The reaction should not proceed 
longer than 45 min due to the risk of shearing nuclei. 
7. Centrifuge the spheroplasted cells at 4000 x g for 5 min. 
8. Wash spheroplasted pellets in 3 ml of spheroplasting buffer (without Zymolase). 
9. Gently pellet again as in step 7. 
10. Suspend each pellet in 8 ml lysis buffer (18 % Ficoll 400, 20 mM K2(HPO4) pH 6.8 
buffer, 1 mM MgCl2, 0.5 mM EDTA pH 8.0, 2 mM phenylmethylsulfonyl fluoride 
(PMSF), 1 µg/ml leupeptin, 1 µg/ml pepstatin and 1 µg/ml aprotinin. 
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11. Lyse cells with 20 strokes of a small Dounce homogenizer with pestle A (we find that 
pestle A is easier to use yet just as effective as pestle B).  This step is performed on 
ice.  The homogenizer should be rinsed as follows:  
a. Pour lysed cells into a sterile tube and wipe the homogenizer handle along 
the tube interior. 
b. Pour 4 ml of fresh lysis buffer over the handle into homogenizer. 
c. Use a pipette to rinse inside of homogenizer with the remaining lysis buffer. 
d. Pipette the buffer rinse into the conical tube, resulting in 12 ml final volume of 
homogenized solution. 
12. Spin samples at 3500 x g for 10 min to remove cell debris (nuclei in supernatant, 
debris is in pellet). 
13. Transfer supernatant into (16 x 76 mm) tubes and pellet nuclei in Type 50 Ti rotor at 
50,000 x g for 35 min 
14. Suspend nuclei in 200 µl NP buffer (0.34 M sucrose, 20 mM Tris-HCl pH 7.4, 50 mM 
KCl, 5 mM MgCl2, with protease inhibitors added as in step 10.  Vigorous pipetting 
may be required to suspend the nuclei pellet.  Aliquot and store nuclei at -80 °C. 
Using the above protocol, nuclei were prepared from the WT, set2∆ and rtf1∆ strains 
and western blot analysis was performed as in section 4.2.1.  As shown in Fig. 4.3, this 
method is effective for a variety of difficult antibodies such as the H3K36me2 or H3K79me3.  
However, when comparing WCE versus nuclei, it is evident that nuclei provide no additional 
benefit when using antibodies that perform well in WCE (Fig. 4.3, compare H3K4me3 and 
H3K36me3 blots).  While one might predict that increasing the WCE load could allow for an 
increased signal for difficult antibodies (see Fig. 4.3 H3K79me3 and H3K36me2 blots), we 
note that the maximum amount of WCE that can be loaded is near 100 µg when using our 
gel apparatus (see section 4.2.2).  Beyond this WCE maximum load, the extract lodges in 
the well and the high protein concentration results in significant smearing and insufficient 
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resolution of bands.  In our experience, dramatic increases in WCE loading do not 
significantly improve western results with poor performing antibodies.  Importantly, 
equivalent protein concentrations were used between WCE and nuclei (WCE: 60 µg and 
nuclei: 15, 30, and 60 µg), thus confirming that the nuclei preparation method enriches for 
the histone proteins and is superior to WCE for the detection of histone modifications.  In 
addition to the analysis of histone modifications, the purified nuclei could be useful for the 
analysis of any nuclear protein that may otherwise be undetectable in WCE due to low 
antibody avidity or a low relative abundance of the protein in total cellular extract. 
 
4.3 Concluding Remarks 
The methods and approaches outlined in this article provide for time-saving and 
precise global analysis of even modest changes in histone modifications.  We have provided 
three key points concerning the analysis of histone modifications in yeast: (i) altering the salt 
type or salt concentration (ionic strength), within the ranges we tested, results in little to no 
improvement in the ability to detect histone modifications; (ii) a titration and membrane 
stripping approach is superior in gauging quantitative changes in histone modification levels; 
and (iii) our abbreviated nuclei preparation method is beneficial in the detection of rare 
histone modifications or if an antibody’s avidity is low.  
Interestingly, changes in the ionic strength or salt concentration of WCE buffers do not 
lead to an appreciable change in the total protein concentration extracted or enrichment of 
histones (Fig. 4.1).  Empirically, there is greater freedom in buffer components than may 
have been predicted.  Also of importance is the observation that modest changes in histone 
modification levels could be missed in a cursory screen of WCEs.  The results shown in Fig. 
4.2 demonstrate that a careful, yet rapid analysis of yeast extracts using a titration and 
stripping approach aids in identifying genes, that when deleted, may have a minor, yet 
biologically relevant change in specific histone modification levels.  This approach has been 
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utilized in several recent reports to demonstrate selective changes in specific histone 
modification states (Laribee et al., 2005; Qiu et al., 2006).  Without the use of this titration 
approach, a factor with genuine effects on a specific histone modification could appear to 
have no effect (Fig. 4.2A,B compare lanes 1,4,7 and 3,6,9).  Also presented here is an 
abbreviated nuclei preparation procedure, which provides a midpoint in quality and time 
expenditure between the rapid WCE and a time-consuming histone acid-extraction (Fig. 
4.3).  Previously, use of antibodies with low avidity often resulted in low-quality blots and 
required large-scale preparation of core-histones or nuclei for clear detection (Laribee et al., 
2005; Shahbazian et al., 2005).  The enriched histone procedure provided through the 
abbreviated nuclei preparation presented in this report is also applicable for use with 
antibodies that have low avidity or when there is a low abundance of the target 
modification/protein in the cell that would be difficult to analyze using WCE (see Fig. 4.3 
WCE vs. nuclei).  In a similar manner, the enriched nuclei could also be of use for the 
analysis of low-abundance nuclear proteins.  Collectively, the applications discussed in this 
article allow for clear and reproducible detection of nuclear proteins and/or global changes in 
histone modification levels. 
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Table 4.1: Extraction buffers evaluated for effectiveness in detecting histone modifications
 Buffer Ia Buffer IIb Buffer IIIc Buffer IV d 
Salt type and 
concentration 320 mM (NH4)2SO4 300 mM NaCl 600 mM NaCl 200 mM KC2H3O2 
Other 
componentse 
 
200 mM TRIS-HCl 
pH 8.0 
 
20 mM EDTA pH 
8.0 
 
10 mM EGTA pH 
8.0 
 
5 mM MgCl2 
1 mM DTT 
10% glycerol 
protease inhibitors 
50 mM TRIS-HCl 
pH 8.0 
 
1 mM EDTA 
0.1% NP40 
1 mM Mg(C2H3O2)2
1 mM imidazole 
10% glycerol 
protease inhibitors 
10 mM TRIS-HCl 
pH 7.4 
 
5 mM EDTA 
300 mM sorbitol 
5 mM MgCl2 
10% glycerol 
protease 
inhibitors 
20 mM HEPES 
7.6 
 
1 mM EDTA 
10% glycerol 
protease 
inhibitors 
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Figure 4.1:  Evaluation of WCE buffer components reveals equal effectiveness in the 
detection of histone methyl modifications.
A 100 ml culture of the indicated strains was separated into four identical pellets, and WCE 
were prepared for each pellet using one of four distinct buffers (see Table 4.1 for a complete 
list of buffer components).  WCEs (30 µg) were resolved by SDS-PAGE, transferred to 
PVDF, and probed with antibodies directed against H3 di-methyl lysine 4 (αH3K4me2), tri-
methyl lysine 4 (αH3K4me3), tri-methyl lysine 36 (αH3K36me3), and di-methyl lysine 79 
(αH3K79me2).  An antibody directed against the C-terminus of H3 (αH3) was used as a 
loading control.  Cell pellets, buffers, and extracts prepared by K. Kizer, western transfer 
and blots prepared T. Xiao.
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Figure 4.2:  Titration and stripping approach is helpful for the precise detection of 
changes in histone modification levels.
(A) Following the standard WCE protocol (see Section 4.2.1.), extracts were prepared from 
WT, set2∆ and bur2∆ strains using Buffer II described in Table 4.1.  The titration approach 
consisted of three concentrations of extract from each strain resolved by SDS-PAGE and 
transferred to PVDF (generally a range between 10 and 90 µg).  Each membrane probed for 
a histone modification was stripped and re-probed for the H3 loading control.  We note that 
the use of the same membrane to blot for the loading control and modification of interest 
avoids the complications that arise from variations in gel loading and transfer efficiency 
which occur between gels.  However, we also find that comparisons between two 
independent membranes (one probed for the modification of interest and one probed for the 
histone loading control) generally results in a similar conclusion, but is best confirmed with 
multiple independent repeats.  Asterisks denote non-specific bands.  Cell pellets, buffers, 
and extracts prepared by K. Kizer, western transfer and blots prepared T. Xiao.  (B) 
Quantification of band intensities for the H3K36me3 blot is displayed as a ratio of 
H3K36me3 band intensity to the corresponding H3 loading control. Band intensities are 
plotted relative to the WT level (set to 100%) in each lane.  Important to note is that at the 
highest concentration loaded, bur2∆ appears to effect a negligible change in H3K36me3 
(compare lanes 3 and 9 of the H3K36me3 blot), yet the lowest concentration (lanes 1 and 7) 
reveals the decreased H3K36me3 found to occur in the absence of Bur2 (Chu et al., 2006).  
This observation is consistent for these blots regardless of exposure time.
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Figure 4.3:  The abbreviated nuclei preparation method improves detection of histone 
modifications with low  modification abundance or antibody avidity.
In each panel, nuclei were isolated from the indicated strains using the abbreviated nuclei 
method and compared to WCEs of identical strains.  For comparison of antibody 
effectiveness, 60 µg WCE was compared to a range of nuclear extract at 15, 30 or 60 µg.  
The location of H3 is indicated and asterisks indicate a partial N-terminal H3 breakdown 
products detectable in the nuclear extract.  Important to note is that more protease cleavage 
(breakdown product) of H3 is typically observed in nuclei preparations as compared to WCE 
preparations.  For both panels, cell pellets and buffers prepared by K. Kizer, Nuclei 
prepared and blotted by T. Xiao.  (A) WCEs (left) and nuclei (right) were resolved by SDS-
PAGE, transferred to PVDF, and probed with antibodies directed against H3 tri-methyl 
lysine 79 (αH3K79me3) and tri-methyl lysine 4 (αH3K4me3) while an antibody directed 
against the C-terminus of H3 (αH3) was used as a loading control.  (B) WCEs (left) and 
nuclei (right) were resolved by SDS-PAGE, transferred to PVDF, and probed with antibodies 
directed against H3 di-methyl lysine 36 (αH3K36me2) and tri-methyl lysine 36 
(αH3K36me3), with an antibody directed against the C-terminus of H3 (αH3) used as a 
loading control.  Although the abbreviated nuclei extraction method allows for better 
detection when using a poorly performing antibody, it does not appear to provide an 
advantage when the antibody performs sufficiently well in WCE (compare WCE vs. nuclei 
with the H3K36me3 and H3K4me3 antibodies). 
119
BA
WT rtf1∆
W
T
rtf
1∆
WCE Nuclei
H3- αH3K79me3
*
αH3K4me3H3-
αH3
*
H3-
WT set2∆
W
T
se
t2
∆
WCE Nuclei
H3- αH3K36me2
αH3K36me3
*
H3-
αH3
*
H3-
120
 
 
 
 
 
 
CHAPTER 5 
 
 
CONCLUSIONS, CURRENT QUESTIONS, AND FUTURE WORK 
 
 
 
 
 
 
 
 122
5.1 Advances in our understanding of the function of H3K36 methylation 
 The studies presented here, which focused on the yeast methylase Set2, have 
advanced our knowledge of the functions and regulation of histone lysine methylation.  We 
have reconciled a false assumption from an earlier study (Li et al., 2002) regarding the 
region of Set2 responsible for RNAPII interaction.  As described in Chapter 2, our detailed 
mapping of the Set2 C-terminus revealed the presence of the SRI domain and allowed for a 
more careful investigation of the role of Set2-RNAPII interaction on Set2 function.  We have 
advanced our understanding of the repressive effect of H3K36 methylation in transcription 
through observations of RNAPII density changes in the absence of Set2.  Our data 
presented in Chapter 3 have provided insight into the regulation of Set2 function through 
observations of Set2 dependence on Ctk1, Bur1, and Spt6.  Finally, as described in Chapter 
4, we have developed improved methods for the future analysis of histone modifications.   
Concurrent studies from other laboratories 
 As with all scientific endeavors, these studies were not completed in a vacuum.  
Simultaneous discoveries and ideas from other laboratories were crucial in the direction of 
our work.  Collectively, our work along with studies from other groups over the past six years 
has matured investigators’ abilities to examine and understand the roles of histone 
modifications in the regulation of the genetic code.  Following our identification of the SRI 
domain in Set2, two independent publications described the structure of the SRI domain (Li 
et al., 2005b; Vojnic et al., 2006).  These studies confirmed our observations that the SRI 
domain binds to doubly phosphorylated CTD repeats (see Fig. 2.4) and our prediction of an 
SRI domain within the human Set2 homologue (see Table 2.1).  In addition, a separate 
study from our laboratory found that the Set2-RNAPII interaction is functionally conserved in 
the Schizosaccharomyces pombe Set2 homologue (Morris et al., 2005).  The publication of 
large-scale yeast genetic analyses during the course of our work has provided much insight 
into the inter-relationships between various histone modifying enzymes, transcription 
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factors, and other proteins (Krogan et al., 2002b; Krogan et al., 2003b; Schneider et al., 
2004; Wood et al., 2005a; Wood et al., 2005b).  These studies provided the basis for follow-
up investigations to better understand the related functions of these genetically-linked 
proteins including Set2 (Keogh et al., 2005; Laribee et al., 2005; Wood et al., 2005a; Wood 
et al., 2007; Xiao et al., 2005; Xiao et al., 2007; Laribee et al., 2007).   
One of many observations resulting from these screens was the discovery that the 
histone deacetylase (HDAC) Rpd3, and Set2, are required to repress the formation of 
incomplete transcripts at certain loci.  As introduced in Chapter 3.1, these incomplete 
transcripts are the result of transcription initiation from cryptic start sites within the body of 
genes.  Further study revealed that acetylation at H3 lysine 14 (H3K14ac) and H3 lysine 16 
(H3K16ac) allows this defective initiation, which is normally repressed by deacetylation by 
the HDAC Rpd3 (Kadosh and Struhl, 1998).  Rpd3 was found to be a component of two 
distinct complexes, the Rpd3C(S) and Rpd3C(L) complex (Carrozza et al., 2005; Joshi and 
Struhl, 2005; Keogh et al., 2005).  The Eaf3 and Rco1 proteins are distinct to the Rpd3C(S) 
complex, although Rpd3, Sin3 and Ume1 are found within both complexes.  These studies 
revealed that the Eaf3 subunit binds to nucleosomes methylated at H3K36, via its 
chromodomain, and recruits Rpd3C(S).  Through an early phenotypic screen, shown in 
Figure 5.1A, I observed a similarity in function between Set2 and Eaf3 based on a similar 
characteristic 6AU resistance seen in these deletion strains.  My preliminary results were 
confirmed through the thorough studies published by our laboratory and others (Carrozza et 
al., 2005; Joshi and Struhl, 2005; Keogh et al., 2005).  In addition, I found that a RAD6 
deletion strain displays sensitivity to 6AU, in contrast to SET2 deletion (Fig. 5.1B), a result 
that was supported by work from our colleagues that further examined the role of Rad6-
mediated histone H2B ubiquitination in transcription (Xiao et al., 2005).  This study and 
others demonstrated the complexity of the upstream regulation of H3K4 and H3K79 
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methylation, and is a parallel example of the emerging work identifying the regulation of 
H3K36 methylation. 
 
5.2 Deciphering the pathway of regulation for histone methylation 
Links between methylation and RNAPII transcription  
Proper transcriptional regulation by RNAPII is accomplished, in part, through the 
regulated association of a number of factors and complexes.  Key to the proper function of 
RNAPII is the role of the CTD in the association of these regulatory proteins.  Through the 
course of our studies, our laboratory and others have made significant advances in the 
understanding of RNAPII transcription as it relates to histone modifications in yeast.  
Subsequent to our discovery of the SRI domain in Set2, two aforementioned studies further 
characterized the requirement of CTD phosphorylated at both Ser2 and Ser5 of the repeat 
sequence for direct SRI domain binding (Kizer et al., 2005; Li et al., 2005b; Vojnic et al., 
2006).  As illustrated in Figure 5.2, these findings promoted the possibility of Ser5 and Ser2 
phospho co-existence along CTD repeats in a transitory stage between transcription 
initiation and elongation where H3K36 methylation is predominant (Kizer et al., 2005; 
Krogan et al., 2003b; Li et al., 2003; Xiao et al., 2003b).  This doubly-phosphorylated 
RNAPII-CTD state was not expected to be of significant functional relevance based on the 
apparent predominance of either Ser5 or Ser2 phosphorylation alone, at either the promoter 
or 3’ end of most genes, respectively (Gerber and Shilatifard, 2003; Hampsey and Reinberg, 
2003).  Over the past five years, a great deal of evidence has emerged that emphasizes the 
importance of CTD phosphorylation in recruiting proteins involved in the regulation of 
transcription and chromatin structure (for review, see (Phatnani and Greenleaf, 2006).  
Binding to the phosphorylated CTD is crucial for the proper function of a variety of histone-
modifying enzymes such as the H2B ubiquitinating Paf1 complex, Set1-containing 
COMPASS complex and Set2 (Krogan et al., 2003a; Ng et al., 2003a; Shi et al., 1996; 
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Wood et al., 2005b; Krogan et al., 2003b; Li et al., 2003; Li et al., 2002; Schaft et al., 2003; 
Xiao et al., 2003b; Ng et al., 2003b).  
The role of histone methylation in RNAPII transcription must be considered in the 
context of the complex relationship between the maintenance of chromatin structure, control 
of the initiation, elongation and termination phases of transcription, mRNA processing, and 
histone modifications that likely signal for a variety of these processes in ways not yet 
understood.  Examples of this complexity include early observations that suggested the 
passage of transcribing polymerase results in alternations of chromatin structure, dependent 
in part on Spt16 and Pob3 (FACT) (Formosa et al., 2002).  Later it was found that FACT 
removes H2A/H2B dimers in preparation for RNAPII passage, and functions cooperatively 
with H2B ubiquitination via the Paf1 complex to facilitate elongation in a reconstituted 
human chromatin system (Belotserkovskaya et al., 2003; Pavri et al., 2006).  In addition, the 
ATP-dependent chromatin remodeling protein Isw1 was found to coordinate with histone 
methylation by Set1 and Set2 to regulate the release of initiated RNAPII into productive 
elongation (Morillon et al., 2005).  The histone chaperones Spt2 and Spt6, along with the 
elongation factors Spt4 and Spt5 (also known as DSIF) were found to regulate elongation 
through changes in chromatin structure or by regulating RNA-processing events (Hartzog et 
al., 1998; Kaplan et al., 2003; Lindstrom et al., 2003; Nourani et al., 2006; Proudfoot et al., 
2002; Qiu et al., 2006; Wada et al., 1998).  In summary, recent genetic and biochemical 
studies of the CTD and chromatin-modifying enzymes have revealed a functional interplay in 
the preparation of chromatin for RNAPII passage, proper RNAPII initiation and elongation, 
mRNA formation, and then the proper re-establishment of certain histone modifications post-
transcription.  In regard to these processes, a current model of the dynamic role of 
nucleosomes in transcription will be discussed in section 5.3. 
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Upstream regulation of Set2 
Observations from our lab and others that deletion of SET2, or members of the 
Rpd3C(S) complex, bypasses lethality of a BUR1 deletion has revealed clues as to the 
interconnectedness of elongation factors and Set2 (Fig. 3.1, (Chu et al., 2006; Keogh et al., 
2005).  Other connections have also revealed a requirement of Spt6 in H3K36 methylation 
(Figs. 3.2-3.5, (Chu et al., 2006).  Most importantly, these new data give a clearer picture of 
the function and regulation of Set2-catalyzed H3K36 methylation as well as reveal a 
potentially complex network of proteins in the upstream regulation of Set2.  These 
publications, in combination, have led to a new model of the function of Set2 and H3K36 
methylation along genes (Fig. 5.2).  In this model, Set2 binds to the Ser2 and Ser5 doubly-
phosphorylated CTD via the SRI domain and is recruited to active genes.  Set2 is then able 
to methylate nucleosomes that are properly configured by Spt6 and/or other factors may be 
regulated by Bur1 such as Spt2 or Spt4 (see Fig. 3.8 and Fig. 5.2).  Subsequent 
methylation recruits Eaf3 and the Rpd3C(S) for deacetylation and restricts RNAPII from 
initiating at cryptic start sites.   
A greater understanding of the configuration of the RNAPII-CTD has also contributed 
to an updated model of Set2 function along genes.  A recent study demonstrated a mode of 
regulation for H3K36 methylation through the proline isomerase Fpr4.  Fpr4 exhibits control 
over Set2-catalyzed methylation of H3K36 through the isomerization of H3 proline 38 
(Nelson et al., 2006).  This isomerization results in an H3 configuration that is non-
permissive for H3K36me3.  This antagonism, however, was only detected at basally 
transcribed genes, and could be overcome with a high RNAPII density (bringing along Set2) 
that is present at highly active genes.  An additional enzymatic antagonistic relationship with 
Set2 was demonstrated by the identification of acetylation at H3K36 in vivo, catalyzed by 
Gcn5 (Morris et al., 2006).   
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Enzymatic demethylation 
 Histone methylation has long been seen as a stable modification, based in part on 
early data that suggested that methylation was essentially irreversible (Byvoet et al., 1972; 
Duerre and Lee, 1974).  Subsequent analyses of the mammalian H3K9 methylase G9a 
supported this earlier view, based on observations that methylation persists for several 
rounds of cell division even after inactivation of the methylase (Su and Tarakhovsky, 2006).  
Is methylation simply a static modification?  It would seem unlikely that an effective signaling 
mark could exist with only an “on” state?  This question persisted during the course of our 
work, although the mechanism of histone replacement accounted for the positions of histone 
variants during transcription and as a mechanism of essentially “demethylating” a 
nucleosome (Ahmad and Henikoff, 2002; Briggs et al., 2001; Goll and Bestor, 2002; Turner, 
2002).  Concurrent with our studies, a variety of discoveries have been made in the area of 
histone demethylation.  Specifically, multiple demethylase enzymes have been identified 
from yeast to human.  These enzymes appear specific to the demethylation of particular 
methylated residues using functional domains and enzymatic mechanisms.  The human 
enzyme LSD1 is specific for demethylation of mono- or dimethyl H3K4 by a amine oxidation 
mechanism, but is unable to demethylate H3K4me3 (Shi et al., 2004).  A separate class of 
demethylases containing the Jumonji C (JmjC) domain were later identified through which 
demethylation is accomplished through a hydroxylation mechanism (Schneider and 
Shilatifard, 2006; Shi and Whetstine, 2007).  The demethylase JHDM1, and its homologue 
in budding yeast, specifically demethylate H3K36me2 (Tsukada et al., 2006).  While 
JHDM2A demethylates H3K9me2 in humans, the demethylase JHDM3A/JMJD2A can 
remove the trimethyl moiety from H3K9 or H3K36 (Klose et al., 2006; Whetstine et al., 2006; 
Yamane et al., 2006).  Although these enzymes have been confirmed as capable 
demethylases in vivo, examinations of the deletion or over-expression of these enzymes 
revealed only a modest affect on global levels of methylation (Shi and Whetstine, 2007; 
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Tsukada et al., 2006).  This is due at least in part to the specificity of the majority of these 
enzymes for a mono- or di-methylated substrate, and can account for prior difficulty in their 
detection.  As described in Chapter 3, the upstream regulation of methyltransferases is a 
key regulatory pathway for the positioning of the methyl modifications.  As illustrated in 
Figure 5.2, enzymatic demethylation and histone replacement demonstrate additional 
mechanisms for the regulation of H3K36 methylation.  Based on the improvement of 
techniques to detect demethylases in vitro, it is anticipated that additional demethylases, 
such as those responsible for demethylation at H3K79, will be discovered in the near future  
(Schneider and Shilatifard, 2006; Shi and Whetstine, 2007; Trojer and Reinberg, 2006).  
However, we note that the kinetics of H3K79 methylation and its loss in heterochromatin 
formation display marked differences from that of H3K4 methylation.  A study of 
heterochromatin formation in yeast found a more rapid loss of H3K4 methylation from that of 
H3K79 methylation, which more closely represented the rate of cell division (Katan-
Khaykovich and Struhl, 2005).  Therefore, H3K79 may more closely represent the heritable 
epigenetic mark initially attributed to all histone methyl modifications due to their predicted 
stability.   
 
5.3 Distribution of specific histone modification states 
Genome-wide analyses of histones and histone modifications 
 The genome-wide detection of histone modifications has provided significant insight 
as to the distribution of particular modifications, data that is crucial for future work in 
understanding the histone code.  The past five years have seen a dramatic rise in the use 
and effectiveness of microarray in the analysis of histone modifications.  The first genome-
wide analysis of histone modifications in yeast focused on histone deacetylases and the 
genomic regions they target (Robyr et al., 2002).  The principle of microarray analyses 
centers around the presentation of the entire genome (or representation thereof) prepared 
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by the spotting of DNA oligos onto microscopic arrays that are available for binding to 
complementary sequence.  Using a traditional ChIP approach, DNA corresponding to a 
particular protein bound or modified region is amplified by PCR and labeled with fluorophors.  
The enrichment of DNA corresponding to these protein bound or modified states is 
compared to DNA prepared from an appropriate control sample, such as ChIP DNA using 
an unmodified histone antibody, that is labeled with an alternate fluorophore.  These DNAs 
are then hybridized to the microarray chip and enrichment of a particular region along the 
array is measured by the relative intensities of fluorescence at the wavelengths of each 
fluorophore.  This “ChIP-on-chip” approach allows for the genome-wide detection of regions 
where a particular protein binds or where particular histone modifications exist.   
 One of many important genome-wide observations using the ChIP-on-chip approach 
was the reduction in nucleosome density at active promoters.  Prior results revealed a 
decreased nucleosomal density at the PHO5 and GAL promoters upon gene activation in 
yeast (Boeger et al., 2003; Fedor and Kornberg, 1989; Lohr, 1997; Svaren and Horz, 1997).  
These studies focused on specific genes, however, and could not effectively test for 
nucleosomal removal (or shifting) at a genome-wide scale.  Using the ChIP-on-chip 
approach, various investigators found that nucleosomal occupancy at promoters decreases 
in proportion to the rate of transcription initiation (Bernstein et al., 2004; Lee et al., 2004).  
Consistent with this, FACT was shown to remove histone H2A/H2B dimers in the path of 
transcribing RNAPII (Belotserkovskaya et al., 2003).  Further study using high-resolution 
arrays demonstrated that the majority of nucleosomes are positioned in a well organized 
fashion along transcribing genes, while depleted in promoters (Yuan et al., 2005).   
 In regard to H3K36 methylation, several studies have advanced our knowledge of 
the localization of this modification across the genome.  Analysis of the H3K36me2 
modification found this mark to be predominant in the body of genes transcribed by RNAPII.  
This data provided support to existing data that Set2 activity is directed through its 
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association with RNAPII in vivo (Kizer et al., 2005; Rao et al., 2005; Xiao et al., 2005), 
however the genome-wide results revealed that H3K36me2 did not correlate with the rate of 
transcription by RNAPII.  Interestingly, this study revealed that nucleosomes carrying the 
H3K36me2 modification were predominantly retained in highly transcribed genes.  As 
nucleosomes are inhibitory for transcription, this result was consistent with later 
observations of a role for H3K36 methylation in preventing RNAPII initiation at cryptic 
promoters (Carrozza et al., 2005; Joshi and Struhl, 2005; Keogh et al., 2005).   
The ChIP-on-chip approach in yeast continues to be optimized by the preparation of 
higher resolution arrays.  A multitude of other studies were published over the past few 
years using these improved arrays to analyze regions in the genome where specific proteins 
were bound or where certain histone modifications were present.  A later analysis of 
H3K36me3 revealed that this modification, in contrast to H3K36me2, was positively 
correlated with transcription rates (Pokholok et al., 2005).  These results, in combination with 
other studies of H3K36 and H3K4 methylation, demonstrate the existence of distinct 
mechanisms by which modification states are regulated and function in transcription (Chu et 
al., 2006; Wood et al., 2005a; Wood et al., 2005b; Wood et al., 2007).   
Taken together, genome-wide studies of histones and histone modifications in yeast 
have supported gene-specific analyses by ChIP and global analyses by western blot that 
demonstrate a correlation between histone modifications and transcription.  A variety of 
recent genome-wide studies in yeast have solidified three key points: 1) histone acetylation 
and methylation are correlated with active transcription (Kurdistani et al., 2004; Liu et al., 
2005; Pokholok et al., 2005; Rao et al., 2005; Xu et al., 2005), 2) histone deacetylases and 
histones themselves are often negatively correlated with transcription (Kurdistani et al., 
2002; Lee et al., 2004; Robyr et al., 2002), while 3) histone variants (i.e. Htz1) are usually 
correlated with active transcription (Millar and Grunstein, 2006; Zhang et al., 2005).  
Interestingly, as in the case of H3K36me3 functioning to repress cryptic initiation, a positive 
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correlation between a particular modification and transcription does not necessarily indicate 
a modification positively influences transcription.  Indeed, the role of histones and histone 
modifications in transcriptional regulation is a complex ‘code’ that will only be understood by 
high resolution genome-wide studies, in combination with biochemical and genetic analyses.  
Genome-wide studies of histone modifications, however, demonstrate that the location and 
density of histone modifications only correlate, and not exactly predict, the transcriptional 
state of a particular gene.  It is most likely that histone modifications are only one 
component of a complex cross-communication between nucleosomal structure, DNA 
sequence, and histone modifications that allow for transcriptional regulation as a collective 
‘code’. 
Distribution of specific histone modification states at a typical gene 
Recent insight into the interaction between RNAPII and chromatin modifying 
machinery has revealed one mechanism by which specific histone modification states are 
regulated.  The specific modification states at a particular histone residue (e.g. H3K4 mono-, 
di-, and tri-methylation) were predicted to be independently regulated and to signal for 
specific downstream functions (Schotta et al., 2004; Turner, 2003).  This hypothesis 
continues to be supported by recent studies, including observations of the selective 
regulation of H3K4me3 by Bur1 and the Ccr4/Not complex (Laribee et al., 2005; Laribee et 
al., 2007) and H3K36me3 by Bur1 (Chu et al., 2006).  The complexity of transcriptional 
regulation and histone modifications is further emphasized by a recent study of the CTD 
kinase, Ctk1 (Wood et al., 2007; Xiao et al., 2007).  Deletion of CTK1 results in a near 
abolition of H3K4me1, with a corresponding increase in H3K4me2 and H3K4me3 into the 
body of genes.  Results from this study suggested that Ctk1 serves to maintain the 
configuration of suppressive chromatin by regulating H3K36 methylation (a mark associated 
with the repression of initiation) and preventing the spread of H3K4me3 into the body of 
genes (a modification linked to transcription initiation).  Over the past five years, our 
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knowledge of the locations of chromatin modifications has grown from a general knowledge, 
to a more genome-wide and gene-specific scale.  In summary, the distributions of specific 
histone modification states along a typical gene suggest a direct link to the various stages of 
RNAPII transcription, as illustrated in Figure 5.3.  However, a crucial question is illustrated 
well in a recent review that notes the complexity of histone modifications and the apparent 
dilemma from observations that histone modifications respond to changes in gene function, 
rather than predict them, and could potentially mask a more predictable, but as-yet, 
undetected epigenetic code (Nightingale et al., 2006). 
Recently identified histone modifications and binding proteins in yeast 
 As we return our focus to considering histone modifications on a broader scope, it is 
relevant to consider the newly identified histone modifications in yeast, as well as 
discoveries in the binding domains that link functionality to these marks.  Several new post-
translational modifications in yeast have been identified since our work began.  Perhaps the 
most relevant to our work was the identification of H3K36 acetylation by Gcn5, which may 
antagonize Set2-catalyzed H3K36 methylation (Morris et al., 2006).  The increasing use of 
mass spectrometry as a tool for the analysis of post-translational modifications on specific 
proteins has allowed the identification new histone modifications such as acetylation at 
H3K56 in yeast (Hyland et al., 2005; Masumoto et al., 2005; Xu et al., 2005).  Acetylation at 
H3K56 represents another post-translational histone modification, like H3K79 methylation, 
that is found within the globular domain rather than the N- or C-terminal tail.  Initial results 
indicate that this modification, as with H3K79me3, H3K4me3, and many chromatin 
remodeling enzymes, is involved in the DNA damage response (Feng et al., 2002; 
Masumoto et al., 2005; Ng et al., 2002; Osley and Shen, 2006).  Additional work revealed 
Rtt109 as the HAT responsible for catalyzing H3K56 acetylation (Driscoll et al., 2007), 
although additional studies also found this HAT activity to be largely dependent on the 
histone chaperone Asf1 (Adkins et al., 2004; Adkins et al., 2007; Natsume et al., 2007; 
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Prado et al., 2004; Schwabish and Struhl, 2006).  It is interesting to consider a potential 
pattern illustrated between Asf1-Rtt109 and Spt6-Set2, that reveals a requirement for proper 
nucleosomal configuration by a specific histone chaperone (Asf1 or Spt6) prior to the 
addition of a particular histone modification (Rtt109 and H3K56ac or Set2 and H3K36me).  
Furthermore, the application of mass spectrometry allows the identification of low-
abundance modifications that may have a functional role in vivo, such as the detection of the 
monomethylated species at H3K9 and H4K20 in budding yeast (Garcia et al., 2006).  These 
modifications were previously not considered to be conserved in budding yeast as 
compared to multi-cellular eukaryotes.  Based on these and other recent reports, a revised 
illustration of the histone H3 modifications currently known to exist in yeast are presented in 
Figure 5.4A.   
The recent identification of new binding proteins that target specific histone 
modifications, illustrated in Figure 5.4B, allows for a better understanding of the 
downstream functions of these post-translational marks.  Experiments in mammalian 
systems had already identified bromodomains and chromodomains as binding to acetylated 
or methylated lysine residues, respectively (Bannister et al., 2001; Dhalluin et al., 1999; 
Lachner et al., 2001; Nakayama et al., 2001).  However, it remained to be established 
whether chromodomain or bromodomain-containing proteins in yeast would demonstrate the 
same binding specificity.  This question was addressed in part through studies discussed 
earlier, that identified the Rpd3C(S) member, Eaf3, as recognizing H3K36me3 and binding 
via its chromodomain (Carrozza et al., 2005; Joshi and Struhl, 2005; Keogh et al., 2005).   
Therefore, specific downstream functions in transcription are communicated through the 
recognition of modified histone residues, as predicted by the histone code theory.  Studies 
over the past two years of the mammalian lysine demethylase JMJD2A revealed it to contain 
a double Tudor domain, which was capable of recognizing H3K4me2 for subsequent 
demethylation (Huang et al., 2006).  Later, the plant homeodomain (PHD) region was found 
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to recognize modified histones, resulting in the recognition of methylated histone residues, 
such as H3K4 methylation by the PHD domain of mammalian Ing2 (Li et al., 2006; Pena et 
al., 2006; Shi et al., 2006; Wysocka et al., 2006).  Examination of all the PHD-containing 
proteins in yeast later revealed this domain to recognize either H3K4me3 or H3K36me3 
residues (Shi et al., 2007).  The cross-talk functions of various histone modifications is 
illustrated by the PHD domain-functionality in the yeast proteins Yng1 and Nto1 (reviewed in 
(Mellor, 2006b).  As components of the NuA3 acetyltransferase complex, Yng1 and Nto1 
bind to H3K4me3 and H3K36me3 (weakly) via their PHD domains, which allows subsequent 
NuA3 association with chromatin (Martin et al., 2006b; Martin et al., 2006a; Shi et al., 2006).    
Analysis of SET2 null cells and point mutations at H3K36 revealed that Set2 is 
required to prevent the spreading of silenced chromatin from the mating locus HMRa and 
telomeric regions (Tompa and Madhani, 2007).  Unexpectedly, deletion of Rpd3C(S) 
members did not display this effect, indicating that the role of H3K36 methylation in 
preventing the spread of silenced chromatin is independent of Eaf3 binding and subsequent 
effects by Rpd3-mediated histone deacetylation (Tompa and Madhani, 2007).  Most 
importantly, recent work has further demonstrated the wide variety of functional 
consequences for other sites of histone methylation.  The modifications within the histone 
H3 globular domain, H3K56 acetylation and H3K79 methylation, are linked to cell-cycle 
control through regulation of the DNA damage response (Adkins et al., 2007; Feng et al., 
2002; Green et al., 2005; Masumoto et al., 2005; Natsume et al., 2007; Schwabish and 
Struhl, 2006).  In summary, recent studies of yeast histone modifications and their 
downstream functions has advanced our understanding of the mechanisms through which 
the histone code allows signaling for downstream processes in transcriptional regulation and 
the maintenance of DNA integrity.  However, turning our focus from studies of specific 
histone modifications to the level of nucleosomes will best illustrate the current directions in 
the study of chromatin structure and function. 
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5.4 Nucleosome dynamics and consequences in transcription 
Mechanisms effecting nucleosome dynamics 
 Histone-DNA interactions compose one of the most stable protein-DNA complexes, 
yet alterations in these interactions result in nucleosome displacement, re-positioning, or 
conformational changes.  These nucleosome dynamics are a crucial component of 
transcriptional control (Kouzarides, 2007; Li et al., 2007; Mellor, 2006a; Workman, 2006).  
To describe the regulation of nucleosome structure and positioning in all eukaryotes, we 
consider four key components that are responsible for the control of these processes. 
The first component is the ATP-dependent nucleosome remodeling family of 
proteins, such as Swi/Snf, RSC, Chd1, and Isw1 (Lorch et al., 2006).  The chromatin 
remodeling proteins allow the displacement of nucleosomes from DNA, and in particular, 
from promoter DNA (Kouzarides, 2007; Li et al., 2007; Mellor, 2006a; Workman, 2006).  The 
mechanism for this displacement is thought to be by forcing bulges of DNA into the 
nucleosome that, through cooperation with various transcription factors, results in a 
destabilizing effect on the nucleosome-DNA interaction (Cairns, 2005; Lorch et al., 2006).   
Nucleosome displacement, or destabilization of nucleosomes through removal of 
H2A-H2B dimmers, appears to occur primarily at the promoter of active genes and upstream 
of the transcribing polymerase (Mellor, 2006a; Workman, 2006).  This process is facilitated 
by the second key component in the control of nucleosome dynamics, the histone 
chaperone proteins.  Histone chaperone proteins, such as Asf1, Spt2, Spt6, and FACT, 
function as histone sinks by which a new or displaced nucleosome is held nearby for 
reassembly post-RNAPII passage (Kouzarides, 2007; Li et al., 2007; Lorch et al., 2006; 
Mellor, 2006a; Workman, 2006).  Histone chaperones also appear to reconfigure the newly 
re-assembled nucleosome in a fashion compatible for subsequent histone modification.  
Examples of this process include the aforementioned Spt6-Set2 and Asf1-Rtt109 
relationships (see Chapter 3) through which the histone chaperone (in these examples: Spt6 
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or Asf1) work in concert with a histone modifier (Set2 or Rtt109) to allow a specific 
subsequent modification (Adkins et al., 2007; Natsume et al., 2007).   
The configuration of nucleosomes also involves incorporation of the histone variant 
H2A.Z (Htz1), the third component in the control of nucleosome positioning.  Recent 
genome-wide studies of H2A.Z localization found that this variant is enriched in silent 
promoters, while it is depleted in the promoters of active genes (Guillemette et al., 2005; Li 
et al., 2005a; Raisner et al., 2005; Workman, 2006; Zhang et al., 2005).  Although 
unmodified H2A.Z is displaced at promoters upon gene activation, H2A.Z that is acetylated 
at lysine 14 is retained (Millar et al., 2006).  Additional studies revealed that acetylation at 
H4K16 is required for H2A.Z incorporation near silent chromatin at telomeres, contributing to 
the mechanism by which heterochromatin spreading is controlled (Shia et al., 2006).   
The influence of acetylation on the incorporation of H2A.Z within nucleosomes 
demonstrates the importance of the fourth mode of nucleosomal regulation: histone 
modification.  As described extensively in this report, histone modifications can signal for the 
recruitment of a variety of transcription factors or other histone modifying enzymes.  As 
discussed in recent reviews (Kouzarides, 2007; Li et al., 2007; Mellor, 2006a; Workman, 
2006), histone modifications, in coordination with ATP-dependent remodeling activities, may 
delineate a transcriptional clock through which progression through the cycles of 
transcription is directed.  This process may also be cell-cycle regulated, as multiple histone 
modifications are implicated in the regulation of DNA repair activities and inhibition of 
transcription to allow proper repair (Osley and Shen, 2006).  Rather than repeating the many 
influences of histone modifications in transcriptional regulation, it is important to highlight the 
fact that histone modifications are only one component influencing nucleosome dynamics.   
While nucleosome depletion is generally observed only at active promoters, specific 
studies have revealed that nucleosomes are depleted within highly active genes, such as 
the induced GAL or heat-shock genes (Lee et al., 2004; Zhao et al., 2005).  In addition, 
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observations of multiple promoters and genes across several species have revealed 
significant differences in the order in which histone modifications, chaperones, and 
remodeling factors appear (Mellor, 2006a).  These results demonstrate a current principle 
girding the field of chromatin structure and function: nucleosomal changes are likely specific 
to any given gene, therefore we cannot make a generalized set of rules that will predict 
when certain combinations of histone modifications or nucleosomal changes will occur for 
any gene.  The complexity of gene regulation is clearly a topic with room for further 
investigation and discovery.  Most importantly, studies in this area continue to yield results 
applicable to the treatment of human disease.  
Newly discovered links between chromatin function and human disease 
 Extensive evidence regarding the mechanism of carcinogenesis indicate that 
malignant cells selectively manipulate histone modifying and chromatin remodeling 
enzymes, thereby altering normal nucleosomal structure or positioning, and result in 
increased cell proliferation, altered differentiation, and the evasion of apoptosis (Dey, 2006).  
Histone acetylation, in particular, has been implicated in carcinogenesis although the 
mechanism for this process is only now becoming understood.  HDAC inhibitors are known 
to inhibit the growth of tumor cells, in part through their ability to reactivate the expression of 
tumor suppressor genes (Johnstone, 2002).   The HDAC inhibitor compounds display a 
remarkable tumor specificity, although the reason for this specificity are not well understood 
(Marks et al., 2004).  Interestingly, in a study examining the mechanism by which HDAC 
inhibitors act in the treatment of solid malignancies, investigators found that HDAC inhibitors 
diminish the demethylase activities at H3K4.  This interesting observation links histone 
demethylase and deacetyase enzymes in the potential treatment of solid malignancies.  
(Lee et al., 2006).  In addition, a newly discovered link between histone acetylation and 
phosphorylation in yeast revealed a series of histone modification reactions that promote a 
cellular switch from proliferation to cell death.  Histone phosphorylation and subsequent 
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chromatin condensation has been linked to apoptosis in human cells.  A recent report 
demonstrated that deacetylation of H2B lysine 11 in turn mediates H2B serine 10 
phosphorylation, thereby promoting cell death (Ahn et al., 2006).   
A study into the mechanism of pathogenesis for Huntington’s disease revealed that 
the H3K9 methylase ESET is highly expressed in patients or transgenic mice with the 
disease, with a corresponding increase in the level of H3K9me3 (Ryu et al., 2006).  This 
study also revealed that transcriptional activators responsible for ESET expression were 
elevated in neuronal cells.  Examination of the anti-tumor antibiotic mithramycin revealed 
that this drug interferes with the transcriptional activation of ESET, resulting in a 
corresponding decrease of H3K9me3 in neuronal cells and a 40% increase in survival of 
transgenic mice (Ryu et al., 2006).  These data further established the role of mis-regulated 
histone modifications in cancer and other human disease (see Chapter 1.3).  The recent 
data linking histone modifications to human disease demonstrate the functional interplay 
between histone modifications such as acetylation, methylation, and phosphorylation.  The 
pathways regulating histone modifications must be better understood in order to more 
directly treat specific human cancers. 
 
5.5 Unanswered questions and future work 
Specific questions remaining regarding Set2 regulation 
 Studies from our laboratory (presented in Chapters 1-4) and others (highlighted in 
Chapter 5) have significantly advanced our understanding of histone methylation in yeast, 
specifically methylation at H3K36.  This advancement has also revealed a series of new 
questions regarding Set2 and H3K36 methylation that remain to be answered through future 
work.  In Chapter 2, we described our study of the Set2 domain structure and identification 
of regions which were shown (SRI domain) or suggested (coiled-coil motif) to have important 
roles in Set2 function.  Further study of the potential role of the coiled-coil or other regions in 
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Set2 is necessary to better understand the regulation and function(s) of this 
methyltransferase.  Future work in this area could include: 1) testing whether the coiled-coil 
motif is responsible for protein-protein interactions between Set2 and other factors, relevant 
to Set2 function, and 2) further study of the domain structure of Set2 to determine 
mechanisms that may influence the stability of the protein.  A careful analysis of the stability 
of Set2 and mechanisms which control this stability are important avenues of future study 
based on evidence that mutation or deletion of certain transcription factors, such as Spt6 
and Ctk1, influences the protein level of Set2.   
 In addition to further work focusing on the domain structure of Set2, a more in-depth 
investigation into the roles of Bur1, Ctk1, and Spt6 control on Set2 methylation may reveal 
novel mechanisms through which Set2 and other methyltransferases are regulated.  
Specifically, future work in this area should first involve a careful test of our model of Bur1, 
Spt6, and Ctk1 influence on Set2 (see Chapter 3).  Either support or a rebuke of our model 
will ultimately increase our understanding of how transcription factors coordinate with Set2 
to influence the transcription process.  Our model should be further tested through a genetic 
and biochemical approach in order to determine the pathway though which Set2 protein and 
subsequent H3K36 methylation is regulated.  For example, will further work support the 
pathway in which Ctk1 regulates Spt6 recruitment to genes, while Spt6 in turn targets 
nucleosomes for proper configuration for recognition by Set2?  In regard to the role of Bur1 
in the regulation of histone modifications, the candidate protein Spt2, which has similar 
functions to Spt6, should be examined to determine whether Bur1 may regulate Spt2, and in 
turn influence nucleosome conformation in a manner similar to Spt6.  
A second example of future work relevant to advancing our understanding of the 
regulation of Set2 involves studying the dynamics of Set2 association with RNAPII and 
chromatin.  As has been explored in the case of the enzyme responsible for H2B 
ubiquitination, Rad6 (Xiao et al., 2005), knowing the kinectics of a transcription factor’s 
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association with RNAPII provides for a clearer understanding of the factor’s role in 
transcription, as well as the regulation of this factor’s influence.  In regard to Set2 and the 
duration of its interaction with RNAPII, is Set2 always associated with the transcribing 
polymerase during each round of transcription?  Alternatively, is Set2 associated only with 
the pioneering round of transcription, as apparently seen with Rad6 (Xiao et al., 2005)?  To 
address this new question, we began preliminary studies in which we monitored the 
association of Set2 at the FMP27 gene by ChIP, at various time points after induction or 
after induction was terminated.  For this experiment, we used a strain containing a GAL 
promoter flanking the FMP27 gene, which was a kind gift from K. Struhl and prepared 
according to their published method (Mason and Struhl, 2003).  Our preliminary results 
presented in Figure 5.5 indicate that Set2 is associated with the active FMP27 throughout 
the gene’s transcription, and not simply when the gene is first induced, as with Rad6.  A 
further study of the kinetics of Set2 recruitment and H3K36 methylation on genes could 
allow for a greater prediction of what proteins may be involved in proper targeting of Set2 to 
genes.  For example, is H3K36me3 removed by demethylases when a gene is turned off, or 
do methylation levels decrease primarily due to effects of histone exchange?  In the 
absence of H3K36me3, what are the effects of cryptic transcription at the yeast homologues 
of oncogenes?  Ultimately, these specific questions regarding Set2 can lead to broader 
applications such as the development of new treatment options in humans – especially 
those linked to defects in histone methylation as described in Chapter 1.3 and 5.4.  
The Big Picture: broad questions and applications regarding histone modifications 
 Although our work has focused largely on a single methyltransferase in yeast, the 
collective studies of histone modifications and gene regulation in yeast are important to 
understanding the recently completed human genome project, as well as applications in 
treating human disease.  Importantly, significant links have been established between 
various histone modification activities and the cell cycle (Millar and Grunstein, 2006).  
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Histone modifications, the DNA damage response, and certain growth-regulating genes are 
influenced, or controlled by various stages of the cell cycle.  How will the improper regulation 
of histone modifications affect cells that are already carrying damaged DNA?  It is possible 
that a clearer understanding of the interplay between histone modifications and cell cycle 
control in cancer cells would allow for the development of drugs to re-order these 
modifications and control tumor progression.  Significant headway in this area has already 
been made in the case of HDAC inhibitors, as described in Section 5.4. 
 Taken together, existing studies in yeast and humans emphasize that the 
maintenance of nucleosomal positioning and conformation is largely responsible for 
downstream effects in histone modification and gene expression or repression.   Increasing 
evidence suggests the coordination of chromatin remodeling activities, such as FACT, Spt6, 
Spt2, and Asf1, with histone modifications such as H3K4, H3K36 methylation, and H3K56 
acetylation (Adkins et al., 2007; Belotserkovskaya et al., 2003; Biswas et al., 2006; Chu et 
al., 2006; Nourani et al., 2006; Pavri et al., 2006) is a component of the regulation of 
nucleosomal structure.  Further study in the interplay between nucleosome conformation 
and histone modification activities may allow for accurate predictions of the extent and type 
of histone modifications present on a given gene, as well as their effects.  Ultimately, 
significant advancement in our understanding of these areas could allow for the monitoring 
of the proper nucleosomal structure and gene expression in particular cancer cell lines, 
resulting in the development of drugs or techniques to realign these mechanisms.   Most 
scientific investigations are interesting at the individual experiment level, but the greatest 
excitement comes when research leads to improvements in human health and our 
stewardship of it.  
Figure 5.1: Deletion of RAD6 results in sensitivity to 6AU, while EAF3 or SET2
deletion display resistance.
(A) Based on existing genetic data (Krogan et al., 2002b; Krogan et al., 2003b), several 
gene deletions in the BY4741 background were tested for similar 6AU phenotypes as SET2
deletion.  Deletion strains were plated on synthetic dextrose-uracil medium with or without 
6-azauracil (6AU, 100 µg//ml) and grown at 30°C for 2 to 3 days to monitor for transcription 
elongation phenotypes as in Figure 2.6.  The DST1 deletion strain is a positive control for 
6AU sensitivity.  (B) A RAD6 deletion in an H2B-Flag tagged strain was tested for growth on 
6AU as in panel A.  All strains contained the plasmid pRS316 expressing the URA3 gene, 
except yeast strain YCB647, which contains an integrated URA3 gene.
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Figure 5.2:  Current model of Set2 function along genes.
The binding of Set2 via the SRI domain to the hyperphosphorylated CTD (at Ser2 and Ser5 
positions) is shown in this current model of Set2 function.  A downstream function of 
H3K36me3 in recruiting Eaf3 and the Rpd3C(S) is illustrated in the body of the example 
ORF.  The upstream regulatory proteins required for Set2 function along genes, Ctk1 and 
Spt6, are indicated at the top.  Also displayed is the possible demethylation of H3K36me3 
by JMJD1 and isomerization of H3P38 by Fpr4, which function to limit H3K36me3 as 
described in the text.  Image designed by Brian Strahl and used with permission.
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Figure 5.3:  Relative distributions of histone methylation and acetylation at active 
genes.
A schematic representation of an a typical actively transcribing gene is shown, with the 
promoter, coding, and intergenic regions indicated. The extent of modification at H3K4, 
H3K36, H3K79, H3K9, and H3K14 are shown. The level of modification is depicted by the 
height of the colored shape.  For example, H3K4me3 is most enriched at the 5' end of active 
genes, whereas H3K36me3 is found in increasing amounts at the 3' end of the coding 
region.  Data used to compile this figure was obtained from various gene-specific and 
genome-wide studies (Millar and Grunstein, 2006; Pokholok et al., 2005; Rao et al., 2005; 
Wood et al., 2007; Xiao et al., 2007).  Adapted by permission from Macmillan Publishers 
Ltd: Nature Reviews in Molecular Cell Biology, Millar, C., and Grunstein M., Genome-wide 
patterns of histone modifications in yeast., Volume 7, Copyright 2006
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Figure 5.4:  Current depiction of yeast histone H3 post-translational modifications, 
binding proteins, and  related enzymes.
(A) Illustration of currently identified histone H3 post-translational modifications found in 
yeast, along with the enzymes that catalyze or antagonize these modifications.  Newly 
identified modifications are indicated in green and are complied from recent reports 
(Carrozza et al., 2005; Garcia et al., 2006; Hyland et al., 2005; Joshi and Struhl, 2005; 
Keogh et al., 2005; Martin et al., 2006; Morris et al., 2006; Natsume et al., 2007; Nelson et 
al., 2006; Shi et al., 2006).  (B) Indicated here are the current proteins known to bind to H3 
residues in a modification-dependent manner.  Adapted from TRENDS in Genetics, Volume 
22, Mellor, J., Dynamic nucleosomes and gene transcription, 320-329, Copyright 2006, with 
permission from Elsevier (Mellor, 2006).
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Figure 5.5: Set2 is associated with an active gene through each round of 
transcription.
(A) The GAL-FMP27 yeast strain was analyzed by chromatin immunoprecipitation (ChIP) to 
determine the relative enrichment of RNAPII or Set2 on chromatin at the FMP27 gene 
during induction with galactose, using the 8WG16 antibody (RNAPII) or the Set2 antibody 
(described in Section 3.2).  Individual cell pellets were collected before or after galactose
induction at the indicated timepoints, and ChIP was performed as for Fig. 2.6C.  The DNA 
isolated from each IP was analyzed in PCR reactions using primer pairs for the indicated 
regions of the FMP27 gene or an intergenic region at chromosome V (ChV), used as a 
loading control in all PCR reactions.  The histogram displays the relative enrichment values 
of RNAPII or Set2, calculated by dividing the ratio of band intensities for IP DNA/ChV with 
the ratio of intensities for the Input DNA/ChV.  (B) The unaltered GAL-FMP27 yeast strain 
(F-WT) or one in which SET2 was deleted (F-set2∆) was analyzed as in (A), but with GAL 
induction terminated through addition of dextrose.  The relative enrichment of RNAPII or 
Set2 at the FMP27 gene was determined as in (A), using individual cell pellets collected 
after induction shut-off for the indicated durations.  The enrichment of Set2 displayed at the 
promoter and 4kb region in the case of SET2 deletion is likely an error in the particular PCR 
reaction, as these initial data were obtained from only one experiment.  The GAL-FMP27 
strain was a kind gift from K. Struhl and prepared according to their published method 
(Mason and Struhl, 2003).
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